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ABSTRACT 
The goals of this dissertation research were to develop an integrated 
computational and experimental platform for characterizing protein isoforms and post 
translational modifications (PTMs) in microbial systems by top-down FT-ICR mass 
spectrometry.  To accomplish this goal, we employed methodologies of microbial 
growth, intact protein and protein complex extractions, followed by sample preparation 
and then progressed to identification of the instrumentation needed to integrate the top-
down and bottom-up proteomics methodologies used in these studies. Emphasis is placed 
on the development of integrated top-down and bottom-up informatics and the challenges 
faced in the integration of these two large mass spectrometry data sets and extraction of 
relevant biological data. We then illustrate how top-down and bottom-up methods can be 
applied to the analysis of complex protein mixtures, protein complexes, and microbial 
proteomes. Through the work of this dissertation we have contributed to the advancement 
of top-down proteomics by providing an experimental platform which will aid in the 
analysis of intact proteins and their associated PTMs and isoforms, as well as providing a 
computational method that allows for the integration of top-down and bottom-up data 
sets.  
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Chapter 1 
 
Introduction to the Analysis of Intact Proteins and PTMs in Microbial Systems by 
Mass Spectrometry 
Some of the text presented below has been published as Nathan C. VerBerkmoes, Heather 
M. Connelly, Chongle Pan, and Robert L. Hettich, Mass Spectrometric Approaches to 
Characterizing Bacterial Proteomes. Expert Review in Proteomics (2004), 1, 433-445. 
 
The large amounts of information generated in the genomics era have begun to 
reveal the complexities of microbial systems.  For example, complete genome sequence 
reveals the blueprint for life, in that it includes all information about the genes and gene 
products used by the organism for all of its life functions. This level of global genome 
information about an organism now makes it possible to begin to pursue an integrated 
approach to understanding how these organisms live and function by cataloging and 
understanding all of the biological components, their functions, and all of their 
interactions in a living system and communities of living systems [1]. A natural extension 
of genomics (the study of the complete set of genes for an organism) research is the 
characterization of the gene products, most of which are proteins. This latter research 
area is defined as proteomics (the study of the entire suite of proteins from a genome). 
Proteome analyses, whether in simple microbes, yeast, or higher organisms, present a 
much greater challenge than the genomics sequencing efforts. While the genome is 
relatively static, the proteome is very dynamic. The genome generally contains a set 
number of copies of every gene; however, proteins in the proteome can be expressed in a 
wide concentration range, varying from only a few copies per cell for regulatory proteins 
to many thousands per cell for ribosomal subunits.  
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Proteins are complex 3D structures, which constitute the machinery of a cell and 
at any time point perform the structural, catalytic, and signaling processes critical to 
cellular life. To aid in these complex processes, proteins often contain post translational 
modifications (PTMs); more than three hundred of these modifications have been 
identified to date [2].The term post translational modification (PTM) refers to 
modifications that occur during or after translation of the polypeptide chain.These post 
translational modifications are important to provide protein heterogeneity, thereby 
allowing a protein to exist in multiple isoforms.  Most proteins must be modified in one 
or more of a number of ways with PTMs before they achieve their final functional form.  
PTM categories include: (a) covalent modifications such as phosphorylation, 
methylation, and glycosolation; (b) proteolytic processing e. g., the removal of signal and 
or pre-peptide sequences; (c) nonenzymatic modifications including deamidation and 
racemization. Some common modifications found in bacteria and therefore addressed in 
this study include: N-terminal methionine truncation, acetylation, methylation, 
phosphorylation, and the removal of signal sequences.  
The first of these modifications is the N-terminal methionine truncation, in which 
the N-terminal residue of the newly-synthesized protein is modified in bacteria to remove 
the formyl group.  The N-terminal methionine may also be removed by certain 
methionine aminopeptidases. The truncation of the N-terminal methionine depends on the 
charge and size of the amino acid side chain occupying the next position from the N-
terminal methionine.  The truncation event follows what is known as the “N-end rule”.  
This rule states that residues bearing small uncharged side chains, such as alanine, which 
are considered stable, allow docking of methionine peptidases that cleave the N-terminal 
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methionine[3]. Also, there are approximately 12 destabilizing residues, according to the 
“N-end rule”, that mark the protein for degradation by ubiquitin ligase.  Therefore, 
biologically the truncation may relate to the half-life of the protein.. 
 In the case of acetylation, the amino-terminal residues of some proteins are 
acetylated, as well as lysines and arginines within the protein sequence. The biological 
significance of amino-terminal modification varies; some proteins require acetylation for 
function whereas others that are acetylated do not absolutely require the modification. It 
is possible that only a subset of proteins actually requires this modification for activity or 
stability, whereas the remainders are acetylated only because their termini fortuitously 
correspond to consensus sequences. Proteins with serine and alanine termini are the most 
frequently acetylated, and these residues, along with methionine, glycine, and threonine, 
account for over 95% of the amino-terminal acetylated residues [4, 5]. Only a subset of 
proteins with any of these amino-terminal residues are acetylated, however, none of them 
guarantees acetylation [6]. The complexity of the termini that are acetylated is due to the 
presence of multiple N-acetyltransferases (NATs), each acting on different groups of 
amino-acid sequences and whose specificity is determined by two or more residues at the 
amino-terminal positions [7]. Amino-terminal acetylation does not necessarily protect 
proteins from degradation, as has often been supposed, nor does it play any obvious role 
in protection of proteins from degradation by the 'N-end rule' pathway that determines 
whether to degrade proteins according to their amino-terminal residue.   
The second common class of modifications includes amino acid side chain 
modifications. Common examples of these side chain modifications include methylation, 
acetylation, and phosphorylation. Methylation is an example of a common PTM found 
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primarily on lysine and arginine. These two residues have very polar side chains that are 
positively charged.  When these residues are blocked by a methylation, the basic nature 
of that site within the protein can be changed, thereby making it more or less accessible 
to other protein targets. Also, when the basic nature of lysine and arginine are changed, it 
may serve to alter the protein structure. Many proteins have conformations that are pH 
dependent, and when altered unfold or fold in a new configuration; methylation may play 
a role in this process.  Finally, within this class of side chain modifications is 
phosphorylation.  Phosphorylation of proteins (at Ser, Thr, Tyr and His residues) is an 
important regulatory mechanism.  For example, phosphorylation of tyrosine residues is 
an important aspect of signal transduction pathways, and bacterial cells sense and 
respond to environmental signals through histidine phosphorylation [8]. The final 
category is proteolytic processing, or the removal of signal and or pre-peptide sequences. 
As a protein is being synthesized, decisions must be made about sending it to the correct 
location in the cell, where it will be required. The information for doing this resides in the 
nascent protein sequence itself. Once the protein has reached its final destination, this 
information may be removed by proteolytic processing. This class of proteins all contains 
an N-terminus termed a signal sequence or signal peptide. The signal peptide is usually 
13-36 predominantly hydrophobic residues, flanked on the N-terminal side by one or 
more positively charged amino acids such as lysine or arginine, and containing neutral 
amino acids with short side-chains (such as glycine or alanine) at the cleavage site. The 
signal peptide is recognized by a multi-protein complex termed the signal recognition 
particle (SRP). As proteins with signal sequences are synthesized, they are bound by the 
SecB protein. This prevents the protein from folding. SecB delivers the protein to the cell 
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membrane where it is secreted through a pore formed by the SecE and SecY proteins. 
Secretion is driven by the SecA ATPase. After the protein has been secreted, the signal 
sequence is removed by a membrane bound leader peptidase [9]. 
Understanding these complex PTMs is often a difficult task.  However, 
difficulties exist, progress has been made toward identifying PTMs across multiple 
microbial species.  One of the major goals of this dissertation was to develop methods for 
the identification of PTMs from microbial species under multiple growth conditions 
(Chapter 7).  The two chosen species include Rhodopseudomonas palustris and 
Escherichia coli.  Rhodopseudomonas palustris belongs to the α- proteobacteria and is a 
purple nonsulfur anoxygenic phototrophic bacterium found in diverse environments from 
fresh water to soil. One of the unique features of R. palustris is its ability to grow and 
function under many metabolic states. These states include: photoheterotrophic, where 
energy is obtained from light and carbon from organic carbon sources; photoautotrophic, 
where energy is from light and the main source of carbon is from carbon dioxide; 
chemoheterotrophic, in this state carbon and energy are from organic compounds; and 
finally chemoautotrophic, where energy is from inorganic compounds and carbon from 
carbon dioxide [10, 11, 12].  These multiple growth states provide the wild type R. 
palustris (strain CGA0010) with the ability to be a biofuel producer by generating 
hydrogen gas as a byproduct of nitrogen fixation, as well as a greenhouse gas sink by 
converting carbon dioxide into cell mass.   
Since most of these metabolic states can easily be attained in laboratory settings, 
R. palustris is an ideal model system for the study of diverse metabolic modes and their 
control within a single organism. Recently, the genome of R. palustris has been 
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sequenced, revealing a 5.4 Mb genome with 4836 potential protein encoding regions 
[13]. This sequencing and annotation effort, along with proteome profiling [121], protein-
protein interaction studies, global gene knockouts [14], and transcriptome profiling [15] 
will provide a detailed systems biology characterization of this microbe.  
The second microbe chosen for study was Escherichia coli. This microbe is a γ-
proteobacteria and found commonly as a facultative anaerobe that colonizes the lower gut 
of animals but also survives when released into the environment.  E. coli are rod-shaped 
bacteria that possess adhesive fimbriae.  Escherichia coli has become a model organism 
for studying many of life's essential processes, partly due to its rapid growth rate and 
simple nutritional requirements. Researchers have well established information about E. 
coli's genetics; and have completed many of its strains genome sequences.  E. coli K-12, 
was the earliest organism to be "suggested as a candidate for whole genome sequencing" 
[16]. Several strains of E. coli have been sequenced and studied in detail.  It has a single 
circular chromosome with 4,639,221 base pairs and 4288 protein-coding genes. Of these 
protein-coding genes, 38% have no attributed function. E. coli K-12's genome, has a 
50.8% G+C content. Genes that code for proteins account for 87.8% of the genome, 
stable RNA-encoding genes make up 0.8%, 0.7% is made of noncoding repeats, and 
about 11% is for regulatory and other functions [16]. An interesting feature of E. coli 
K12 is the ability to develop antibiotic resistance to streptomycin through point mutations 
within the ribosomal proteins, and is the reason why this organism was used for study in 
this dissertation (chapter 4). 
Characterization of a bacterial proteome typically refers to the comprehensive 
detection and identification of the entire suite of proteins expressed by the microbial cell. 
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The entire suite of proteins may not be expressed under one growth condition or time 
point, therefore multiple growth states or time points may be examined to look at the 
entire complement of proteins in an organism. One of the techniques of choice to perform 
these complex characterizations of proteins from within the cell, is mass spectrometry.  
Mass spectrometry provides a powerful method to measure ions of intact and fragmented 
molecules in order to provide molecular mass information, as well as ion manipulation 
capabilities for obtaining detailed structural information at the isomeric level, including 
differentiation of isomers in many cases. Originally, mass spectrometry was known for its 
use in small molecule evaluation, but advances in the 1980’s made it possible to extend 
its applications to large biomolecules such as proteins, nucleic acids, and their 
complexes.   These key advances included the ability to ionize these large molecules 
using two new techniques.  The new ionization techniques of electrospray ionization 
(ESI) [17] and matrix-assisted laser desorption/ionization (MALDI) [18,19] provided a 
new way of forming gas-phase ions from these larger molecules. These advances enabled 
mass spectrometry to become a leading technology for proteome measurements, due to 
its inherent ability to identify proteins, including hypothetical species, at high mass 
accuracy, resolution, and throughput, even from complex mixtures [20,21]. 
Currently, there are two major methods for analyzing proteins by mass 
spectrometry.  The top-down method involves measuring intact proteins, either with or 
without MS/MS of these intact proteins.  This method was first introduced with 
electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry, 
ESI-FTICR-MS [22, 23, 24] and expanded to ion traps with novel ion-ion reactions [25].  
In the bottom-up, method, intact proteins are digested with a protease such as trypsin, 
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Glu-C or cyanogen bromide (CNBr), and the resulting peptide mixtures are analyzed by 
MS or MS/MS.  It should be noted that in this definition it does not matter whether the 
initial separations are performed on intact proteins or peptides; rather, the experiment 
type is defined by the species measured by the MS.  Thus, 2D-PAGE of intact proteins 
followed by in-gel digestion and MS analysis is considered a bottom-up approach.  The 
actual development of the bottom-up methodology cannot be traced to a single lab, but 
rather evolved from multiple labs using very different techniques including gel-based[26, 
27, 28, 29, 30] and solution-based separations[31, 32, 33] followed by MS or MS/MS for 
protein identifications.  These two general approaches can be summarized as follows: 
Bottom-up proteomics:  Protein mixtures (from cell lysate or protein complexes) are 
proteolytically digested (usually with trypsin), and the resulting peptide mixture is 
examined by mass spectrometry.  The MS data are used to query a peptide database from 
the specific organism to identify the protein components of the original mixture.  This 
method is excellent for determining protein identities, but provides very limited 
information about the molecular form of the intact proteins. 
Top-down proteomics:  Complex protein mixtures from cell lysates or protein complexes 
are examined directly by on-line or off-line MS.  No digest is conducted; rather the intact 
proteins are measured with MS and MS/MS [34].  This method provides fewer protein 
identities, but does give detailed information about the intact molecular forms of the 
proteins, including post-translational processing (small molecule additions, truncation, 
mutations, and signal peptides). 
Both techniques have advantages and disadvantages and will be discussed in 
detail below.  Bottom-up proteomics is by far the more widely used method, mainly 
 9
because it is much simpler to conduct and does not require high performance MS 
instrumentation.  The progress in the field of bottom-up proteomics has been staggering.  
It has now become possible (if not routine) to measure ~1000-1500 proteins from a 
microbe under a given growth condition with a high degree of confidence in a 1-3 day 
period, depending on the technology used.  Furthermore, if enough mass spectrometers 
are assembled, this analysis can be rapidly repeated for protein identification for an 
organism under a variety of different growth conditions. 
Bottom-up proteomics has become almost routine to perform, although, top-down 
proteomics has moved at a slower pace.  This lag in development is primarily due to the 
following factors:  liquid-based separations of intact proteins are more difficult than 
peptides, MS and MS/MS analyses of intact proteins are more difficult to conduct and 
interpret than peptides, the high performance MS instruments capable of adequate 
analysis of intact proteins from complex mixtures are fairly expensive and have not been 
designed for routine operation in most cases, and the algorithms to analyze MS/MS of 
intact proteins are not as well developed or commercially available.  Even with these 
experimental challenges, top-down proteomics provides a level of information that the 
bottom-up technique does not, which is the intact state of the protein.  Information on the 
intact state of the protein is critical, since proteins function as intact molecular species, 
not as a combination of simple, small peptides.  Thus, a full understanding of the intact 
state of proteins (PTMs, truncation, mutations, and signal peptides) is necessary.  
Bottom-up MS proteomics has become very powerful over the past five years, 
although, it is clear that this is an indirect protein identification technique, as the intact 
protein species are never measured directly, but rather only a fraction of the proteolytic 
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peptides for any given protein are identified.  This leads to some concern that subtle 
aspects of the protein, such as the presence of isoforms, or post-translational 
modifications, might be missed by the bottom-up approach.  This need for intact protein 
measurements in complex mixtures has prompted investigation into developing MS 
technologies for this task.   At initial thought, this may seem straightforward based on the 
extensive past work on characterizing purified protein samples, in fact, this approach 
turns out to be a formidable analytical challenge for proteomes due to at least three 
factors.  First, the protein molecules masses can range from 5–200 kDa, requiring high 
performance MS technology for accurate measurements.  Second, the extreme 
heterogeneity of protein sequences gives rise to a substantial ionization suppression effect 
when very complex mixtures of proteins are examined.  Thus, the proteins with the 
largest amount of surface charge will ionize most easily and will be over-represented in 
the mass spectrum relative to their abundance in the sample.  This factor suggests that 
some type of pre-fractionation, or on-line chromatography, will most likely need to be 
used for intact protein measurements.  Third, the unambiguous identification of larger 
proteins is difficult, due to the isotopic packet that confounds accurate mass 
measurements and the inability to extensively fragment these proteins, under tandem 
mass spectrometry conditions, to get complete sequence information.  All three of these 
factors are much easier for peptides because of their lower molecular masses and more 
extensive fragmentation.  However, research is underway in several laboratories and has 
shown remarkable progress in overcoming these challenges for the top-down approach.  
One particular factor that must be noted is that most of the developments of the top-down 
approach have focused on the experimental LC and MS measurement technologies.  As a 
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result, the bioinformatics component is much less developed for the top-down data 
analysis.  
 One of the challenges in separating complex protein mixtures is keeping the 
proteins intact and soluble during the preparation/fractionation process.  Because MS 
measurements do not require the proteins to be in their active forms, it is sometimes 
desirable to denature the entire complex mixture as early in the clean-up process as 
possible.  While this usually inactivates cellular proteases, it also can cause undesirable 
protein precipitation in the samples.  For the bottom-up MS approach, it is advantageous 
to denature and digest the complex protein samples as early as possible in the clean-up 
process.  Because only peptides are measured, protein stability is not an issue for this 
method.  In contrast, protein stability is critical for the top-down MS approach.  To 
enhance this, during the cellular lysing process, a protease inhibitor cocktail is often 
added to arrest protein degradation.  The protease inhibitors, which are often small 
molecules, stabilize the protein samples, but can often be removed prior to MS 
characterization.   
The critical component for top-down proteomics by MS is measurement of the 
molecular masses of the intact proteins.  The five important experimental aspects of this 
measurement are mass accuracy, mass resolution, dynamic range, mass range, and 
detection sensitivity.   
(i) Mass resolution.  The measure of how well adjacent peaks can be 
differentiated in the mass spectrum.  This value is typically given as the peak 
full width at half maximum (FWHM). 
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(ii) Mass accuracy. The comparison of the measured mass to the calculated mass.  
This value is typically given as error in either percentage or parts-per-million 
(ppm). 
(iii) Mass range. The difference between the largest and smallest molecular mass 
that can be measured. 
(iv) Detection limits. The smallest amount of sample that can be measured with a 
signal/noise of at least 3:1. 
(v) Dynamic range. The molar difference between the least abundant component 
and the most abundant component that can be detected in a single sample. 
The wide molecular range of possible proteins experienced in proteomics has 
researchers proposing the use of technologies such as MALDI-TOF-MS.  This approach 
does provide an advantage for the analysis of large protein species, but does have some 
draw backs such as limited mass resolution and accuracy.  For example, a protein with a 
molecular mass of 50 kDa can generally only be measured using a TOF-MS to about 
0.02% (~ 10 Da).  While this mass measurement is far superior to what is obtainable from 
gel electrophoresis, this value could still correspond to many proteins within a given 
database.  Therefore, a much more accurate measurement, providing a higher level of 
mass accuracy, is needed to limit the number of possible proteins identifications from 
employed databases. This is the driving force to employ techniques such as ESI-FTICR-
MS for intact protein measurements.  This technology provides unprecedented 
capabilities for high performance measurements, although, many experimental 
parameters are difficult to employ and need further development. For example, the same 
protein with a molecular mass of 50 kDa could be measured with the FTICR-MS 
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technique to about 0.0005% or 5 parts-per-million (~0.25 Da).  Thus, high resolution and 
accurate mass measurements of intact proteins are often sufficient information to identify 
many bacterial proteins, without further structural information.  However, this statement 
is true in many cases, confounding the identification of intact proteins are protein 
truncations and post-translational modifications that alter the measured molecular masses, 
making it difficult to correlate the measured protein mass with the value predicted from 
the genome data. For this reason, it is best to integrate the measured molecular mass 
information with either structural data obtained by tandem mass spectrometry or with 
data obtained by the bottom-up MS method on the same organism [35].   
High-resolution molecular mass measurements of intact proteins reveal the complex 
isotopic packet resulting from the combination of naturally-occurring isotopes.  This 
necessitates comparing the measured and calculated isotopic distributions to verify 
protein identification [36].  In practicality, the high-resolution molecular mass 
measurement is used to query a protein database for a given organism.  The possible 
protein matches falling within the specified mass accuracy window are tabulated, and a 
calculated isotopic distribution is determined for each one (for FTICR-MS 
measurements, there are usually no more than 3-4 possible proteins within the 5-10 ppm 
range of the measured mass).  For each putative protein, the calculated isotopic 
distribution and most abundant peaks are compared to the measured values for final 
protein identification. 
 Even with the high-resolution molecular mass measurements discussed above, the 
dynamic range and heterogeneity of intact proteins in these complex mixtures can 
confound the MS measurements.  The basic problem stems from the limited ability to 
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simultaneously measure hundreds (or even thousands) of proteins in a single mixture.  An 
obvious solution to this dilemma is to incorporate some aspect of protein fractionation, 
either off-line or on-line, with the MS measurement.  This increases the sample handling 
and possible contamination or sample losses, but the MS measurement requirements are 
greatly relaxed.  For example, off-line anion-exchange chromatography can be used to 
fractionate complex protein mixtures from crude cell lysates.  Each fraction, which 
contains between 50-200 proteins, is more easily interrogated by mass spectrometry [35].  
The most common protein fractionation approach has been to incorporate reverse-
phase liquid chromatography on-line with the MS.  This arrangement permits the proteins 
to be physically separated by their hydrophobicity on the stationary phase of the column, 
and then eluted, sequentially, directly into the mass spectrometer. Reverse phase 
chromatography columns, employed in this research, have a stationary phase composed 
of silicate which has reactive hydroxyl groups. In order to cap these hydroxyl groups and 
keep them from reacting with the proteins, alkyl chains are added. The longer the alkyl 
chain caps of the silicate ends, the further the proteins are from the reactive hydroxyl 
groups. Generally, most peptide work employs a C18 stationary phase for the best 
separations.  However, this is not the case for intact proteins wherein the shorter the 
carbon backbones within the stationary phase generally mean better separation of intact 
proteins. This need for shorter carbon chains is due to the large size and variation of 
hydrophobicities of intact proteins.  Therefore, most intact protein separations employing 
reverse phase chromatography use a C2 to a C4 carbon backbone.  This form of 
separation and measurement takes longer, (usually about 2 hours for the LC-MS 
experiment), although, a much more extensive analysis of the complex protein mixture is 
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possible.  This approach has been demonstrated for the characterization of the chloroplast 
grana proteome [37] and the yeast large ribosomal subunit [38], and resulted in not only 
protein identifications but also detection of post-translational modified species.  It is 
feasible to employ a multi-dimensional chromatographic approach for more enhanced 
protein fractionation.  For example, a two-dimensional LC-MS experiment has been 
conducted on Saccharomyces cerevisiae by using a version of gel electrophoresis 
employing acid-labile surfactants, followed by reverse-phase LC directly into an FTICR-
MS [39]. 
There are several alternatives to on-line chromatography.  One such approach 
involves surface enhanced laser desorption/ionization TOF-MS approach [40].  For this 
method, a variety of chemical (hydrophobic, ionic, or mixed) or biochemical (antibody, 
DNA, enzyme, or receptor) surfaces are used to preferentially absorb selected protein 
species.  This allows the fractionation to be fairly generic or highly specific, thereby 
selectively reducing the complexity of the protein sample.  These surfaces can be 
incorporated into protein chips, providing a high-throughput sampling methodology for 
MALDI-TOF-MS, although the identification of proteins from only their low-resolution 
molecular mass is difficult.  Another alternative to liquid chromatography focused on 
exploiting the demonstrated power of gel electrophoresis.  As a modification of 
conventional 2-D PAGE, mass spectrometry has been used to replace the size-based 
separation component of the SDS-PAGE separation [41].  For this method, the proteins 
separated according to pI are then measured by MALDI-TOF-MS, with either post-
source decay dissociation of intact proteins, or peptide mass mapping experiments.  Such 
information can be used to construct virtual 2-D gels.   
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To unambiguously verify the protein assignment by top-down MS, it is 
advantageous to acquire at least some structural information for the intact proteins 
[23,42].  This can be accomplished with a variety of tandem mass spectrometry 
experiments, involving collisional dissociation, electron dissociation, or 
photodissociation.  Proteins usually fragment much less extensively than peptides, but 
there is often sufficient fragment ion information to confirm or reject a possible protein 
identification from the accurate mass measurement.  For example, the presence of only 
three or four fragment ions from a protein was found to be sufficient for a 99.8% 
probability of identifying the correct protein from a database of 5,000 bacterial protein 
forms [43].   This methodology can be applied for proteins both with and without 
disulfide bonds [44,45].  Electron capture dissociation shows promise for the most 
extensive fragmentation of intact proteins in a high-throughput manner [46,47].  Electron 
capture dissociation uses low-energy electrons to neutralize the charges on the protein 
producing cleavage of the amide bond to form c and z ions, and usually provides 
extensive sequence coverage of proteins even up to 45 kDa in size [48].  A combination 
of collisional dissociation and electron capture dissociation can be used to provide 
complementary information on intact proteins in bacterial proteomes [49]. Collisional 
activated dissociation (CAD) traditionally has been one of the most common 
fragmentation methods for proteins in top-down mass spectrometry. CAD is capable of 
producing high fragmentation efficiency with relatively simple implementation [50].  For 
very large proteins (molecular masses exceeding 150 kDa), it may be advantageous to 
employ partial proteolytic digestion to make large peptides (5-50 kDa), and then 
characterize these species [51].  One of the more extensive techniques for top-down MS 
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is a combination of capillary LC-MS with infrared multiphoton dissociation (IRMPD) 
[52].  IRMPD offers a method of fragmentation where no single frequency excitation is 
required and the ions of all m/z values are dissociated at the same time [53]. This method 
has been demonstrated to be useful with proteins and peptides. 
 As stated above, the bottom-up and top-down MS approaches each have unique 
capabilities and limitations.  One approach to exploit the power of each technique is to 
integrate them together, with the goal of more comprehensive proteome characterization.  
A flow-chart describing how this integrated technique might be designed is illustrated in 
Figure 1.1.   Off line fast protein liquid chromatography (FPLC) is used in this integrated 
method to separate the large complex mixtures of proteins mixtures for top-down analysis 
due to its proven ability to reduce down the complexity of the mixture. Therefore, by 
reducing the complexity of the protein mixture, this method allows for better separation 
from the on-line HPLC methods used, as well as more comprehensive protein 
identifications [35]. This method of off line FPLC fractionation followed by on line 
HPLC does take a large amount of protein starting material this is not of great concern 
due to the ability to produce more than enough material from the chosen microbe’s 
cultures. Another area of concern using this strategy is the loss of protein during the off 
line separation. This problem is unavoidable due to the need to have a prior separation of 
the complex protein mixture before the top-down analysis. 
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Figure 1.1: Integrated protein preparation and identification. 
Flow chart illustrating how an integrated top-down and bottom-up MS approach can be 
used to characterize a bacterial proteome. 
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By providing this initial separation step with FPLC, we increase the overall ability 
to analyze and identify more proteins than with no initial separation. We have found this 
technique of off line fractionation followed by on line HPLC to be highly reproducible 
and simple to implement for a large-scale study of multiple samples [35].   An integrated 
top-down and bottom-up approach allows for a more complete characterization of protein 
complexes due to the unique strength of each technique.  In an integrated approach, intact 
protein masses, from the top-down analysis, corresponding to a particular PTM or 
isoform, are then able to be compared to the comprehensive list of proteins provided by 
the bottom-up analysis. This correlation between the two methods can provide PTM 
location and identity with more certainty.  The comprehensiveness of this technique has 
been previously demonstrated in studies of the Shewanella oneidensis [35] proteome as 
well as the 70S ribosomal complex from Rhodopseudomonas palustris [54]. 
 The major goal of this dissertation was to build a platform for the analysis of 
intact proteins from complex mixtures, in order to obtain information about the natural 
state of the proteins.  The hope was to gain greater biological insight into the complex 
systems of microbes by providing starting information about the function, and possible 
cellular location of proteins from bacteria. At the start of this dissertation, top-down 
proteomics was only beginning to be developed in numerous laboratories. Thus, a major 
effort was needed to develop the necessary biological, analytical, and computational tools 
to addresses this daunting technical challenge of analysis intact proteins. The research 
presented here has helped to bring us one step closer to achieving that goal. 
The following is an outline of that effort. Chapter 2 details the current ORNL 
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“top-down” proteomics pipeline for microbial proteomics, which was developed 
primarily through efforts of this dissertation. Chapter 3 details the fundamental work on 
the FT-ICR for the evaluation of proteins and PTMs. These fundamental efforts were 
needed to advance this dissertation work on proteins and PTMs.  Chapter 4 illustrates our 
evaluation of complex ribosomal mixtures for PTMs and isoforms from the two microbes 
R. palustris and E. coli. Chapter 5 further illustrates the effectiveness of examining PTMs 
in protein complexes for key regulation sites from Rhodopseudomonas palustris. Chapter 
6 introduces new computational methods developed for integrated top-down and bottom-
up data for the identification of PTMs. Finally, Chapter 7 concludes with the application 
of “top-down” proteomics for the first characterization of a microbial proteome from 
multiple growth conditions. This dissertation is the culmination of years of effort to 
develop a top-down proteomics platform for the characterization of intact proteins and 
PTMs from microbial proteomes with differing environmental conditions. 
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Chapter 2 
Experimental Platform for the Analysis of Intact Proteins and PTMs in Microbial 
Systems by Mass Spectrometry 
Introduction 
This chapter describes the experimental platform for analysis of intact proteins 
and their associated post translational modifications (PTMs) from either protein 
complexes or microbial cell extracts that was developed through the course of this 
dissertation. While a common experimental thread of analyzing intact bacterial proteins 
for PTMs and isoforms by an integrated top-down and bottom-up mass spectrometry 
approach can be found in all following chapters, the exact methods vary to some degree. 
This chapter breaks each part of the process down and explains variations and advantages 
and disadvantages of the various methods. The ORNL integrated top-down and bottom-
up platform is illustrated in Figure 2.1. The major parts include cell growth, protein 
extraction/sample preparation, liquid chromatography, mass spectrometry, proteome 
informatics and biological information extraction. Each of these subtasks are detailed 
below. 
Cell Growth and Protein Preparation 
For all studies presented in this dissertation bacteria were grown from stock 
solutions in batch format. Generally, glycerol stock solutions of the WT strain or a 
mutant strain are kept at -80oC.  For the R. palustris studies in Chapters 4, 5 and 7, the 
wild-type (WT) strain CGA0010 was a gift from Dr. Caroline Harwood at the University 
of Washington and can be obtained from Dr. Dale Pelletier in the Life Science 
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Figure 2.1: Major steps in integrated top-down and bottom-up proteomics pipeline. 
Illustrated is each major step in the ORNL proteomics pipeline for the analysis of 
individual protein complexes and entire proteomes. 
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Division at ORNL. The Escherichia coli protein purifications that were used in the 
antibiotic resistance work in Chapter 6 were supplied by Dr. Morgan Giddings at the 
University of North Carolina already in the purified intact protein form. 
Growth of Wild Type R. palustris 
R. palustris strain CGA0010, a hydrogen-utilizing derivative of the sequenced 
strain (unpublished C. S. Harwood) and referred to here as the wild-type strain, was 
grown under the three conditions (chapter 7). Wild type R. palustris cells were grown 
anaerobically in light or aerobically in dark on defined mineral medium at 30 °C to mid-
log phase (OD660nm = 0.6). Carbon sources were added to a final concentration of 10 
mM succinate and 10 mM sodium bicarbonate. For the photoheterotrophic N2 fixing 
cultures, ammonium sulfate was replaced by sodium sulfate in the culture medium and N2 
gas was supplied in the headspace. Chemoheterotrophic cells were grown aerobically in 
the dark with shaking at 200 rpm; phototrophic cells were grown anaerobically in the 
light with mixing with a stir bar. All anaerobic cultures were illuminated with 40 or 60 W 
incandescent light bulbs from multiple directions. 4-5 liters of cells were grown for all 
three states and pooled together for each state.  
Protein Extraction of Wild type R. palustris 
The cell pellet from each growth state were resuspended in ammonim acetate 
buffer then lysed using a French Press. Total protein yields range between 60-120 mg of 
protein for each of the three growth states. Cell extract was centrifuged at 10,000 X g for 
35 minutes in a Sorvall centrifuge to remove all unbroken cells. Protein extract was used 
for off-line anion exchange FPLC fractionation. Anion Exchange fractionation was used 
due to the pI range of most proteins is in 3-7 range. By employing anion exchange with 
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buffers in the pH range of 7.5-8, most proteins will not reach their isoelectric point and 
will be eluted off the column according to their pI.  Illustrated in Figure 2.2 is the protein 
isolation process followed by mass spectrometry. To perform off-line anion exchange 
chromatography 60 mg of protein was injected onto a 5 ml HiTrap (HiTrap SP HP, 
Amersham Pharmacia) ion exchange column connected to an AKTA (Amersham 
Pharmacia) FPLC system. After protein injection a 30 minute ammonium acetate gradient 
was run from 0.2 M to 2 M at pH 7.5. Twenty fractions from each growth state (total of 
60 from 3 growth states) were determined to have sufficient protein amounts (400 µg) by 
a Bradford protein assay. Each FPLC fraction obtained was then divided into two 
portions. One portion was examined by 1D LC-MS-MS bottom-up mass spectrometry 
and the other portion of the sample was examined using LC-FTICR-MS for top-down 
mass spectrometry. 
Creation of Affinity Tagged Proteins in R. palustris 
The R. palustris wild type strain (CGA0010), harboring the pBBR5-DEST/42 
modified Gateway expression plasmid (Invitrogen, Carlsbad, CA) with the RPA0274, 
RPA0272, RPA2966 open reading frames (ORF) were generated at Oak Ridge National 
Laboratory by Dr. Dale Pelletier.  The ORFs were cloned into the expression plasmid 
with the V5 and 6xHis affinity tags fused at the C-terminus of the protein.  
R. palustris cells harboring the expression plasmid were grown anaerobically and 
under nitrogen fixing conditions in PM-N2 (photosynthetic nitrogen fixing medium) or in 
PM (photosynthetic medium) under non-nitrogen fixing conditions. Cells were harvested 
at mid-log phase (O.D.660 ~0.8). Cell pellets were re-suspended in NTA binding buffer 
(50 mM NaH2PO4  at pH 8, 300 mM NaCl, 10 mM imidazole, 5 mM ATP, and 10 mM  
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Figure 2.2: Steps in protein purification performed. 
Illustrated are the steps in cell growth to protein purification employed in dissertation.  
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MgCl2, 10 mM KCl, 100 µg/ml PMSF and 10 µg/ml leupeptin) and lysed with 1X 
BugBuster (Novagen).  Cellular debris was removed with an initial centrifugation at 4°C 
using an SS-34 Sorval rotor at 12,100 × g for 30 minutes.  The supernatant was 
centrifuged for an additional 15 minutes at 23,700 × g.  The final resulting supernatant 
was then immediately used in the first stage of the affinity purification.  
Affinity Purification 
The presence of two tags (6X His-tag and V5 antibody tag) within the expressed 
protein allowed for the use of a dual affinity purification strategy to “capture” the 
complexes. Figure 2.3 illustrates the affinity purification process employed. This is a 
standard protocol for large-scale isolation of protein complexes from R. palustris in our 
laboratory, in which a large number of strains each bearing a plasmid encoding a 
different affinity-tagged protein [55].  
In the first purification step, Ni-NTA beads (Qaigen, Valencia, CA) (previously 
washed in NTA Binding buffer 4X) are added to the supernatants and were incubated on 
a rotator for one hour at ambient temperature.  The beads were then collected by 
centrifugation at 425 × g, transferred to new tubes, and washed 4X with NTA wash 
buffer (50 mM NaH2PO4 at pH 8, 300 mM NaCl, 20 mM imidazole, 5 mM ATP, 10 mM 
MgCl2, 10 mM KCl).  Afterwards, bound proteins were eluted from the Ni-NTA beads 
4X with NTA elution buffer (50 mM NaH2PO4 at pH 8, 300 mM NaCl, 500 mM 
imidazole, 5 mM ATP, 10 mM MgCl2, 10 mM KCl).  Combined eluents (approximately 
150 µl total) were diluted with 400 µl buffer (5 mM ATP, 10 mM MgCl2, 10 mM KCl) 
and immediately used for the second affinity purification step.  
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Figure 2.3: Steps in protein affinity purification performed. 
Illustrated are the steps in affinity protein purification employed in dissertation.  
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V5 beads (Sigma, St. Louis, MO) (previously washed in PBS buffer) were added to the 
combined eluents from the Ni-NTA capture and incubated on a rotator for one hour at 
ambient temperature.  The beads were then centrifuged at 425 × g and washed 4X with 
V5 wash buffer (50 mM Tris-HCl, 10 mM CaCl2 at pH 7.6, 5 mM ATP, 10 mM MgCl2, 
and 10 mM KCl).  Afterwards, the bound proteins were eluted three times from the V5 
beads with V5 elution buffer (80% acetonitrile and 1% formic acid).  The combined 
eluents were analyzed by protein chip measurements to give total protein concentration of 
5µg in 150µl of eluent. This affinity purification method was completed 4 times to 
provide 2 purifications for Top-down mass spectrometry analysis and two purifications 
for bottom-up mass spectrometry analysis of each R. palustris growth state. 
Approximately 10 µg of affinity purification eluent from each growth state was digested 
for bottom-up analysis with sequencing grade trypsin added at 1:20 (wt/wt) of protein to 
enzyme.  The digestions were run with gentle shaking at 37 °C for 12 hours.  Samples 
were immediately desalted with an Omics 100 µl solid phase extraction pipette tip 
(Varian, Palo Alto, CA).  All samples were frozen at -80°C until LC-MS/MS analysis. 
FTICR-MS 
Rationale for Using Fourier Transform Ion Cyclotron Resonance Mass Spectrometry 
(FTICR-MS) for the Characterization of Intact Proteins and PTMs in Microbial Systems 
The analysis of large bio-polymers i.e. proteins, and their associated complexes is 
a current area of scientific investigation addressed in this dissertation.  Fourier 
Transform-Ion Cyclotron Resonance-Mass Spectrometry (FTICR-MS) is an analytical 
tool that has found particular application in the area of biological mass spectrometry [56].  
FTICR-MS is particularly suited to the analysis of intact proteins as well as peptides [57] 
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because of its unique method of mass analysis and m/z determination. FTICR-MS 
provides mass resolution (FWHM of 100,000 to 150,000) far superior to other types of 
instruments and also provides high mass accuracy (1 to 10 ppm for molecules of 100 to 
30,000 Da) with proper calibration [57, 58]. In addition, its ability to comprehensively 
measure a wide dynamic range (up to 105) provides an exceptional tool for the analysis of 
complex mixtures. FTICR-MS has mass resolving power unparalled by other mass 
analyzers consequently, what appears as an unresolvable mixture with other techniques 
appears as a data rich mass spectrum. This resolving power can be utilized at low mass as 
well as high mass applications. However, it is important to remember, the FTICR-MS 
resolving power does decrease with increasing mass to charge.    
The high performance that can be achieved only by FTICR-MS was particularly 
crucial for analyzing intact proteins and their modified forms. Because of multiple carbon 
atoms in the molecule, the molecular region of the protein exists as a population of 
numerous isotopic species. The mass of a protein is determined most accurately if 
different isotopic species are resolved. Even for smaller proteins, FTICR-MS is only the 
instrument that can comprehensively resolve all of these isotopic species. Resolution of 
isotopic species is even more important when analyzing modified proteins. For example, 
as described in Chapter 4, the GlnK proteins in R. palustris are modified with an 
uridylylation. The modified forms of the protein have a mass shift of 306.2 Da and are 
difficult to resolvable in other low resolution instruments, such as ion traps. Another 
PTM that is sometimes difficult to resolve in lower resolution instruments is the 
methylation. The mass of methylation is 14 Da, which is very close to the mass of other 
common side chain losses such as water or ammonia (18 and 17 Da, respectively).  Such 
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mass differences of intact proteins can be probed only when isotopic species are 
comprehensively resolved.  In the next section, the fundamental principles of FTICR-MS 
will be illustrated. A more detailed description of FTICR-MS can be found in [57, 58]. 
Basic Principles of FTICR 
 In all FTICR-MS experiments preformed ions were generated in an electrospray 
source, de-solvated in a heated glass capillary, accumulated in a external hexapole, 
transferred into a high vacuum region with a quadrupole lens system, and then detected in 
the cylindrical analyzer cell of the mass spectrometer (Figure 2.4). Ion detection was 
achieved in an ultra low vacuum region (~2 X 10-10 Torr) through the use of differential 
pumping stages. Initial pumping was achieved using a mechanical pump which lowered 
the pressure to the millitorr range. The next stage of pumping was achieved using a turbo-
pump to lower the pressure to ~ 10-5 Torr. Finally, two cryopumps lowered the base 
pressure to approximately 2 X 10-10 Torr. Once the ions reach the analyzer cell under the 
low pressure, the process of detection takes place.  Detection in a FTICR is unique when 
compared to other mass spectrometers.  FTICR-MS measurements rely on the cyclotron 
motion of ions in a magnetic field.  This cyclotron motion is due to magnetic forces that 
bend the ion motion into a circle.  The frequency of the ion cyclotron motion is unique to 
an ion of a particular mass/ charge. On the other hand, the frequency of the ion cyclotron 
motion is independent of ion velocity and proportional to magnetic field strength. Thus 
ions of a given mass to charge will have the same cyclotron frequency, regardless of the 
time the ion enters the cell or the velocity with which the ion enters the cell.  
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Figure 2.4: Schematic of IonSpec FTICR-MS. 
Illustrated is the IonSpec ES-FTICR-MS instrument. Ions are introduced through the 
Analytica electrospray ion source and transferred through a heated glass capillary into a 
mechanically-pumped region, next through a skimmer, then into a turbopumped rf-only 
hexapole for accumulation and storage at 2 X 10-5 Torr. Finally, the ions are then gated 
through a shutter, down a quadrupole ion guide into the Penning cell within the high 
magnetic field. The penning cell is at ~10-10 Torr provided by two cryopumps. Figure is 
courtesy of IonSpec (www.IonSpec.com). 
Hexapole
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Measuring the cyclotron frequency permits ultra-high mass resolution [57, 58]. To put 
this into context, the base equation of ion cyclotron frequency can be examined [57]. 
ω = q B/m 
In this equation (ω) is the cyclotron frequency, (B) the magnetic field strength, (q) the 
charge of the ion and (m) the mass of the ion examined [57]. The frequency of the ion 
cyclotron is independent of ion velocity and proportional to magnetic field strength, and 
is inversely proportional to the mass/charge of the ion. In our case the magnetic field of 
the FTICR-MS used is 9.4T, therefore, the ion frequencies are in the radio frequency (rf) 
range of 10 kHz to 3 MHz. Using the above equation, the frequency of the ion cyclotron 
motion can be used to determine the mass/charge of an ion; what is ultimately measured 
in FTICR-MS. 
It is important to understand that the ions are confined within the analyzer cell by 
an electrostatic potential and magnetic fields. The electrostatic potential is applied on two 
plates positioned perpendicularly to the magnetic field in the cell.  Ions trapped in a 
magnetic field generally have incoherent cyclotron motion (i.e. they are moving 
independent of each other). In this mode, it is impossible to detect their net motion. To 
force the ions to move coherently, an electric field at the appropriate frequencies need to 
be applied.  Normally the radius of an ion’s orbit will be about 0.1 mm, but if an RF 
frequency is sent to the cell that is equal to the cyclotron frequency of the ion, it will gain 
energy from the rf field and move into a larger orbit. As a positively charged ion passes 
near the first electrode (forming part of the ICR cell), it will induce electrons toward the 
electrode. Then, as the ion moves away and approaches the second electrode, the 
electrons migrate to the second electrode instead [57].  
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While absorbing power, the ions are accelerated, and at the same time, all ions of the 
same mass/charge are forced to move in a phase coherent motion forming a packet of 
ions. This coherent ion cyclotron motion is called the ion cyclotron resonance (ICR).  On 
the other hand, if the frequencies of rf and ion cyclotron are different, the ions will not 
absorb power. This time dependent migration of the electrons is converted to an image 
current by placing a resistor on the wire connecting the two electrodes, and the resulting 
image current is a sinusoidal signal (Figure 2.5).  The signal produced is amplified and 
then fed into a computer.  The amplitude of the image current is proportional to the 
number of ions within the ion packet. If there are only ions of a single mass/charge in the 
mass analyzer cell, the image current will resemble a pure sine wave. This sine wave can 
be expressed in the time domain as a function of voltage amplitude with respect to time. 
By a mathematical operation called Fourier transformation, the time image current can be 
converted into the frequency domain. In the frequency domain, amplitude is proportional 
to the abundance of ions trapped in the analyzer cell. In other words, the mass spectrum is 
a mirror image of the frequency domain. If there are ions with different mass/charge 
ratios, a complex waveform representing multiple image currents from the ion packets 
will be formed. In order to Fourier transform this waveform, it needs to be converted into 
a series of individual waveforms, called the Fourier series. In the Fourier series, the 
waveform is expressed as the sum of all the sine and cosine terms, therefore, forming the 
image current for an individual ion packet [57, 58]. The image current produced by the 
Fourier series is converted into the frequency domain, and the frequency domain is 
further converted into a mass spectrum (Figure 2.6).
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Figure 2.5: Generation of image current within the FTICR-MS. 
(Image was taken from www.IonSpec.com)  
Schematic of how the image current is obtained from the ion cyclotron frequency. The 
magnetic field is represented by the green (B) within the diagram. 
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Figure 2.6: Generation of mass spectrum from the image current within the FTICR-MS. 
(A) The image current produced from a complex protein mixture. (B) The mass spectra 
obtained after a Fourier transform from the image current. 
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Experimental Procedure for Mass Spectrometric Analysis of Protein and Peptides 
Employed In This Study 
ESI-FTICR Mass Spectrometry 
All ESI-FTICR mass spectra were acquired with an IonSpec (Lake Forest, CA) 
9.4-Tesla HiRes electrospray Fourier transform ion cyclotron resonance mass 
spectrometer.  A Harvard syringe pump (flow rate of 1.75 µL/min) was used for direct 
infusion into an Analytica electrospray source (Analytica of Branford, CT).  After 
generation, ions were accumulated in an external hexapole and transferred into the high-
vacuum region with a quadrupole lens system.  Detection then followed in the cylindrical 
analyzer cell of the mass spectrometer.  Calibration of the mass spectrometer was 
accomplished externally with ubiquitin, resulting in a mass accuracy of ±3-5 ppm and 
mass resolutions of 50,000-160,000 (FWHM) as previously described [59].  
Capillary HPLC-FT-ICR-MS 
Capillary HPLC-FTICR-MS was accomplished with a Dionex UltiMate HPLC 
interfaced directly to the FTICR instrument.  A C4 reverse-phase column (VYDAC 
214MS5.325 C4 column 300µm id x 250mm, 300Å with 5µm particles, Grace-Vydac, 
Hesperia, CA) was employed for all separations.  The R. palustris FPLC purification 
eluent and E. coli ribosome purifications consisting of 20-30 µg of total protein was 
injected onto the column and eluted at 4 µl/min into the electrospray ion source of the 
FTICR-MS.  The gradient was run from 100% solvent A (95% water, 5% acetonitrile, 
0.1% formic acid, 50 mM hexafluorisoproponal) to 100% solvent B (95% acetonitrile, 
5% water, 0.1% formic acid, 50 mM hexafluorisoproponal.) over a 75-min. linear 
gradient. Hexafluorisoproponal (HFIP) was added as a chaotrope to help proteins unfold 
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and keep them from forming multimers, which gives better peak resolution. Ions were 
generated with a 3700 V potential between a grounded needle and heated transfer 
capillary. After generation, ions were accumulated in an external hexapole for two 
seconds and transferred into the high-vacuum region with a quadrupole lens system.  
Detection then followed in the cylindrical analyzer cell of the mass spectrometer.  
Calibration of the mass spectrometer was accomplished externally with ubiquitin 
resulting in a mass accuracy of ±3-10 ppm and resolutions of 50,000-160,000 (FWHM). 
Because the mass resolution was at least 50 000 for the intact protein measurements, the 
molecular masses of these proteins could be measured with isotopic resolution. 
Quadrupole Ion Trap MS 
 
The function of the quadrupole ion trap is as follows; preformed solution phase 
peptide ions are sprayed through an electrospray or nanospray source on the front of the 
instrument into a heated capillary. The heated capillary is generally set at 150-2500C and 
functions to desolvate the ions. The ions are then directed through a tube lens and passed 
through a skimmer. The skimmer acts to focus the ion beam and skim off neutrals. Next, 
the ions are directed through a quadrupole and octopole, which acts as an ion beam guide 
to focus the ions into the ion trap. The ion beam enters into the trap through the inlet and 
is trapped through action of the three hyperbolic electrodes: the ring electrode, the 
entrance and exit the endcap electrodes (Figure 2.7) [60]. Various dc and rf voltages are 
applied to these electrodes which results in the formation of a potential well, in which 
ions are trapped.  The ring electrode RF potential produces a 3D quadrupole potential 
field within the trap. This traps the ions in a stable oscillating trajectory within the trap to 
produce what is known as dynamic trapping.  
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Figure 2.7: Schematic of a quadrupole ion trap mass spectrometer. 
The diagram shows the major components to a quadrupole ion trap mass spectrometer. 
At the start of the diagram the ESI needle assembly (electrospray ionization) provides the 
ions travel through the mass spectrometer and are detected by the EM (electron 
multiplier).  Figure Provided by Thermo (www.thermo.com). 
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An ion will be stably trapped depending upon the values for the mass and charge of the 
ion, the size of the ion trap (r), the oscillating frequency of the fundamental rf (Ω), and 
the amplitude of the voltage on the ring electrode ( V). The dependence of ion motion on 
these parameters is described by the two dimensionless parameter qz and az, as evident in 
the formula below [60]. The qz value will determine when m/z ejection takes place. 
m/z eject = 4V/(0.908r2Ω2) 
For detection of the ions, the potentials are altered to destabilize the ion motions resulting 
in ejection of the ions through the exit endcap. The ions are usually ejected in order of 
increasing m/z by a gradual change in the potentials. The "stability diagram" depicts the 
region where radial and axial stability overlap (Figure 2.8). Depending upon the 
amplitude of the voltage placed on the ring electrode, an ion of a given m/z will have a 
(qz) value that will fall within the boundaries of the stability diagram, and the ion will be 
trapped. If the q z value at that voltage falls outside of the boundaries of the stability 
diagram (qz = 0.908), the ion will hit the electrodes and be lost. By sequentially 
increasing the voltage on the ring electrodes, ions trajectories from low m/z to high m/z 
are made unstable (Figure 2.8).  This “stream” of ions generated from this sequential 
ejection are focused onto the detector or electron multiplier of the instrument in order to 
produce the mass spectrum. The initial mass spectrum obtained is what is known as a full 
scan. The ions observed within the full scan are next selected by their m/z values for 
isolation and subsequent fragmentation. This selection is accomplished by destabilizing 
and ejecting all other ions with lower and higher m/z values as described above. The 
process of selection is essentially gas phase purification of the ion inside the mass 
spectrometer.  
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Figure 2.8: Stability diagram for the quadrupole ion trap. 
(Figure taken from Karen R. Jonscher and John R. Yates, III, www.ABRF.org) 
Diagram showing the regions of stability within the quadrupole ion trap depicted in terms 
of the operating voltages and frequencies. The important terms on the diagram are the (a) 
and (qz) functions. These functions represent stability ranges within the 3D trap.  
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The selected ion is then excited by increasing its orbital frequency, which causes it to 
collide with the helium bath gas inside the ion trap mass spectrometer [60]. These 
repeated collisions with the helium gas cause collision induced fragmentation. After 
fragmentation occurs, the fragment ions are maintained within the ion trap mass 
spectrometer.  The same process of destabilizing and ejecting ions that occurred in the 
full scan is performed for the fragment ions thereby producing what is know as an 
MS/MS or MS2 spectrum. The entire MS/MS process is repeated for three to four more 
times for different selected ions within the ion trap before the mass spec returns to a full 
scan. The process of full scans followed by MS/MS is repeated throughout an entire 
chromatographic run, creating thousands of MS/MS spectra and their associated parent 
m/z measurements.  
Within this dissertation, 1D-LC-MS/MS was used for all peptide analysis.  This 
methodology is one of the simplest and easiest to implement, and was the reason it was 
chosen within this body of work. It requires only three major instruments, a low-flow 
HPLC pump, an autosampler, and the electrospray quadrupole ion trap mass spectrometer 
(ES-QIT-MS). 
1D-LC-ES-MS/MS  
All R. palustris and E. coli protein preparations from each fraction were digested 
for bottom-up analysis with sequencing grade trypsin added at 1:20 (wt/wt) of protein to 
enzyme.  The digestions were run with gentle shaking at 37 °C for 12 hours.  Samples 
were immediately desalted with an Omics 100 µl solid phase extraction pipette tip 
(Varian, Palo Alto, CA).  All samples were frozen at -80°C until LC-MS/MS analysis.   
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For all peptide samples, one-dimensional (1D) LC-MS-MS experiments were 
performed with a Famos/Switchos/Ultimate HPLC System (Dionex, Sunnyvale, CA) 
coupled to an LCQ-DECA XP Plus quadrupole ion trap mass spectrometer (Thermo 
Finnigan, San Jose, CA) equipped with a nanospray source as previously described [61]. 
A 160 minute linear gradient from 100% solvent A (95% H2O/5% ACN/0.5% formic 
acid) to 100% solvent B (30% H2O/ 70% ACN/0.5% formic acid) was employed. For all 
1D LC-MS-MS data acquisition, the LCQ was operated in the data dependent mode with 
dynamic exclusion enabled (repeat count 2), where the four most abundant peaks in every 
MS scan were subjected to MS-MS analysis.  Data dependent LC-MS-MS was performed 
over a parent m/z range of 400-2000.  
Data Analysis 
All resulting top-down and bottom-up data sets were analyzed with two methods. 
In the first method, the well established bottom-up algorithm SEQUEST was used to 
identify MS-MS spectra with their counterparts predicted from a protein sequence 
database [62]. The sequence information of the peptide cannot easily be directly 
interpreted from the MS/MS spectrum due to the complexity of the fragmentation 
processes. Instead, SEQUEST performs cross correlation comparisons between the 
observed spectrum and computationally derived spectra from protein and nucleotide 
databases. The parent mass of the peptide provides a look-up function to find candidate 
peptide sequences within the potential mass window of the observed parent peptide. The 
observed MS/MS spectrum is then directly compared to hundreds of potential candidate 
MS/MS spectra and a best scoring candidate match is made.  For all database searches, an 
R. palustris proteome database was used, which contained 4,833 proteins and 36 common 
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contaminants or the E. coli K-12 database plus common contaminants. Distracter 
databases of other organisms, such as yeast, were used to search against for verification 
of false positive rates. All resultant output files from SEQUEST were filtered by 
DTASelect [61] at the 1-peptide, 2-peptides and 3-peptides level with the following 
parameters:  SEQUEST, DeltCN of at least 0.08 and cross correlation scores (Xcorrs) of 
at least 1.8 (+1), 2.5 (+2) and 3.5 (+3), followed by Contrast [61] for comparison.  The 
DTASelect [61] software can take any number of LC-MS/MS analyses and sort and filter 
peptide identifications to provide html and text output files of identified proteins, while 
the Contrast [61] algorithm can compare across multiple outputs from DTASelect [61] 
for multiple proteomics experiments. The filtering levels used for all searches are 
considered to be conservative, generally giving less than 1-5% false positive rates at the 2 
peptide level depending on the data sample size and the database size.  
In the second method, integrated top-down and bottom-up searching was 
performed with PTMSearch Plus software developed at Oak Ridge National Laboratory 
(Chapter 6). Output files containing bottom-up data from PTMSearch Plus were filtered 
by DTASelect [61] at the 2-peptides level with the following parameters:  MASPIC [63], 
scores of at least 23 (+1), 28 (+2) and 43 (+3). These scores were used to give the same 
approximate 5% false positive rate as with the scores applied for SEQUEST above.  The 
output files containing top-down data were filtered with at least three peaks within the 
isotopic package, a 3000 Da mass cutoff and a relative abundance of at least 10%.  The 
false positive rate (proteins identified that are not correct identifications) within the top-
down searching is considerably higher than the bottom-up methods due to the presence of 
PTMs. Post translational modifications increase the likelihood of a combination of PTM 
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masses added to the protein equaling the measured mass being searched. The same 
scenario is true for false negatives. False negatives are real proteins not identified or not 
included in the output of identifications due to low scores. The searching algorithms may 
miss proteins due to a mass with a combination of PTMs giving a better score than the 
real identification. Another area of concern in top-down data analysis is proteins with 
good signal to noise ratios and abundant isotopic packages that are not identified. This 
lack of identification could be due to three reasons. The first reason is degradation and 
truncation products making the mass significantly different from the predicted masses in 
the database. Second, a combination of PTMs or unique PTMs leaves the protein 
unidentified. Finally, missed start calls in the genome annotation process provide wrong 
protein masses within the database. Due to the false positives, false negatives and no 
identifications encountered with top-down searching alone an integrated top-down and 
bottom-up data searching is employed. The integrated searching provides a confident list 
of proteins from the bottom-up data that the top-down data can be compared against. In 
the data searching employed within this dissertation a combination of bottom-up peptide 
data, as well as a top-down intact mass measurement was required for a positive 
identification.    
The PTMSearch Plus program allows for the combined searching of both the top-
down and bottom-up data sets; as well as allowing for the searching of a defined set of 
PTMs (Chapter 6).  In the integrated top-down and bottom-up data searches a standard 
set of PTMs were searched for including: methylation, acetylation, N-terminal 
methionine truncation, and disulfide bonds (restricted to top-down data). Less common 
PTMs such as uridylylation were searched individually. All data outputs generated are 
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manually inspected and then compared using Microsoft Access (Microsoft Corp., 
Redmond, WA). 
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Chapter 3  
Extension of FTICR-MS Methodology for Proteins and Peptides: Advanced Charge 
State Determination and Alternative Fragmentation Approaches 
Data presented below is in preparation for submission or in press 
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Introduction 
In the process of this dissertation work, a need for fundamental advancements in 
the analysis of proteins and peptides was essential.  Two areas of particular interest were 
better methods for determination of charge states for large proteins and advanced protein 
fragmentation methods with FTICR-MS.  Both of these areas were examined to improve 
the overall experimental platform for identifying intact proteins and their associated 
PTMs.   
 The first area of development was the robust determination of charge states for 
large proteins.  Generally, the determination of the charge state for an ion with FTICR-
MS is straight forward if the spectrum is sufficiently resolved to distinguish peaks in the 
isotope packet for the ion. FTICR mass spectrometry provides very high resolution and 
accuracy because of the accuracy with which it is possible to measure the frequency of 
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ion cyclotron motion in the Penning trap [64]. This resolving power enables acquisition 
of mass spectra of electrosprayed intact protein ions with resolved isotopologues. Due to 
the unparalleled mass resolution and accuracy of the FTICR-MS, this is usually not a 
problem for proteins under electrospray conditions in which the analyte concentration 
and ion detection parameters can be optimized. A more challenging scenario is presented 
for situations in which these carefully controlled conditions are not possible, such as LC-
FTICR-MS measurements. In this case, the signal quality is compromised and the direct 
measurement and resolution of charge states from intact proteins is much more difficult.  
Due to the difficulties encountered with ion trap measurements and charge state 
determination, Dr. David Tabb (ORNL post doctoral research associate with the OBMS 
group) developed an automated method for determining charge states from high-
resolution zoom scans within the linear ion trap. Further, we decided this method could 
be applied to LC-FTICR-MS measurements and charge state determination, in order to 
perform an automated method for determining charge states from high-resolution mass 
spectra. Fourier transforms of isotope packets from high-resolution mass spectra are 
compared to Fourier transforms of modeled isotopic peak packets for a range of charge 
states. The charge state for the experimental ion packet is determined by the model 
isotope packet that yields the best match in the comparison of the Fourier transforms. 
The second area targeted for FTICR-MS development was the evaluation of 
proteins and peptide fragmentation methods within the FTICR-MS. A number of tandem 
mass spectrometry methods are employed to dissociate peptides and proteins using a 
FTICR-MS instrument; these include collision activated dissociation (CAD), surface 
induced dissociation (SID), electron capture dissociation (ECD), and multiphoton 
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infrared photodissociation (IRMPD).  Traditionally MS/MS on a FTICR-MS has been 
accomplished with sustained off-resonance irradiation collisionally activated dissociation 
(SORI-CAD).  This method makes use of the off-resonance excitation of the parent ions 
being investigated [65].  SORI-CAD is capable of producing high fragmentation 
efficiency with relatively simple implementation [65].  However, the need for manual 
individual parent ion selection, the low duty cycles required, and the delay for pump 
down after the introduction of pulsed collision gas make SORI-CAD difficult to use on 
complex mixtures. In contrast, electron capture dissociation uses low-energy electrons to 
neutralize the charges on the protein, producing cleavage of the amide bond to form c and 
z ions [66]. Surface induced dissociation (SID) allows for large amounts of energy to be 
deposited into a molecule in a very short amount of time [67].  Also, SID does not have 
the problematic introduction of collision gas, as with SORI-CAD, and has been 
implemented successfully to a FT-ICR for the study of biological molecules by Laskin et 
al. [67].  This method, although successful, can create the problem of charge 
neutralization and requires specialized equipment and implementation that may not be 
readily available in most instances.  IRMPD offers a method of fragmentation where no 
single frequency excitation is required and the ions of all m/z values are dissociated at the 
same time [68]. This method has been demonstrated useful with biomolecules [68].  
However, IRMPD is not always universally available, making another method capable of 
dissociation of all m/z values at the same time desirable.  
Recently, new techniques for dissociation have been employed using the rf-only 
multipole within the external source of an ESI FT-ICR-MS including: multipole storage 
assisted dissociation (MSAD) [69, 70], “ion thrashing”[71], and photon-induced 
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dissociation known as external IRMPD [72]. Previously, it was demonstrated that 
electrospray generated ions can be externally accumulated in an rf-only multipole prior to 
mass analysis by a FT-ICR [73].  Multipole storage assisted dissociation (MSAD) was 
first observed when ions were accumulated in the rf-only multipole for an extended 
period of time [74]. During a MSAD experiment there is not any apparent contact with 
the rods of the hexapole that could generate a surface induced dissociation. Space 
charging in the hexapole seems to push the ions out radially allowing them to obtain rf 
from the rods generating ions with higher kinetic energy [72,75, 76, 77]. The excited ions 
generated are then able to be fragmented with the background gas molecules in the 
hexapole (air at ~10-5 torr), making it a form of CAD [78].  MSAD allows for ion 
activation and dissociation simultaneously with ion accumulation and no collision gas is 
introduced into the analyzer cell, so no pump down period is needed creating a more 
efficient method [78].  Like IRMPD, the MSAD method provides an effective way to 
accomplish dissociation on all m/z values at once, but does not provide a way to perform 
targeted fragmentation.  Also, this method is quite accessible unlike IRMPD since most 
FT-ICR instruments are equipped with a linear ion trap at the interface of the electrospray 
ionization source to the FTICR cell.   
The level of fragmentation observed using MSAD is a function of hexapole 
accumulation time, dc off set voltage applied, and concentration of sample being used 
[75]. The dc offset voltage controls the depth of the electrostatic axial well [77,79]. The 
larger the dc offset voltage that is applied, the greater the capacity of the ion reservoir 
within the hexapole which allows for more space charging and dissociation by MSAD 
[79]. Extended ion accumulation times provide a larger population of ions with in the 
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multipole facilitating in the space charging and ion oscillation at higher amplitudes [80].   
Also important is the total sample concentration; varying sample concentration can 
require the need for different accumulation times to induce dissociation in MSAD 
experiments. 
This method has been used to successfully generate fragment ions in intact 
proteins, although, little has been reported on the efficacy of using MSAD on peptides.  A 
study by Haselmann et al. compared the effects of SORI-CAD, MSAD, and ECD on a 
single peptide and found fragment peaks more abundant with MSAD, when compared to 
SORI-CAD [81].  However, the Haselmann et al. study gave good preliminary results, an 
exhaustive MSAD and SORI-CAD comparison of peptides and peptide mixtures was not 
performed until this study.  In this work, we report on the efficacy of using MSAD 
instead of SORI-CAD on single peptide solutions, simple peptide mixtures and peptide 
solutions from tryptic digest of intact proteins to provide in-depth data on fragmentation 
patterns, ion series generated, and spectral complexity.  
Methods and Materials 
LC-FTICR-MS of Intact Proteins for Charge State Determination 
Five proteins (ubiquitin, chicken lysozyme C, bovine ribonuclease A, bovine 
carbonic anhydrase II, and bovine beta lactoglobulin-B) were dissolved in HPLC grade 
water to give a final concentration of 1 mg/mL of each protein, and diluted as required 
for the analysis. All capillary HPLCFTICR experiments were performed with an Ultimate 
HPLC (LC Packings) coupled to an IonSpec 9.4 T FTICR-MS (Lake Forest, CA) mass 
spectrometer equipped with an Analytica electrospray source. A Vydac 214MS5.325 
(Grace-Vydac, Hesperia, CA) C4 reverse phase column (300 m i.d. X 250 mm, 300 Å 
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with 5 m particles) was directly connected to the Analytica electrospray source with 100 
micron i.d. fused silica tubing. Injections of 30 µg of total protein were made onto a 100 
µl loop. The flow rate was 4 µL/min, with a 75 min gradient going from high water (95% 
water, 5% acetonitrile, 0.5% formic acid) to high organic (95% acetonitrile, 5% water, 
0.5% formic acid). All mass spectra were acquired with a 2 s hexapole ion accumulation 
time; 2 scans were signal averaged, 1024 K data points were acquired, and 2 zero fills 
were performed. The Hann window was used for apodization. Mass resolving powers of 
35,000 to 120,000 FWHM were achieved. Mass calibration was performed externally 
using an ubiquitin protein standard, providing approximately 10–50 millidalton accuracy. 
Mass spectra were viewed via the Omega 8 instrument control software provided by 
IonSpec. The most abundant isotopic mass (MAIM) for each protein was computed [82], 
and a spreadsheet calculated the m/z ratio corresponding to each charge state. To 
compute the MAIM values the most abundant isotopic mass within the isotopic package 
was compared to a calculated most abundant mass within the isotopic package. To obtain 
the calculated MAIM, the sequence of the protein was input in to the PAWS [84] 
software to obtain the number of each molecular atom present for the sequence. Once the 
molecular atoms were obtained, they were input into the Exact Mass Calculator, provided 
as part of the IonSpec software package, in order to determine the calculated most 
abundant isotopic mass within the isotopic package. Three mass spectra from the LC-
FTICR-MS data, containing charge state packets for the five proteins, were chosen for 
charge state analysis. The FTDocViewer “Isotope Clusters” feature displayed the isotopic 
packets from each spectrum along with the assigned charge state(s). A beta-version of 
IonSpec’s PeakHunter algorithm (version 0.0.24) was then used to assess charges for the 
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same spectra. Scripts were developed for examination of the data in external software. 
The mass spectra from the IonSpec instrument are extracted to an MS1 file [83] by 
“MakeMS1”, a Visual Basic Script for FTDocViewer in the Omega8 instrument control 
software. The isotopic packets for proteins ranging in charge from z = 5 to 30 are 
modeled, and FFTs of these charge models are stored. The observed mass spectra are 
read into memory by the “Tact” algorithm, C ++ software created at ORNL for analysis 
of FTICR data from intact proteins. The software identifies the set of nonoverlapping one 
m/z-wide windows containing the highest intensity within each mass spectrum. The FFT 
of each one m/z-wide window is computed, and the charge model FFT that best matches 
the FFT of the observed spectrum (in terms of normalized dot product score) is stored as 
the charge state for that packet. 
Methods for MSAD Fragmentation 
Eight synthetic peptides along with angiotensin I, angiotensin II, Neurotensin, 
Bradykinin, Des-Arg Bradykinin, Thr-Bradykinin, and Meth-Enkephalin were used as 
purchased from Sigma-Aldrich (St. Louis, MO) without further purification.  Each of the 
peptides and protein solutions were prepared in 50/50 Acetonitrile/water: 0.1 % Acetic 
Acid to a total concentration of 10 µM.  Acetonitrile and HPLC grade water were 
purchased from Burdick and Jackson (Muskegon, MI).  Acetic acid (99.9 %) was from 
Sigma-Aldrich (St. Louis, MO).  
 Mixtures of Angiotensin I, Meth-Enkephalin, synthetic peptides 3, 4, 6, and 7 
were made using 10µM concentration solutions at a ratio of 1:1 and also peptide was 
mixed at a 1:100 ratio to the other 5 peptides. Bovine Serum Albumin (Sigma-Aldrich, 
St. Louis, MO) and Horse Apomyoglobin (Sigma-Aldrich, St. Louis, MO) were 
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denatured with 6M Guanidine and 5 mM DTT at 60OC for 1 hour and then diluted in 50 
mM Tris (pH 7.5)/ 5 mM CaCl2 to obtain a final Guanidine concentration of 1 M.  
Sequencing grade trypsin (Promega, Madison WI) was added at a concentration of 1:50 
and allowed to digest for 16 hours.  Trypsin was then added a second time at a 
concentration of 1:50 and digested for another 6 hours, followed by a final reduction step 
with 10mM DTT for 1 hour.  Samples were immediately desalted with a C18 Sep-Pak 
(Waters, Milford MA) and concentrated by centrifugal evaporator (Savant Instruments, 
Holbrook, NY).  Samples were diluted in 50:50:0.1 ACN:H2O:HOAc to a total 
concentration of 10 µM.     
ES-FT-ICR mass spectra were all acquired with an IonSpec (Lake Forest, CA) 
9.4-Tesla (Cryomagnetics Inc., Oak Ridge, TN) HiRes electrospray Fourier transform ion 
cyclotron resonance mass spectrometer.  A Harvard syringe pump set at a flow rate of 
1.75 µL/min was coupled to an Analytica electrospray source (Analytica of Branford, 
CT).  After generation, ions were accumulated in an external hexapole and transferred 
into the high-vacuum region with a quadrupole lens system.  Detection then followed in 
the cylindrical analyzer cell of the mass spectrometer.  Calibration of the mass 
spectrometer was accomplished externally with ubiquitin resulting in a mass accuracy of 
±3 ppm and resolutions of 50,000-160,000 (FWHM) for peptides. 
To perform ion collisional dissociation an ion of interest was isolated from a 
peptide within the analyzer cell of the mass spectrometer and then accelerated into a 
nitrogen target gas under sustained off-resonance irradiation collision-activated 
dissociation (SORI-CAD).  An rf pulse set at ~ 1KHz lower in frequency applied for 2 
seconds at an amplitude range of 2-5 volts was used for the ion excitation in SORI-CAD 
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experiments.  During the ion excitation step a pulsed valve was used to admit the nitrogen 
collision gas into the high vacuum region to a maximum pressure of about 5 X 10-6 Torr. 
Prior to ion detection the base pressure was returned to 6X10-10 Torr. 
Under normal mass spectrum conditions the dc voltage in the rf-only hexapole, 
located at the interface of the electrospray source and the FT-ICR cell, is at -3.5v with an 
ion accumulation time of one to two seconds. These experimental parameters generate 
multiply charged molecular ions with virtually no fragmentation.  When performing a 
MSAD experiment these conditions are altered to facilitate dissociation within the 
hexapole.  The dc offset voltage is decreased to -7 to -11 volts and accumulation time is 
increased to 4-5 seconds creating extensive fragmentation of the ions within the rf-only 
hexapole. After dissociation and injection into the ICR cell, ion detection followed.  
Since no parent ion isolation, activation, or pump down delays from collision gas 
addition were needed, overall scan functions for MSAD experiments generally took 2 to 
6 s per transient acquired. Each spectrum obtained was comprised of 2 co-added 
transients acquired at 1024K data points. Deconvolution of product ion spectra to a zero 
charge state was accomplished with the IonSpec deconvolution software.   
All peptide samples were tested at a number of different offset voltages and 
accumulation times. It was found that a 5 second accumulation and -11 V offset voltage 
were the optimal conditions to produce MSAD fragmentation in all samples, therefore, all 
MSAD data presented have these conditions.  Also important is the total sample 
concentration; this is why all peptide samples were kept at 10uM for both the SORI-CAD 
and MSAD experiments thus preventing the need for different accumulation times to 
induce dissociation in MSAD experiments [70]. Due to the extensive fragmentation 
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observed in a MSAD experiment, a high resolution instrument, such as an FT-ICR, is 
needed to resolve these complex spectra.   
Data analysis was accomplished with the ProteinInfo function of the PROWL 
website provided by the Rockefeller institute [84]. PROWL is a protein analysis website 
that enables users to perform mass calculations, mass spectrometry fragmentation, and 
insilico digest of proteins. These functions within the PROWL website allow for the 
comparison of experimental data to calculated data for the protein. Both CAD and MSAD 
fragments, generated in the mass spectra, were analyzed under the mass spectrometry 
fragmentation function to assign fragmentation patterns. Manual inspection was used to 
verify all PROWL results and to search for additional identification of internal fragments 
from the loss of water, which is due to PROWL only assigning ammonia loss.  For the 
simple peptide mixture, the MSAD spectrum of the mixture was compared to the 
individual MSAD spectrum for each component in order to identify which fragment ions 
were generated from each individual peptide component present in the mixture. These 
matching MSAD fragments could then be assigned identifications using PROWL.  
Fragment ions identified from BSA and Apomyoglobin with PROWL were only reported 
to two decimal places by the program. To obtain a more accurate mass to compare to the 
FT-ICR MSAD fragments for tryptic digest of both BSA and Apomyoglobin, the PAWS 
[84] program was used to determine the atom composition, of MSAD fragment ions.  
Following the determination of atom composition the IonSpec exact mass calculator was 
used to calculate the exact mass of the fragment ion that could be compared to the mass 
of the MSAD fragment ion observed in the spectrum. 
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Results for Charge State Determination of Intact Proteins 
Charge Measurement for Intact Protein Isotope Clusters in FTICR Spectra 
The resolution of FTICR mass spectrometry makes it possible to apply the 
developed charge state determination technique to small sections of normally-acquired 
mass spectra. The Tact software, developed at ORNL by Dr. David Tabb, for intact 
protein identification from FTICR data was adapted to find isotopic packets in collections 
of mass spectra and perform charge state assignments by FT. The FFTs of these packets 
were compared to FFTs of modeled isotopic packets in order to determine charges by 
moving across the experimental isotopic package while comparing how well the 
overlapping experimental isotopic peaks match. Because most proteins adopt multiple 
charge states under electrospray conditions, multiple isotopic packets of known charge 
are available to test charge state detection algorithms. Three mass spectra from a liquid 
chromatographic separation interfaced via electrospray with the FTICR were examined; 
mass spectrum 10 included charge packets for ribonuclease A, mass spectrum 23 showed 
the presence of ubiquitin and lysozyme, and mass spectrum 42 gave evidence for beta 
lactoglobulin and carbonic anhydrase. Table 3.1 compares the performance of IonSpec’s 
“FTDocViewer” and “PeakHunter” software to that of Tact for charge state inference. 
Each charge determination reported from Tact is the top-scoring match.
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Table 3.1: Automated protein charge state assignments from FTICR data 
 
   Charge State Assignment*  
Charge MAIM m/z Intensity FTDoc Z PeakHunter Z Tact Z Tact Score 
Ribonuclease A, Mass Spectrum 10 
7 1956.04 0.05 No Call No Call 5 0.46 
8 1711.66 11.35 10, 8 10,4,4 9 0.58 
9 1521.59 21.14 10, 9 1, 2, 9 11 0.49 
10 1369.53 7.15 10 10 10 0.75 
11 1245.12 5.80 11, 1 11 11 0.87 
12 1141.44 0.83 3, 12 12 12 0.91 
Ubiquitin, Mass Spectrum 23 
5 1713.92 0.06 2, 4 No Call 5 0.76 
6 1428.44 4.80 6 6 6 0.86 
7 1224.52 26.74 7 7 7 0.83 
8 1071.58 19.30 8 8 8 0.84 
9 952.62 15.98 9 9 9 0.97 
10 857.46 5.53 10 10 10 0.97 
11 779.60 2.67 11 11 11 0.92 
12 714.72 0.49 12 12 12 0.89 
Lysozyme, Mass Spectrum 23 
9 1590.87 1.16 9, 2 9, 4 9 0.76 
Beta Lactoglobulin, Mass Spectrum 42 
11 1662.67 0.09 8 No Call 18 0.47 
12 1524.20 0.10 8, 6, 2 12, 3, 3 6 0.37 
13 1407.03 0.40 2, 13 14 13 0.49 
14 1306.60 3.61 2, 14 1, 14 14 0.50 
15 1219.56 2.31 1, 14, 15 15, 2 15 0.59 
16 1143.40 0.09 2 16 16 0.65 
17 1076.20 0.14 No Call 29, 7 27 0.34 
Carbonic Anhydrase, Mass Spectrum 42 
21 1383.08 0.08 4 3 30 0.31 
22 1320.26 0.11 5 4 22 0.31 
23 1262.90 0.38 No Call 8, 8 23 0.26 
24 1210.32 0.30 1 12, 12 8 0.29 
25 1161.95 0.17 1 10, 5 25 0.48 
26 1117.30 0.16 2, 4 26 26 0.38 
27 1075.95 0.14 No Call 29, 7 27 0.34 
28 1037.56 0.07 No Call No Call 28 0.54 
29 1001.82 0.10 No Call 29 29 0.63 
30 968.46 0.07 No Call No Call 30 0.40 
*Correct charge assignments are shown in bold font. 
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While Table 3.1 also lists the Tact score for each top-ranking assignment, it is important 
to emphasize that these scores are not used in an absolute sense, but rather for ranking 
matches for each isotope packet. That is, there is no absolute threshold score above which 
a charge state assignment is accepted. Instead, the reported charge state assignment is 
simply that with the highest Tact score.  While Tact reported only one charge assignment 
for each peak packet, FTDocViewer and PeakHunter can report multiple charge 
assignments for each set of isotopic peaks, giving them a better chance of randomly 
hitting the correct charge, but reducing their specificity.  
The isotopic packets in scan 10 for ribonuclease A were intense, but also 
contained additional isotopic packets near the most intense packets, suggesting that other 
forms of the protein were also present. Perhaps, because of these additional packets, the 
two most intense packets, corresponding to the z = 8 and z = 9 charge states of the 
protein, resulted in multiple charge state calls by FTDocViewer and PeakHunter and an 
incorrect charge assignment by Tact. For less intense isotope packets corresponding to 
higher charge states, Tact and PeakHunter yielded correct results, while FTDoc returned 
multiple possible charges for the z = 11 and 12 states. Scan 23 included isotopic packets 
for ubiquitin and lysozyme. Ubiquitin’s packets for z = 7 through 9 were the most 
intense, and they were more than an order of magnitude more intense than lysozyme’s 
sole isotopic packet at z = 9. All of these packets were assigned the correct charge by all 
three algorithms. The z = 5 charge state for ubiquitin, however, was called correctly by 
only the Tact algorithm. This isotopic packet was the least intense to be assigned a 
correct charge in this collection of mass spectra. Scan 42 comprised a much greater 
challenge.  β- lactoglobulin and carbonic anhydrase both contributed isotopic packets, but 
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β-lactoglobulin’s  z = 14 charge state was approximately 10-fold more intense than the 
most intense carbonic anhydrase isotopic packet. FTDocViewer and PeakHunter both 
yielded multiple charge state calls for many isotopic packets. In several cases, the packets 
for carbonic anhydrase were not assigned charges by these algorithms, presumably 
because these low-intensity peaks were not easily centroided. Tact, however, was able to 
assign four consecutive correct charge states for β-lactoglobulin. For carbonic anhydrase, 
only Tact was able to achieve any consistency, assigning eight of the 10 charge states 
correctly. Scan 42 demonstrates that FFT is particularly powerful for inferring charge 
states from noisy signals of low intensity. Overall, Tact performed comparably to FTDoc- 
Viewer and PeakHunter in determining charge states from ion packets of moderate 
intensity and signal-to noise ratio, while providing an improvement for low abundance, 
noisy isotope packets. It is important to keep in mind that, in the context of this LC-MS 
experiment, the proteins were available during only a limited time for MS data 
acquisition during elution of a peak in a liquid chromatography separation. As such, the 
optimal performance factors for high-resolution mass measurement must be 
compromised somewhat to accommodate the shorter time frame for ion detection (i.e., 
few scans and fewer data points for the transient signal). The exquisite resolution possible 
for FTICR instruments, along with FTDocViewer and PeakHunter processing algorithms, 
enables accurate determination of charge states for proteins up to at least 60 kDa under 
direct infusion conditions, where protein concentrations and ion accumulation and 
detection parameters can be optimized. Accurate charge state determination is a critical 
component for computational programs such as THRASH [85], which seek to combine 
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this information with isotopic abundance in order to permit comparisons between 
measured and predicted mass spectra for molecular identifications. 
Results for the Comparison of MSAD and SORI-CAD for Peptides and Peptide 
Mixtures 
SORI-CAD and MSAD for Single Peptides  
 A range of peptides were examined with MSAD in this study in order to 
determine the general utility of the technique, and to make a general comparison with 
SORI-CAD. It has been previously demonstrated that proteins have similar fragmentation 
patterns in both low energy MSAD experiments and in SORI-CAD [69, 77]. However, in 
this study, high energy MSAD (based on experimental observation) was used to take 
advantage of the unique property of MSAD, which is the ability to put high amounts of 
collisional energy into the peptide. This high energy MSAD was performed by simply 
elongating the accumulation time to 4-5 seconds from 2 seconds and adjusting the 
magnitude of the dc offset to -11V from -7V for all peptides.  These high energy MSAD 
experimental parameters were compared with standard SORI-CAD conditions. SORI-
CAD experiments were accomplished with a rf pulse, set at ~ 1KHz lower in frequency 
than normal mass spectra acusition, applied for 2 seconds at an amplitude range of 2.8-
4.0 volts to ensure complete dissociation of the peptide. 
In this study, we have conducted MSAD and SORI-CAD experiments with 
peptides that exhibit a wide range of diversity in their amino acid sequence, molecular 
weight and post translational modifications (Table 3.2).  The MSAD spectrum and SORI-
CAD spectrum are shown for both synthetic peptide 1 and Bradykinin (Figure 3.1).  
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Table 3.2   Name, sequence and molecular weight of all peptides used. 
 
  Sequence  MW 
synthetic 1  Acetyl-RAYIFAVR-OH  1036.6 
synthetic 2  AQTERKSGKRQTER  1673.9 
synthetic 3  GKAKVTGRWK  1129.7 
synthetic 4  VHLTPVEK  922.1 
synthetic 6  MEMKKVLNS  1079.3 
synthetic 7  FLEEI  649.7 
synthetic 8  YIGSR  594.7 
Angiotensin 1  NRVYIHFPHL  1296.5 
Angiotensin 2  NRVYIHPF  1046.2 
Bradykinin  RPPGFSPFR  1060.2 
Thr-Bradykinin  RPPGFTPFR  1074.2 
Des-Arg Bradykinin PPGFSPFR  904 
Meth-Enkephalin  YGGFM  573.7 
Neurotensin  ELYEDKPRRPYI  1672.9 
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Figure 3.1:  B and Y ion labeled MSAD and SORI-CAD spectrum for Bradykinin and 
Synthetic peptide 1. The loss of water labeled with (*) and the loss of ammonia labeled 
with (o). (A) MSAD spectrum of Bradykinin (B) SORI-CAD spectrum of Bradykinin (C) 
MSAD spectrum of Synthetic 1 (D) SORI-CAD spectrum of Synthetic 1. 
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In the Bradykinin MSAD spectrum (Figure 3.1A) the loss of water and ammonia occurs 
with the prominent b or y ion. In the case of the y7 ion within the MSAD spectrum 
(Figure 3.1A) the loss of water is most likely from the serine side chain contained in the 
sequence of the fragment ion.  In contrast to the MSAD spectrum, the SORI-CAD 
spectrum (Figure 3.1B) for Bradykinin has the same prominent b8, b9, y7, and y6 ions 
without the loss of water and ammonia.  To simulate fragmentation of peptides with post 
translational modifications, synthetic peptide 1 was chosen because it has an acetyl group 
on the N-terminal. In the MSAD spectrum of synthetic peptide 1, the acetyl group is 
maintained only on the b7 ion and not on any other b ions or the y-ion series (Figure 
3.1C). In comparison, the SORI-CAD spectrum has the acetyl group maintained on the 
fragment ion b8 (Figure 3.1D). Both the MSAD fragment ions for synthetic peptide 1 
contain the acetyl group on one ion; the SORI-CAD spectrum also has the acetyl group 
on the prominent b ion within the spectrum.  
Both SORI-CAD and MSAD experiments provided identifiable peptide 
fragmentation patterns when searched using the PROWL website [84].  Comparisons of 
identifiable fragments from both methods reveal a more extensive fragmentation pattern 
in the MSAD spectra, with 10 out of 15 peptides showing more identifiable fragment ions 
than seen with SORI-CAD (Figure 3.2).  
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Figure 3.2:  Comparison of MSAD and SORI-CAD fragment ion identifications for all 
14 peptides.  
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 MSAD experiments produce more fragment ions than SORI-CAD, although, the 
fragment ions that are produced in SORI-CAD are more easily identified and give a 
spectrum where almost all fragment ions are b and y ions, without the internal fragments 
and loss of water and ammonia.  Table 3.3 shows the most abundant MSAD and SORI-
CAD fragment ions for each peptide. On average, there are 2 to 4 fragment ions observed 
in the SORI-CAD spectrum; in comparison, there are 4 to 10 fragment ions in the MSAD 
spectra (Table 3.3).  When comparing the MSAD and SORI-CAD fragment ions, the 
predominant fragment ions in the spectra of both methods are often the same. This can be 
seen in the comparison of MSAD and SORI-CAD spectra for synthetic peptide 4 where 
both methods have a prominent b8 and b7 ions (Table 3.3). The differences in the amount 
of abundant fragment ions in the case of synthetic peptide 4 is the b8 and b7 fragment ions 
in the MSAD spectrum are also accompanied by fragment ions with a loss of water, 
ammonia, or both. Another difference in the number of abundant fragment ions observed 
between MSAD and SORI-CAD spectra are the amount of internal fragments. This is 
demonstrated in synthetic peptide 6, where some of the same predominant b and y ions 
within the MSAD spectrum have five additional internal fragment ions (Table 3.3). 
MSAD experiments allow for the dissociation of all parent ions within the rf-only 
hexapole without pre-selection or isolation of parent ions, as required with SORI-CAD 
experiments.  This simultaneous dissociation of parent ions gives a (b and y) series of 
ions although, this series has numerous internal fragment ions with water and ammonia 
loss.  The internal fragment ions observed are possibly occurring from the layering 
sequential fragmentation, where a y-ion is formed followed by another fragmentation 
event that fragments the y-ion, giving a b-ion creating an internal fragment that has both a  
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Table 3.3: Most abundant fragment ions from MSAD and SORI-CAD 
 
SORI-CAD MSAD 
Peptide mass ID mass ID 
synthetic 1 1019.5735 b8+acetyl 976.5490 b8 
 976.5340 b8  881.4810 b7+acetyl 
   863.4708 b*7 
   839.4692 y7 
   767.4292 y6 
   763.3966 b6 
   692.3616 b5 
   604.3691 y5 
     
synthetic 2 1656.9046 b14 787.4061 y13b8, y12b9 
 1499.8229 b13 700.3772 y7b13 
 1352.7613 b12 642.3486 y*12b8, y12b*8 
 1245.0000 y10 625.3229 y*12b*8 
 300.6062 b3   
     
synthetic 3 874.5290 y7 1130.6771 y10 
 745.4103 y6 797.4930 b8 
 646.3574 y5 797.4831 b8 
   745.4221 y6 
   728.4116 y*6,  
   613.3707 y8b8, y*5b10 
     
synthetic 4 904.5306 b8 922.5342 y8 
 775.4280 b7 904.5360 b8 
 572.3182 y5 886.5207 bo8 
 471.2693 y4 775.4272 b7 
   757.4186 bo7 
   740.3910 b*o7 
   685.4032 y6 
   667.3974 y*6 
   649.3903 y*o6 
     
synthetic 6 859.4900 b7 1060.5515 b9 
 819.4605 Y7 973.5278 b8 
 745.4040 b6 859.4911 b7 
 688.4163 y6 714.4148 y7b8 
   583.3723 y7b*7, y*7b7 
   542.3089 y5b9, y*5 
   697.4080 yo7b8 
   679.3906 yo7bo8 
   649.3341 y5 
     
synthetic 7 631.3324 b5 631.3158 b5 
 518.2440 b4 649.3341 y5 
     
synthetic 8 576.3034 b5 595.3240 y5 
     
Angiotensin 1 1295.7120 y10 1277.6543 b10 
 1027.5310 b8 1181.6592 y9 
 930.5140 b7 1027.5335 b8 
 512.2739 y4 895.4815 y8b9 
   783.4191 b6 
   765.4006 bo6 
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Table 3.3: Continued 
SORI-CAD MSAD 
Peptide mass ID mass ID 
Angiotensin 2 1027.5313 b8 1045.5322 y8 
 931.5180 y7 1027.5125 b8 
   784.4000 b6 
   765.3886 b *6 
   669.3738 y7b6 
     
Bradykinin 1042.5724 b9 886.4480 b8 
 904.4668 y8 869.4369 bo8 
 886.4446 b8 806.4099 y7 
 806.4059 y7 789.3976 y*7 
   709.3550 y6 
   992.3518 yo6 
     
     
Thr-Bradykinin 918.4921 y8 1074.5695 y9 
 554.2995 b5 899.4847 b8 
   820.4328 y7 
   802.4019 yo7 
   803.4057 y*7 
   723.3864 y6 
   705.3649 Yo6 
     
Des-Arg Bradykinin 886.4558 b8 806.3939 y7 
 729.3487 b7 789.3827 y*7 
 709.3772 y6 709.3678 y6 
   652.3238 y5 
   634.3130 yo5 
     
Meth-Enkephalin 555.2069 b5 585.1631 y6b8, y*7b7, y7b*7 
 424.1742 b4 573.2314 y5 
     
     
Neurotensin 660.3990 y5 633.8616 y11b7 
   556.9702 y*6b11, y6b*11 
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y and b end. This effect could be due to the ions multiple pass in the z-direction in the 
hexapole as proposed by Pan et al. [77].  It has also been demonstrated that the proportion 
of fragment ions increase with pressure [86]. The effect of pressure and space charging in 
the rf-only hexapole will lead to a smaller mean free path for the ion and higher 
oscillation amplitudes creating more kinetic energy and therefore leading to the creation 
of more internal fragment ions [86]. Unlike MSAD, SORI-CAD takes place in the ICR 
cell where there is an order of magnitude difference in pressure from the hexapole 
creating ions with a larger mean free path that experience less space charging thereby 
leading to lower oscillation amplitudes and no observed internal fragment ions.   Due to 
the nature of MSAD, where it has been suggested that the lowest energy process is 
selected for dissociation [75], the loss of ammonia and water is often seen as compared to 
SORI-CAD where there is rarely a loss of water or ammonia. The loss of water in a 
MSAD experiment is mainly coming from the side chain of the amino acids, such as 
threonine and serine (since it is a low energy requirement dissociation) [87], while the 
loss of ammonia is primarily coming from the the N-terminal.  SORI-CAD also gives b 
and y ions, but there are rarely water and ammonia loss and also no internal fragment 
ions present. 
MSAD for Simple Mixtures 
Even though MSAD can not isolate a parent ion for fragmentation, a combination 
of peptides, from the single peptide standards, was used to provide individual peptide 
identifications, as well as examine sensitivity and dynamic range for the mixtures.  Six 
individual peptide standards (synthetic 3,4,6,7, angiotensin1, meth-enkephalin) were 
chosen and mixed at a 1:1:1:1:1:1 concentration for all six peptides in order to form a 
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simple peptide mixture. A mass spectrum was obtained for the mixture followed by a 
MSAD spectrum (Figure 3.3). These two spectra were compared to see if any parent ions 
remained and to examine the extent of fragmentation for the individual peptides within 
the mixture. Each parent peptide within the mass spectrum (Figure 3.3A) was assigned a 
color label which was used to label corresponding fragment ions within the MSAD 
spectra (Figure 3.3B). As indicated by the dashed lines, some of the parent peptides did 
remain in the MSAD spectrum for angiotensin1, synthetic 3 and synthetic 4 (Figure 3.3).  
The major fragment ions in the mixture MSAD spectrum were generally the same 
fragment ions found in the MSAD spectrum for the individual peptide. This can 
especially be seen for angiotensin 1 where all of the abundant fragment ions produced in 
the mixture MSAD spectrum are the same as those found in the MSAD spectrum of 
angiotensin 1 (Table 3.3, Figure 3.3B). However, Meth-Enkephalin did not produce any 
major fragment ions within the MSAD spectrum, as seen when fragmented as a single 
peptide, but this could be due to the small size of this peptide (MW=573.7).  The similar 
MSAD fragmentation patterns for individual peptides, as well as in the mixture, make it 
possible to verify the presence of a peptide in a mixture. Furthermore, the identity of the 
parent protein could be determined based on the peptide fragmentation and sequence 
information provided by MSAD. 
 Peptide mixtures were also prepared with varying concentrations for each of the 
individual peptides in order to examine sensitivity and dynamic range.  The mixtures 
contained all six peptides, as before (synthetic 3,4,6,7, angiotensin-1, meth-enkephalin), 
but one peptide was at a 1:100 concentration to the other 5 peptides. This 1:100 mixture 
ratio was repeated for each of the six peptides. 
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Figure 3.3: Dissociation data for 1:1 peptide mixture. A) FT-ICR spectrum of peptide 
mixture with each peptide mass peak labeled a different color. B) MSAD spectrum of 
peptide mixture with fragment ions labeled in the color corresponding to parent peptides. 
Dashed lines show the remaining parent masses in the spectrum.
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Each parent peptide was assigned the same color label as in the 1:1:1:1:1:1:1 mixture, 
which was then used to label corresponding fragment ions within the MSAD spectra 
(Figure 3.4). Generally, the peptide that was at a lower concentration within the mixture 
produced MSAD fragments within the spectrum.  This can be seen for the peptide 
mixture with angiotensin-1 at a lower concentration to the other five peptides (Figure 
3.4).  The major MSAD fragment ions are labeled within the spectrum to show that 
fragment ions from all six peptides are present (Figure 3.4). Only the most abundant 
fragment ions are labeled within the MSAD spectrum, although, the lower abundant 
fragment ions also provided identifications (Figure 3.4). For synthetic peptides 4 and 3, 
the parent ion remains within the spectrum (labeled with a (*) in the corresponding 
color).  This identification of low abundance fragment ions demonstrates the good 
sensitivity and dynamic range of the MSAD method on peptide mixtures of varying 
concentration.  The success rate of MSAD for providing fragment ions for all peptides in 
the mixture is 100%. To test the success rate of smaller peptides at lower concentrations 
meth-enkephalin was mixed at a lower concentration (1:100) to the other five peptides 
(data not shown).  Again, there were identifiable fragment ions from all six peptides 
within the mixture.  The fragment ions from meth-enkephalin were at a lower abundance 
within the spectrum, but still provide an identifiable isotopic packet when the peaks are 
expanded. In this study, the sensitivity and dynamic range afforded by MSAD is 
comparable to other methods of dissociation that do not require pre-isolation of parent 
ions.   
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Figure 3.4:  MSAD spectrum for six peptide mixture containing synthetic 3,4,6,7, 
angiotensin-1, and meth-enkephalin with angiotensin-1 at a 1:100 concentration to the 
other five peptides.  The major fragment ions are color labeled, according to which parent 
peptide they were generated from, within the MSAD spectrum.  Remaining parent 
peptides within the MSAD spectrum are labeled with a (*) and corresponding color. 
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MSAD forTryptic Digest of Apomyoglobin and BSA 
Previously, only limited research has been conducted on MSAD of single peptides 
with no information being provided for more complex mixtures, especially tryptic 
digests. In general, most bottom-up proteomics work requires tryptic digest of intact 
proteins followed by some form of MS/MS analysis. MSAD allows for a MS/MS 
experiment on tryptic digest without pre-selection of parent ions, making it a useful 
sequencing tool that has a lower duty cycle with a smaller time scale than methods such 
as SORI-CAD. In this study, we have conducted MSAD experiments on tryptic digest of 
two large proteins, BSA and Apomyoglobin, to test the utility of MSAD for more 
complex peptide mixtures. 
To examine the efficacy of MSAD on tryptic digests, a mass spectrum was 
obtained for the tryptic digest of apomyoglobin, followed by a MSAD spectrum (Figure 
3.5a-b).  The MSAD spectrum for the tryptic digest of Apomyoglobin shows 22 un-
fragmented parent tryptic peptides (Figure 3.5b).  There are 22 un-fragmented parent 
tryptic peptides remaining in the spectra, but most of these are lower in abundance. The 
five most abundant remaining parent ions within the apomyoglobin tryptic digest MSAD 
spectrum are labeled (*), revealing a wealth of abundant identifiable MSAD fragment 
ions (Figure 3.5b). Also, the MSAD spectrum of apomyoglobin contains a large number 
of internal fragment ions, as well as fragment ions that have a loss of water or ammonia, 
as seen in the single peptide and simple mixtures MSAD spectra (Table 3.4).  This can be 
seen for identified apomyoglobin tryptic peptide 17-VEADIAGHGQEVLIR-31, 
spanning amino acids 17 through 31, which has all internal fragment ions with loss of 
water or ammonia (Table 3.4).   
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Figure 3.5: BSA and Apomyoglobin Tryptic digest MSAD spectrum. A) Apomyoglobin 
tryptic digest FT-ICR spectrum. B) Apomyoglobin tryptic digest MSAD spectrum with 
surviving parent masses labeled with (*). C) BSA tryptic digest FT-ICR spectrum. D) 
BSA tryptic digest MSAD spectrum with surviving parent masses labeled with (*). 
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Table 3.4: Apomyoglobin tryptic digest MSAD fragmentation data 
 
 
MSAD 
fragment 
ion 
(measured) 
MSAD fragment ion (calculated) 
Sequence of Tryptic Peptide Mass Mass ID Sequence 
 
32-LFTGHPETLEK-42 618.3272 618.32246 y5 ETLEK 
 540.2588 540.25706 y10b6 FTGHP 
     
32-LFTGHPETLEKFDKFKHLK-50 540.2588 540.25706 y18b6 FTGHP 
 760.4654 760.40338 Y*9b*16 KFDKFK 
 602.3585 602.31899 y*12b12 TLEKF 
 618.3272 618.26494 y*16b*9 GHPETL 
 585.335 585.29244 y*12b*12 TLEKF 
     
32-LFTGHPETLEKFDKFKHLKTEAEMK-56 618.3272 618.26494 y*22b*9 GHPETL 
 585.335 585.29244 y*18b*12 TLEKF 
 602.3585 602.31899 y*18b12 TLEKF 
 737.4197 737.431 y10b21 KHLKTE 
     
32-LFTGHPETLEKFDKFK-47 618.3272 618.28875 y*13b9 GHPETL 
 540.2588 540.25706 y18b6 FTGHP 
 585.335 585.29244 y*9b*12 TLEKF 
 760.4654 760.40338 y*6b*16 KFDKFK 
     
1-GLSDGEWQQVLNVWGKVEADIAGHGQEVLIR-31 540.2588 540.23057 y*14b23 EADIAG 
 687.3822 687.31021 y*9b*29 GHGQEVL 
 660.3053 660.26293 y*14b*24 EADIAGH 
 706.4031 706.35643 y*23b*14 QVLNVW 
 679.4 679.33028 y*17b*21 GKVEADI 
 588.2961 588.2418 y*13b*25 ADIAGHG 
     
119-HPGDFGADAQGAMTK-133 626.2714 626.20983 y*14b*8 PGDFGAD 
     
103-YLEFISDAIIHVLHSKHPGDFGADAQGAMTK-133 626.2714 626.20983 y*14b*24 PGDFGAD 
 588.2961 588.2418 y*17b*20 ADIAGHG 
 719.4053 719.37281 y*26b12 SDAIIHV 
 613.3476 613.3561 y27b10 ISDAII 
     
97-HKIPIKYLEFISDAIIHVLHSKHPGDFGADAQGAMTK-133 588.2961 588.2418 y*17b*26 SKHPGD 
 719.4053 719.37281 y*26b18 SDAIIHV 
 579.3518 579.303 y*27b*16 ISDAII 
 630.3732 630.35029 y*33b9 IKYLE 
     
97-HKIPIKYLEFISDAIIHVLHSK-118 719.4053 719.37281 y*11b18 SDAIIHV 
 613.3476 613.3561 y12b16 ISDAII 
 579.3518 579.303 y*12b*16 ISDAII 
 630.3732 630.35029 y*18b9 IKYLE 
     
103-YLEFISDAIIHVLHSK-118 719.4053 719.40786 y6 HVLHSK 
 613.3476 613.3561 y12b10 ISDAII 
 579.3518 579.303 y*12b*10 ISDAII 
     
17-VEADIAGHGQEVLIR-31 687.3822 687.31021 y*9b*13 GHGQEVL 
 660.3053 660.26293 y*14b*8 EADIAGH 
 588.2961 588.2418 y*13b*9 ADIAGHG 
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Table 3.4: Continued 
 
MSAD 
fragment ion 
(measured) 
MSAD fragment ion (calculated) 
Sequence of Tryptic Peptide Mass Mass ID Sequence 
1-GLSDGEWQQVLNVWGK-16 706.4031 706.35643 y*8b*14 QVLNVW 
 585.335 585.31491 y5b16 NVWGK 
     
78-KKGHHEAELKPLAQSHATK-96 660.3053 660.32178 y18b7 KGHHEA 
 803.4717 803.40518 y*8b*19 LAQSHATK
 708.3645 708.36806 y15b10 HEAELK 
 692.365 692.33676 y*8b16 LAQSHAT 
 617.3262 617.30474 y*9b16 PLAQSH 
 537.3076 537.25605 y*14b*10 EAELK 
     
79-KGHHEAELKPLAQSHATK-96 803.4717 803.40518 y*8b*18 LAQSHATK
 708.3645 708.36806 y15b9 HEAELK 
 692.365 692.33676 y*8b17 LAQSHAT 
 617.3262 617.30474 y*9b15 PLAQSH 
 537.3076 537.25605 y*14b*9 EAELK 
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There are also many identified apomyoglogin peptides in the mixture that have missed 
enzymatic cleavages. This phenomenon is evident when examining the identified 
sequences of the fragment ions. For example, the first four peptides in Table 3.4 all start 
at amino acid number 32 but end at varying lengths from amino acid number 42 to 56 
(Table 3.4).  These missed cleavages create a series of fragment ions that have the same 
mass and sequence for the different tryptic peptides. However, there are repeating 
fragments within the MSAD spectrum due to missed enzymatic cleavages, the fragment 
ions obtained allow for the identification of these missed cleavage locations within the 
amino acid sequence of the peptide and protein.  Therefore, the extensive fragmentation 
provided by MSAD gives the ability to identify peptides with missed enzymatic 
cleavages.  
In order to examine efficacy of using MSAD on a tryptic digests of a large 
protein, tryptic digests of BSA were used in this study. For comparison, a mass spectrum 
was obtained for the tryptic digest of BSA followed by a MSAD spectrum (Figure 3.5c-
d). Similar to apomyoglobin, the MSAD spectrum of the BSA tryptic digest reveals 20 
un-fragmented parent tryptic peptides within the spectrum (Figure 3.5d).  Of these 20 un-
fragmented parent peptides, only six (labeled with a (*)) are abundant within the MSAD 
spectrum (Figure 3.5d). Again, similar to apomyoglobin, the MSAD spectrum of BSA 
tryptic digest contains a large number of internal fragment ions with the loss of water 
and/or ammonia (Table 3.5).  The fragment ions obtained by MSAD for BSA are more 
distinct, with less repeating fragment ions, than apomyoglobin. However, there are still 
identified missed enzymatic cleavages for BSA as well as identified non-tryptic peptides.  
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Table 3.5: BSA tryptic digest MSAD fragmentation data 
 
 
 
MSAD 
fragment ion 
(measured) MSAD fragment ion (calculated) 
Sequence of Tryptic Peptide Mass Mass ID Sequence 
224-LSQKFPK-230 588.3166 588.31457 y6b6 SQKFP 
     
143-YLYEIAR-149 616.3291 616.30949 y*5b7 YEIAR 
     
580-LVVSTQTALA-589 616.3291 616.33062 y9b7 VVSTQT 
     
506-AFDEKLFTFHADICTLPDTEK-526 616.3291 616.29825 y*20b6 FDEKL 
 616.3291 616.29825 y*19b7 DEKLF 
 751.3986 751.3986 y*7b*21 TLPDTEK 
     
511-LFTFHADICTLPDTEKQIK-529 751.3986 751.3986 y*10b*16 TLPDTEK 
 716.365 716.3675 b6 LFTFHA 
     
268-YICNQDTISSKLK-281 711.4109 711.35649 y*8b*13 DTISSKL 
     
384-HLVDEPQNLIKQNCDQFEK-402 711.4109 711.41535 y12b13 NLIKQN 
 810.4057 810.39976 y8b10 DEPQNLI 
     
231-AEFVEVTKLVTDTKVHKECCHGDLLE 711.4109 711.35649 y*13b*50 DTISSKL 
CADDTADLAKYICDNQDTISSKLKECCDK-286 887.5088 887.52021 y12b52 TISSKLKE 
     
384-HLVDEPQNLIK-394 810.4057 810.39976 y8b10 DEPQNLI 
     
329-DAFLGSFLYEYSR-341 810.4057 810.40378 y10b10 LGSFLYE 
     
551-TVMENFVAFVDK-562 660.3739 660.37209 y6b12 VAFVDK 
     
27-GLVLIAFSQYLQQCPFDEHVK-47 660.3739 660.37209 y18b9 LIAFSQ 
     
342-RHPEYAVSVLLR-353 663.3358 663.27785 y*11b*7 HPEYAV 
     
83-VASLRETYGDMADCCEKQE 663.3358 663.3466 y35b8 LRETY 
PERNECFLSHKDDSPDLPK-120 751.3986 751.3986 y*22b22 KQEPER 
 716.365 716.36192 y14b30 CFLSHK 
     
83- VASLRETYGDMADCCEKQEPERNECFLSHKD 663.3358 663.3466 y57b8 LRETY 
DSPDLPKLKPDPNTLCDEFKADEKKFWGK-142 751.3986 751.3986 y*44b22 KQEPER 
 716.365 716.36192 y36b30 CFLSHK 
 887.5088 887.47795 y*7b60 EKKFWGK 
 647.4093 647.37684 y*27b39 PDLPKL 
     
292-SHCIAEVEKDAIPENLPPLTADFAEDK 751.3986 751.3986 y*28b*10 IAEVEKD 
DVCK-322 716.365 716.36192 y14b24 PLTADFA 
     
246-VHKECCHGDLLECADDRADLAK-267 655.3993 655.38913 y6b22 RADLAK 
     
121-LKPDPNTLCDEFKADEKKFWGK-142 887.5088 887.47795 y*7b22 EKKFWGK 
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For example, peptide 224-LSQKFPK-230 has a missed cleavage, but the most abundant 
fragment ion y6b6 was able to provide an identification of the peptide as well as the 
verification of a missed cleavage site (Table 3.5). Also identified was the non-tryptic 
BSA peptide 580-LVVSTQTALA-589 from the predominant fragment ion y9b7 (Table 
3.5). The ability to identify missed cleavages and non-tryptic peptides provides another 
argument for the viability of MSAD with complex peptide mixtures. 
Identification of MSAD fragments from BSA and Apomyoglobin were made 
using the PROWL website mass spectrometry fragmentation function.  Fragment ion 
identification in PROWL is output with two decimal places.  In order to obtain a more 
accurate mass match for each PROWL identified MSAD fragment ion, the fragment ion 
mass was calculated to four decimal places in order to match back to the mass of the 
MSAD fragment from the spectrum.   Identification of MSAD fragments from BSA and 
Apomyoglobin using PROWL and calculated masses show several possible tryptic 
fragments corresponding to each identifiable MSAD fragment in the spectra (Tables 3.4 
& 3.5).  However, this is in part a consequence of multiple tryptic peptides that are 
capable of producing fragment ions with the same sequence.  There is also a preference 
toward certain fragment ions within the MSAD spectrum.  Each tryptic peptide gives a 
preferential MSAD fragment ion that can have different combinations of water and 
ammonia loss (Table 3.4 & 3.5). 
The use of MSAD, as a replacement for more commonly applied fragmentation 
methods such as SORI-CAD with a FT-ICR is a feasible option for simple peptide 
solutions, tryptic digest and simple mixtures.  MSAD provides a fragmentation method 
that can fragment all peptides in the sample, in one step, eliminating the isolation step 
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needed for SORI-CAD, which provides a more operationally simple and time saving 
method. This is especially important if sample limitation is of concern.  On preliminary 
inspection, the MSAD method provides a more extensive identifiable fragmentation 
pattern than SORI-CAD.  However, the MSAD method does lead to more internal 
fragment ions making identification more complicated.  The MSAD method works well 
on simple peptides, but when applied to complex tryptic digest the lack of fragmentation 
of major parent ions and the number of internal fragment ions produced does present a 
rather complex spectrum, but this is not of enough significance not to provide 
identification of the peptide or protein. A large number of MSAD fragments from tryptic 
peptides were identified.   MSAD on simple mixtures gives a rather rich spectrum of 
identifiable fragment ions when the peptides are at equal concentrations.  The sensitivity 
of MSAD could provide some problems, but for complex mixtures being examined by 
FT-ICR-MS where rapid dissociation of parents ions is needed MSAD provides a very 
useful alternative to SORI-CAD. 
Conclusions 
Through these two studies, better methods for protein charge state determination 
under liquid chromatography conditions and fragmentation of proteins and peptides 
within the FTICR-MS were examined.  By applying new methods, such as the TACT 
program and MSAD fragmentation, fundamental advancements in these areas were made.  
The TACT program allowed for the determination of large proteins charge states under 
liquid chromatography time frames better than previously applied software. Also shown 
in this study, was that complex mixtures being examined by FT-ICR-MS, where rapid 
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dissociation of parent ions is needed, MSAD provides a very useful alternative to SORI-
CAD. 
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Chapter 4 
Application of the Integrated Top-Down Bottom-Up Methodology for the 
Characterization of Ribosomal Protein Mixtures for PTMs and Isoforms 
Data presented below is in final preparation for submission or published as the following 
 
Heather M. Connelly, Eric Hamlett, David Robinette, Kevin Ramkissoon, Hsun-
Cheng Hsu, Ming Yu, Robert L. Hettich, and  Morgan C. Giddings. 
Characterization and Comparison of Ribosomal Protein Heterogeneity and 
Isoforms in Wild-Type and Variant Strains of E. coli. Nature Biotechnology, In 
final preparation (2006). All FTICR top-down and LCQ Bottom-up sample 
preparation, experiments and data analysis were performed by Heather M. 
Connelly. 
 
Strader, M.B.; VerBerkmoes, N.C.; Tabb, D.L.; Connelly, H.M.; Barton, J.W.; Bruce, 
B.D.; Pelletier, D.A.; Davison, B.H.; Hettich, R.L.; Larimer, F.W.; and G.B. Hurst. 
Characterization of the 70S Ribosome from Rhodopseudomonas palustris using an 
Integrated “Top-Down” and “Bottom-Up” Mass Spectrometric Approach. Journal of 
Proteome Research, 2004; 3, 965-978. All bottom-up MS, sample preparation, 
experiments and data analysis on Rhodopseudomonas ribosomal complex were 
performed as a joint effort between Nathan C. VerBerkmoes, Brad Strader,and David 
Tabb, All  top-down experiments and data analysis was performed by Heather M. 
Connelly with assistance from Robert L. Hettich. 
 
 
Introduction 
Integrating “top-down” and “bottom-up” MS-based proteomic strategies provides 
a powerful tool to examine complex protein mixtures, such as proteins in multi-
component complexes, or even complete proteomes.  The first of these methods is intact 
protein, or top-down mass spectrometry, which can be used to provide intact protein 
identification, as well as insight into protein modification states. This powerful method 
can provide information on the natural state of intact proteins, including details about 
post-translational modifications (PTM’s), truncations, mutations, signal peptides, and 
isoforms, due to the ability to measure the molecular mass of a protein very accurately 
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and detect any covalent modifications that alter the mass of a protein. The top-down mass 
spectrometry approach for proteins was first introduced with electrospray-Fourier 
transform ion cyclotron resonance mass spectrometry (ESI-FTICR-MS) [22, 23, 24].  The 
dynamic range, sensitivity, and mass accuracy offered by high performance FT-ICR-MS 
affords not only unambiguous protein identification in many cases, but also detailed 
information about protein modifications.  Eventough, top-down methodologies provide a 
powerful analytical approach, some limitations do exist; on-line chromatography of intact 
proteins is often difficult due to the wide range of protein sizes and hydrophobicities. 
Furthermore, data are often difficult to analyze and interpret due to limited bioinformatics 
tools.   
The more common peptide or “bottom-up” mass spectrometric approach involves 
enzymatic digestion of intact proteins with a protease such as trypsin, Glu-C or cyanogen 
bromide in order to generate a peptide mixture. This peptide mixture is then analyzed by 
MS/MS methods to generate peptide fragmentation spectra that are compared back to a 
database with searching algorithms. This “bottom-up” proteomics approach is able to 
quickly and efficiently provide a comprehensive list of proteins present in a large multi-
protein complex.  Bottom-up methods provide a comprehensive list of proteins, although, 
vital information about post translational modifications may be missed if the peptides 
containing the particular modification escape detection.   Furthermore, identifying 
peptides that come from a complex protein mixture does not provide information on the 
presence of different isoforms that may exist for a particular protein. 
An integrated top-down and bottom-up approach allows for a more 
comprehensive characterization of protein complexes due to the unique strength of each 
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technique. In an integrated approach, intact protein masses from the top-down analysis 
corresponding to a particular PTM or isoform can be compared to the comprehensive list 
of proteins provided by the bottom-up analysis. This correlation between the two 
methods can provide PTM location and identity with more certainty.  The 
comprehensiveness of this technique has been previously demonstrated in a study of the 
Shewanella oneidensis proteome [35].   
Since this technology was to be ultimately used for whole proteomes under 
multiple growth states (Chapter 7), we started with the 70S Ribosome from 
Rhodopseudomonas palustris and progressed our technique into the examination of 
ribosomal proteins from multiple strains of antibiotic resistant E. coli. The ribosome has 
been a model protein complex for the development of MS-based proteomics techniques; 
due to the ease of purification, the limited complexity and the presence of numerous post-
translational modifications [88]. The ribosome is the universal macromolecular machine 
involved in translating the genetic code into proteins. Bacterial ribosomes are composed 
of a small subunit (30S) containing about 20 proteins and a single rRNA (16S), and a 
large subunit (50S) consisting of over 30 proteins and two rRNAs (23S and 5S). The 
bacterial ribosomal proteins have been shown to be well conserved across different 
species, and this includes their PTMs.   
In our first study, the ribosomal proteins from R. plaustris were examined for 
positive identification of the protein, as well as identification of associated PTMs.  For 
this study, the bottom-up approach was expanded to the use of 1D and 2D LC-MS/MS 
methodologies for the analysis of the enzymatically digested protein complex. This was 
necessary due to the increased complexity of the protein complex. The top-down 
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methodology was performed with the high resolution and high mass accuracy FT-ICR 
instrument. For these experiments, we performed LC-ES-FT-ICR for intact protein 
measurements. Using this integrated approach, we were able to identify a complement of 
ribosomal proteins and their associated PTMs. 
In the second study, we employ an integrated top-down and bottom-up approach 
to characterize the ribosomal proteins from wild type K12 and two streptomycin resistant 
strains of E. coli. Using this method, a complement of ribosomal proteins with unique 
PTM series, isoforms, and point mutations were identified from all three strains.  With 
this integrated top-down and bottom-up approach, we were able to provide a more 
comprehensive examination of the role of ribosomal proteins in antibiotic resistance than 
if an individual method had been employed.      
Results Characterization of the R. palustris 70S Ribosome 
Top-down and Bottom-up Characterization of the R. palustris 70S Ribosome 
The 70S ribosome from R. palustris was characterized with the integrated top-
down and bottom-up technique.  Integration of results was achieved by using protein 
identifications from the analysis of top-down data to refine analysis of bottom-up data, 
and vice versa, in an iterative manner to increase the number of characterizations of 
ribosomal proteins obtained. For example, identification of a methylated protein by the 
top-down approach could provide motivation to examine more closely the bottom-up 
results for the presence of a methylated peptide from that protein. The combined top-
down bottom-up MS analysis identified a total of 53 of the predicted 54 ribosomal 
proteins [Table 4.1]. The data indicated the presence of 21 proteins for the small subunit 
and 33 for the large subunit (S20 and L26 are identical). No orthologue of E. coli S22 
 86
was identified for R. palustris ribosomes. We also identified isoforms for L7/L12 from 
the large subunit. These isoforms included one form with 3 methylations and a second 
form with an acetylation.  Within this work, each of the R. palustris ribosomal proteins 
(RRP) is named after the corresponding ribosomal protein in E. coli.  The L7/L12 
isoforms were therefore named RRP-L7/L12A and RRP-L7/L12B. 
Intact proteins from three separate aerobically grown ribosome samples were 
examined by LC-FT-ICR-MS, and the resulting data were pooled. From this top-down 
analysis, we identified 42 intact R. palustris ribosomal proteins. The four largest 
ribosomal proteins (RRP-S2 at 36 kDa, RRP-S1 at 62.8 kDa, RRP-L2 at 31.6 kDa, and 
RRP-S3 at 26.3 kDa) were not observed. Even though the FT-ICR-MS has sufficient 
mass range to observe these species, prior experience with intact proteins suggests that 
larger species, such as these, are difficult to elute from the C4 reverse-phase column 
under the experimental conditions employed for the top-down liquid chromatography. It 
is likely that the increased hydrophobicity of these larger proteins results in irreversible 
binding on the reverse-phase column, making these proteins difficult, if not impossible, 
to elute from the column. 
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Table 4.1.  Ribosomal protein identification by top-down ESI-FTICR-MS [54] 
Protein Modification Calc. Massa Meas. Mass
Mass error 
(ppm) 
L1 loss of Met 23877.832 23877.449 16.0 
L3 plus Methyl 25622.463 25622.159 11.9 
L5 plus 2 Methyl 21064.992 21064.576 19.7 
L6 loss of Met 19272.408 19272.674 -13.8 
L7/L12 loss of Met + 3 Methyl 12754.07 12754.089 -1.5 
L9 none 21178.022 21178.268 -11.6 
L10 loss of Met 19067.739 19067.617 6.4 
L11 loss of Met+Acet+ 9 Methyl 15507.107 15507.246 -9.0 
L14 none 13488.498 13488.645 -10.9 
L15 none 16836.243 16836.259 -1.0 
L17 plus 3 Methyl 15716.353 15716.056 18.9 
L18 loss of Met 12904.93 12905.157 -17.6 
L19 none 14296.764 14296.899 -9.4 
L21 loss of Met 13358.081 13358.533 -33.8 
L22 loss of Met 13826.007 13825.6447 26.2 
L23 none 10907.949 10908.021 -6.6 
L24 loss of Met 10998.226 10998.231 -0.5 
L24 loss of Met + Methyl 11012.241 11012.146 8.6 
L29 loss of Met 7849.213 7849.239 -3.3 
L30 loss of Met 7092.967 7092.988 -3.0 
L31 none 8566.315 8566.334 -2.2 
L32 loss of Met 6860.73 6860.636 13.7 
L33 loss of Met + Methyl 6248.504 6248.45 8.6 
L35 loss of Met 7415.278 7415.278 0.0 
L36 none 5063.971 5063.952 3.8 
S4 loss of Met + Methyl 23441.536 23441.69 -6.6 
S5 loss of Met 20522.086 20522.411 -15.8 
S7 loss of Met 17556.27 17556.629 -20.4 
S8 loss of Met 14477.6316 14477.683 -3.6 
S8 loss of Met+Acet+4 Methyl 14575.704 14575.619 5.8 
S10 none 11667.363 11667.404 -3.5 
S11 loss of Met + Methyl 13760.215 13760.314 -7.2 
S12 none 13874.799 13875.167 -26.5 
S13 loss of Met 14313.985 14313.596 27.2 
S14 loss of Met 11331.399 11331.9 -44.2 
S15 loss of Met 10010.563 10010.562 0.1 
S16 loss of Met 12017.595 12017.575 1.7 
S17 loss of Met 9553.253 9553.316 -6.6 
S18 plus 6 Methyl 9178.219 9177.834 41.9 
S19 loss of Met 10087.371 10087.379 -0.8 
S20 loss of Met 9577.324 9577.387 -6.6 
S21 none 10062.669 10062.722 -5.3 
 
a MAIM (most abundant isotopic mass) 
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In total, 42 proteins were tentatively identified, with the majority (25) at better 
than 10 ppm mass accuracy, and only 3 differing by >30 ppm from the calculated value. 
Of these 42, ten correspond directly to the predicted gene products, 21 are processed by 
only methionine truncation, and the remaining 11 appear to be modified by further 
acetylation and/or methylation.  Three proteins, RRP-L24, RRP-L7/L12 and RRP-S8, 
were found to be present in two different forms.  The most highly modified species 
identified was RRP-L11, which is methionine-truncated, and contains multiple 
methylations and/or acetylations.  About ten additional species were measured from the 
ribosome sample, but could not be identified. It is likely that these species correspond to 
the other ribosomal proteins, but are altered substantially (possibly by combinations of 
other PTMs, oxidation, and more extensive truncation) such that they are beyond the 
scope of our simple “look-up table” (excel table with all combinations of searched for 
PTMs) or they could be common contaminants identified in the bottom-up analysis as 
well. Using this integrated approach for the R. palustris ribosomal proteins we were able 
to provide a comprehensive analysis of PTMs and isoforms that was previously unknown 
for this organism.  
Results for E. coli Ribosomal Proteins From All Three Strains 
General Analysis of E. coli Ribosomal Proteins from All Three Strains 
Proteins from three strains of K12 E. coli were examined with a combined top-
down and bottom-up strategy.  The three strains included a K12 wild type strain (WT), a 
K12 streptomycin resistant strain (SmR), and a K12 streptomycin resistant compensated 
strain where cell growth was allowed to return to a normal state (SmRC).   To obtain the 
accurate mass values for the top-down measurements, the most abundant isotope 
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measurement method (MAIM) was used as previously described [89]. In this method the 
MAIM value are obtained for the top-down measured masses and then compared to the 
calculated MAIM values for each ribosomal protein. Bottom-up identifications are also 
made for each ribosomal protein with the number of unique peptides identified and 
protein sequence coverage recorded.  To investigate the fidelity of the top-down database 
searching, two distracter database searches were performed with the bacterium 
Rhodopseudomonas palustris and yeast  Saccharomyces cerevisiae ribosomal protein 
databases plus the entire E. coli database to see how many proteins are identified using 
the measured E. coli protein masses. When using the R. palustris ribosomal database, five 
E. coli ribosomal measured masses are identified within 1.0 Da from the R. palustris 
database; these include L31, S17, S10, L36, and L28.  L31 was identified with to have a 
N-terminal methionine truncation for E. coli that was not identified in R. palustris search.  
For the searches against the yeast database, only three yeast proteins were identified 
within 1 Da using the measured E. coli masses, including the 60S L28, 60S L44, and 40S 
S21 proteins. The yeast 60S L44 protein has homology to the E. coli L12 protein which 
could provide a match within the yeast database. 
In the WT strain measurement, a total of 52 of the 57 ribosomal proteins were 
identified by the bottom-up approach and 43 of the 57 were identified by top-down 
analysis [Table 4.2]. The bottom-up analysis of the WT strain indicated the presence of 
20 out of a total 22 proteins from the small subunit (denoted S1-S22), with S12 and S22 
not being seen, and 30 of the possible 36 proteins from the large subunit (denoted L1-
L36), with L26, L31, and L34-L36 not being identified [Table 4.2].  
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Table 4.2: Combined top-down and bottom-up data for the WT strain. 
Subunit Avrg Sequence Mass Measured Mass PTM PPM BU Seq Cov Unique Peptides
S1 53.9 24
S2 54.8 9
S3 25852.07850 25852.80623 DEM -28.14992226 44.2 13
S4 23337.93550 23337.98857 DEM -2.27402291 37.9 9
S5 17514.26790 17514.22458 DEM, ACE 2.473640363 62.3 12
S6 34.4 3
S7 19887.93140 DEM 45.8 13
S8 13995.39720 13995.439 DEM -2.986624774 27.7 3
S9 14725.03120 DEM 13.8 2
S10 11735.60360 11735.4623 12.04053961 47.6 6
S11 13727.78420 DEM, MET 39.5 3
S12 13651.88700 13652.15343 DEM, BMT -19.51598339
S13 53.4 10
S14 11449.31400 11448.96907 DEM 30.12687048 12.9 1
S15 10137.58300 DEM 7.9 2
S16 9190.56590 9190.601945 -3.921956536 30.5 3
S17 9573.27380 9573.259505 DEM 1.493219592 9.5 1
S18 29.3 2
S19 10299.11000 10298.42837 DEM 66.18348576 12 3
S20 9553.21800 9553.368212 DEM -15.72370692 12.6 1
S21 8368.77370 8368.72685 DEM 5.598191764 14.1 1
S22
L1 24598.48930 24598.41311 DEM 3.097547946 59 16
L2 28729.30750 28728.46272 DEM 29.40499001 34.4 9
L3 22257.57560 22257.41732 MET 7.111421425 33.5 8
L4 28.4 4
L5 20170.42370 20170.53916 DEM -5.724074106 57.5 12
L6 18772.61160 DEM 49.9 10
L7 12206.06290 12206.05081 DEM, ACE 0.990737153 64.5 10
L9 51 9
L10 17580.43760 17579.97320 DEM 26.41566783 31.5 5
L11 14870.47030 14870.38882 DEM, 9-MET 5.479315607 26.1 6
L12 12206.06290 12206.05081 DEM, ACE 0.990737153 64.5 10
L13 16918.57380 16918.02986 32.15052323 34.5 4
L14 13541.06560 13540.54586 38.38242981 21.1 3
L15 14980.44430 14980.42223 1.472987019 34.7 5
L16 32.4 4
L17 14364.62170 14364.05432 39.49877775 26.8 5
L18 12769.64490 12769.87237 -17.81365118 19.7 2
L19 13002.05480 13001.53381 DEM 40.06982035 36.5 4
L20 13365.77070 DEM 28 6
L21 11565.05541 11564.3661 59.60239496 44.7 5
L22 42.7 7
L23 11199.13960 27 3
L24 11185.02740 11185.06116 DEM -3.017873698 52.9 8
L25 10693.46300 10693.44982 1.23280924 60.6 8
L26
L27 8993.28970 8993.038869 DEM 27.89090626 25.9 2
L28 8875.31060 8874.791879 DEM 58.4453912 12.8 1
L29 7273.46450 7273.217968 33.89471414 46 3
L30 6410.61260 6410.67098 DEM -9.106773977 33.9 2
L31 7871.10070 7871.263986 -20.74500203
L32 6315.19890 6314.680172 DEM 82.139614 26.3 1
L33 6254.42280 6254.571417 DEM, MET -23.76190494 27.3 1  
DEM = N-terminal methionine truncation 
ACE = acetylation 
MET = Methylation 
BMT = beta- methylthiolation and a K to T point mutation 
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In the top-down analysis 10 of the small subunit proteins were not identified 
including S1, S2, S6, S7, S9, S11, S13, S15, S18, and S22; while 11 proteins from the 
large subunit were not found including L4, L9, L6, L16, L20, L22, L23, L26, and L34-
L36 [Table 4.2]. Ribosomal proteins from the WT strain, not found by bottom-up and 
top-down, include S22, L26, and L34-L36.    
From the SmR strain analyses 44 of the 57 ribosomal proteins were identified by 
the bottom-up method while 41 were identified using the top-down approach [Table 4.3]. 
The data from the SmR strain shows the S13 and S22 proteins from the small subunit as 
well as the of L26, L27, L30-L32, and L34-L36 proteins from the large subunit were not 
detected by bottom-up analysis [Table 4.3].  In the SmR strain the S17, S22, L26, L31, 
and L34-L36 were not found by bottom-up and top-down measurements. 
Within the SmRC strain of streptomycin resistant E. coli 49 of the 57 ribosomal 
proteins were identified by bottom-up methods and 43 by the top-down method [Table 
4.4].  From the small subunit ribosomal proteins of the SmRC strain the S22 protein was 
not observed by bottom-up analysis; while the large subunit proteins L26, and L34-L36 
were not observed [Table 4.4].  The top-down analysis shows the S1, S2, S6, S13, S18, 
and S22 proteins from the small subunit not detected and the L4, L9, L22, L26, L31, and 
L34-L36 proteins from the large subunit not detected [Table 4.4]. Top-down and bottom-
up measurements did not identify the S22, L26, and L34-L36 ribosomal proteins from the 
SmRC strain. 
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Table 4.3: Combined top-down and bottom-up data for the SmR strain. 
Subunit Avrg Sequence Mass Measured Mass PTM PPM BU Seq Cov Unique Peptides
S1 46.3 25
S2 54.8 14
S3 25852.07850 25852.1039 DEM -0.982551558 42.1 13
S4 23337.93550 23337.94815 DEM -0.542035948 40.3 12
S5 17514.26790 17514.30762 DEM, ACE -2.267808179 62.9 14
S6 42.7 4
S7 19887.93140 19887.97468 DEM -2.176194151 46.4 15
S8 13995.39720 13995.30806 DEM 6.369594141 21.5 2
S9 14725.03120 14724.9854 DEM 3.110349946 20 5
S10 11735.60360 11735.49733 9.055350165 13.6 1
S11 13727.78420 13727.72578 DEM, MET 4.255603027 40.3 6
S12 13651.88700 13624.85 DEM, BMT, K-T 21.8 1
S13 53.4 10
S14 11449.31400 12.9 1
S15 10137.58300 10137.89412 DEM -30.68966242 33.7 1
S16 9190.56590 9190.203623 39.41835616 13.4 1
S17 9573.27380 9572.489042 DEM 81.97383846
S18 13.3 1
S19 10299.11000 10299.02371 DEM 8.378393861 20.7 3
S20 9553.21800 9552.866332 DEM 36.81147023 24.1 4
S21 8368.77370 8368.720287 DEM 6.382416578
S22
L1 24598.48930 24598.32132 DEM 6.828752691 59 20
L2 28729.30750 37.4 12
L3 22257.57560 22257.60407 MET -1.279249839 33.5 10
L4 28.4 7
L5 20170.42370 20170.28273 DEM 6.988797166 57.5 14
L6 18772.61160 18772.58227 DEM 1.562169432 40.7 11
L7 12206.06290 12206.52929 DEM, ACE -38.20937216 64.5 9
12220.1022 DEM, ACE, MET
L9 36.2 9
L10 17580.43760 17580.72068 DEM -16.10215891 31.5 9
L11 14870.47030 14870.58317 DEM, 9-MET -7.590210513 19.7 3
L12 12206.06290 12206.52929 DEM, ACE -38.20937216 64.5 9
L13 16918.57380 16917.8734 41.39840676 35.9 5
L14 13541.06560 13541.00182 4.709969059 28.5 4
L15 14980.44430 14980.63423 -12.6781954 34.7 8
L16 32.4 6
L17 14364.62170 26.8 5
L18 12769.64490 12770.35352 -55.49285086 19.7 2
L19 13002.05480 13002.40935 DEM -27.2689206 36.5 4
L20 13365.77070 13365.48241 DEM 21.56905176 16.1 4
L21 11565.05541 44.7 3
L22 12226.31560 12226.03966 22.56935033 51.8 9
L23 11199.13960 11199.07846 5.459347966 15 1
L24 11185.02740 11185.04528 DEM -1.598207976 44.2 8
L25 10693.46300 10693.45309 0.927108459 25.5 2
L26
L27 8993.28970 8993.445437 DEM -17.31702249
L28 8875.31060 12.8 1
L29 7273.46450 7272.763565 96.36879372 22.2 1
L30 6410.61260 6410.312477 DEM 46.81658661
L31 7871.10070 7871.051347 6.27015228
L32 6315.19890 6314.651869 DEM 86.62134141
L33 6254.42280 6254.318399 DEM, MET 16.69234769 27.3 1
L34
L35
L36 4364.35210 4364.816693 -106.4517686  
DEM = N-terminal methionine truncation 
ACE = acetylation 
MET = Methylation 
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Table 4.4: Combined top-down and bottom-up data for the SmRC strain. 
Subunit Avrg Sequence Mass Measured Mass PTM PPM BU Seq Cov
S1 52.8
S2 45.6
S3 25852.07850 25852.02755 DEM 1.970905357 42.1
S4 23337.93550 23337.41086 DEM 22.48026609 32.00
S5 17514.26790 17514.31651 DEM, ACE -2.775565629 57.5
S6 34.4
S7 19887.93140 19887.90318 DEM 1.418850429 46.4
S8 13995.39720 13995.38833 DEM 0.633851249 34.6
S9 14725.03120 14724.25623 DEM 52.62949799 20
S10 11735.60360 11735.62495 DEM -1.818824214 34
S11 13727.78420 13727.65999 DEM, MET 9.048364848 39.3
S12 13651.88700 13624.78221 DEM, BMT, K-T 21.8
S13 53.4
S14 11449.31400 11449.16009 DEM 13.44263945 12.9
S15 10137.58300 10137.58642 DEM -0.336865306 6.7
S16 9190.56590 9190.203623 39.41835616 30.5
S17 9573.27380 9573.121732 DEM 15.88463917 9.5
S18 29.3
S19 10299.11000 10298.68954 DEM 40.8251781 29.3
S20 9553.21800 9553.340992 DEM -12.87440525 12.6
S21 8368.77370 8368.84807 DEM -8.886606648 14.1
S21 8466.96200 8466.674 7 MET 34.01456154
S22
L1 24598.48930 24598.81402 DEM -13.20072936 59
L2 28729.30750 29729.05438 DEM -34798.85058 34.4
L3 22257.57560 22257.65787 MET -3.696044955 33.5
L4 28.4
L5 20170.42370 20170.46279 DEM -1.937936485 52.5
L6 18772.61160 18773.16783 DEM -29.62960146 40.1
L7 12206.06290 12206.84246 DEM, ACE -63.86686734 64.5
12220.08980 12220.34692 DEM, MET, ACE -21.04051641
L9 52.3
L10 17580.43760 17579.99728 DEM 25.046248 31.5
L11 14870.47030 14870.62168 DEM, 9-MET -10.18017567 31.7
L12 12206.06290 12206.84246 DEM, ACE -63.86686734 64.5
L13 16918.57380 16918.49658 4.564037188 34.5
L14 13541.06560 13540.92976 10.03207606 28.5
L15 14980.44430 14980.31488 8.639329876 34.7
L16 15365.83597 2 ACE 32.4
L17 14364.62170 14365.25629 -44.17721631 26.8
L18 12769.64490 12770.35352 -55.49285086 19.7
L19 13002.05480 13002.20087 DEM -11.23453194 36.5
L20 13365.77070 13365.53097 DEM 17.93618979 22.9
L21 11565.05541 11564.49163 48.74857753 44.7
L22 41.8
L23 11199.13960 11199.11761 1.963632992 27
L24 11185.02740 11185.03471 DEM -0.653641671 52.9
L25 10693.46300 10693.34952 10.61199725 52.1
L26
L27 8993.28970 8993.271975 DEM 1.970913936 16.5
L28 8875.31060 8875.421703 DEM -12.51820979 12.8
L29 7273.46450 7273.491698 -3.739345947 46
L30 6410.61260 6410.667045 DEM -8.492948084 33.9
L31 7871.10070 21.4
L32 6315.19890 6314.651869 DEM 86.62134141 26.3
L33 6254.42280 6254.446543 DEM, MET -3.796193631 27.3
L34
L35
L36  
DEM = N-terminal methionine truncation 
ACE = acetylation 
MET = Methylation 
BMT = beta- methylthiolation and a K to T point mutation 
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Figure 4.1 presents an example of data from the top-down approach. Shown in 
Figure 4.1 is the first 15 minutes of the total ion chromatogram of the SmRC strain where 
all elution of the purified ribosomal sample from the reverse phase separation occurred, 
along with a deconvoluted mass spectrum corresponding to the chromatographic peak at 
2.38 minutes with the isotopic pattern for the component at nominal mass 11184 Da 
shown. The measured isotopic packet of this species is consistent with the calculated 
isotopic packet (MAIM) of intact ribosomal protein L24. The measured isotopically 
resolved peak at 11,184.383 Da was within 8 part per million of the calculated MAIM 
value of 11,184.286 Da for this protein.  For comparison, searching the entire E. coli 
proteome database for measured mass 11,184.383 Da (L24) reveals only one protein 
within 9.0 Da, and when searching the entire database including a maximum of 5 PTMs 
and a 2 Da mass window five proteins are found. These proteins, even with 
modifications, are well within the separable mass range for the FT-ICR-MS.  
The bottom-up MS measurements often provide a more extensive list of proteins than the 
top-down, and indicate the presence of some other components that are consistent across 
the ribosomal purification process for each of the three strains. The most abundant of 
these proteins, observed in all three strains, include bacterioferrin observed at 39-63% 
sequence coverage and 6-8 unique peptides, GroEL with 23-42% sequence coverage and 
9-16 unique peptides, and a Co-A linked acetaldehyde dehydrogenase with 35-39% 
sequence coverage and 25-27 unique peptides. 
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Figure 4.1: 15 minutes of the total ion chromatogram for the SmRC strain.  Showing 
where all elution of the purified ribosomal sample from the reverse phase separation 
occurred, along with a deconvoluted mass spectrum corresponding to the 
chromatographic peak at 2.38 minutes with the isotopic pattern for the component at 
nominal mass 11184 Da shown. The measured isotopically resolved peak at 11,184.383 
Da was within 8 part per million of the calculated isotopically averaged value of 
11,184.286 Da for the L24 protein. Methionine truncation within the figure is labeled as 
MET. 
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Post Translational Modifications of Antibiotic Resistant E. coli Ribosomal Proteins 
The integrated top-down and bottom-up approach allows for the identification of 
PTMs, their location, as well as isoforms of ribosomal proteins.  Included in the top-
down PTM searches were N-terminal modifications of methionine truncation, 
methylation, acetylation, and β-methylthiolation.  In addition, the bottom-up analysis 
contained β-methylthiolation of aspartic acid, single acetylations, and mono-, di-, and 
trimethylated lysines and arginines. All of these modification types have been previously 
identified in ribosomal proteins from E. coli [90, 89, 91, 92, 93].  Phosphorylation is 
common in eukaryotic ribosomal proteins, although, this has yet to be definitively 
identified in prokaryotic ribosomal proteins, and was therefore excluded from the subset 
of modifications searched for [94].  
N-terminal Methionine Truncations 
N-terminal methionine truncation was the most prevalent PTM identified by top-
down analysis.  Of the 57 ribosomal proteins, 31 ribosomal proteins from all three strains 
(WT, SmR, SmRC) were identified to have an N-terminal methionine truncation by top-
down analysis in this study [Table 4.2-4.4]. The top-down approach identified an N-
terminal methionine truncation if the measured intact mass for a ribosomal protein 
matched that obtained by subtracting the mass of a methionine residue (131.0405 Da) 
from the mass calculated from the DNA-derived amino acid sequence. The results of this 
searching agreed perfectly with previous identified E. coli ribosomal proteins with N-
terminal methionine truncations [90]. 
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β-methylthiolation 
The novel β-methylthiolation PTM is known to occur at the D88 residue of the 
S12 E. coli ribosomal protein [93].  In the top-down analysis of the WT strain, a MAIM 
molecular mass of 13651.527 was observed corresponding to the S12 ribosomal protein 
with a β-methylthiolation and an N-terminal methionine truncation with a calculated 
MAIM mass of 13651.469. These top-down measured and calculated MAIM values for 
S12 are within a -4.2 ppm mass accuracy.  The S12 protein was identified in the bottom-
up analysis, although the peptide containing the D88 β-methylthiolation was not 
observed. Even though the bottom-up search did not yield any positive peptide matches 
the mass accuracies provided by the top-down measurement still provides strong 
evidence.  The SmR and SmRC strains also contain this modification along with a point 
mutation and will be discussed later.   
Acetylation 
A number of ribosomal proteins from the three streptomycin resistant strains of E. 
coli were identified by top-down and bottom-up methods to have an acetylation, 
including L7, S5, L15, and L16. The L7 protein in E. coli is known to have an N-terminal 
methionine truncation and acetylation of the serine at first position [90, 89].   This 
modification state was found for L7 in all three strains (WT, SmR, SmRC) of antibiotic 
resistant E.coli in the top-down analysis. The measured MAIM value for the modified L7 
protein was 12205.520 and the calculated MAIM value was 12205.502 providing a mass 
accuracy of -1.5 ppm. The bottom-up analysis did not find the N-terminal peptide for this 
protein therefore missing the acetylation at the serine.  
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Both bottom-up and top-down measurements provide conformation of the N-
terminal truncation and acetylation of the S5 protein in all three strains.  The bottom-up 
analysis shows the N-terminal peptide acetylated at the alanine for all three WT, SmR, 
and SmRC strains.  Further more, the top-down analysis confirms this with a high mass 
accuracy of 12 ppm. 
Methylation 
The S21 protein only in the SmRC strain was found in top-down analysis with 2 
isoforms present (Figure 4.2). The first isoform present is S21 with a N-terminal 
methionine truncation, the second observed isoform within the same mass spectrum is the 
S21 protein with a N-terminal methionine truncation plus 7 methylations. For the S21 
isoform with 7 methylations, the measured MAIM value of 8465.699 was obtained, and 
when compared to the calculated MAIM value of 8465.806 Da, a ppm of 16 is obtained.  
However, only two peptides, with low protein sequence coverage, were obtained for S21 
in the bottom-up analysis and these two peptides did not contain a methylation. This 
could be due to peptides with Methylations being lost from this small protein when the 
trypsin digestion was performed.    
Also identified by top-down and bottom-up analysis were the L11, S11, L3, and 
L33 ribosomal proteins with methylations. The only observed isoform of the L11 protein 
was found in the SmRC and WT strains with an N-terminal methionine truncation and 9 
methylations.  
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Figure 4.2: The S21 protein in the SmRC strain was found with top-down analysis to 
have 2 isoforms present. The first isoform present is S21 with a N-terminal methionine 
truncation, the second observed isoform within the same mass spectra is the S21 protein 
with a N-terminal methionine truncation plus 7 methylations. 
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The S11, L3 and L33 proteins were all identified with a single methylation.  This data is 
consistent with previous studies of E. coli ribosomal proteins [90].   
Point Mutations 
The S12 protein was identified only in the SmR and SmRC strain with a N-
terminal methionine truncation, β-methythiolation, as well as a lysine 42 to a threonine 
point mutation (Figure 4.3).  The top-down analysis shows the S12 protein with a 
retention time of 1.58 minutes and a measured MAIM value of 13624.45 providing a ppm 
of -1.9 when compared to the calculated MAIM value of 13624.42 (Figure 4.3). 
Searching of the bottom-up data found the S12 protein with the point mutation.  Peptide 
36-VYTTTPTKPNSALR-49 was found with the threonine in position 42 instead of the 
lysine (Figure 4.3).  The y-ion series is labeled in Figure 4.3 for peptide 36-
VYTTTPTKPNSALR-49 with the y8 ion highlighted corresponding to the threonine.   
Discussion of Antibiotic Resistant E. coli Results 
Two strains of streptomycin resistant E. coli (SmR and SmRC) ribosomal proteins 
were analyzed and compared to the wild type K12 E. coli strain in order to see any 
differential post translational modifications or amino acid substitutions present that may 
confer streptomycin resistance in E. coli.  The wild type strain (WT) was used as a 
baseline to ensure growth, purification, and analysis was consistent for the SmR and 
SmRC strains.  Also the WT strain was used to provide a baseline modification state that 
the SmR and SmRC strains could be compared to and see how far antibiotic strains vary 
from the parent strain. In the bottom-up analysis of the WT strain, five ribosomal proteins 
were not observed including L34, L35, L36, L26 and S22.  
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Figure 4.3: Total ion chromatrogram ans MS/MS spectrum for S12. The total ion 
chromatogram is shown for the SmRC sample with the S12 protein, at retention time 1.58 
min, expanded out containing a N-terminal methionine truncation, β-methythiolation, as 
well as a lysine 42 to a threonine point mutation. The y-ion series is labeled for peptide 
36-VYTTTPTKPNSALR-49 with the y8 ion highlighted corresponding to the threonine 
point mutation. 
S12 – methionine + B-methythiolation with Lysine 42 to Threonine point mutation 
Retention time 1.58 
13624.4
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The L34, L36 and S22 proteins have a high percentage of basic residues providing a large 
number of trypsin cleavage sites.  The L34 protein has 16 lysines and arginines with its 
46 amino acid sequence, followed by L36 with 12 and S22 with 11.  Due to these 
sequences being so rich in trypsin cleavage sites, many of the resulting peptides fall 
below the lower m/z limit for isolation and fragmentation within the mass spectrometer.  
In the top-down analysis, three of the larger proteins S1, S2, and L4 were not observed.  
The FT-ICR-MS has sufficient mass range to analyze these proteins, but prior experience 
with intact protein chromatography indicates that larger species such as these three 
proteins are difficult to elute off an on-line C4 reverse phase column, under the top-down 
experimental conditions employed.  Low abundance and different hydrophobicities may 
prevent proteins from being observed due to irreversible binding to the reverse phase 
column, and lower than detectable concentrations. 
 When the total number of proteins observed in both the SmR and SmRC strains 
are compared, a higher number of ribosomal proteins are observed for the SmRC strain.  
A total of 41 ribosomal proteins were observed in the top-down analysis for the SmR 
strain as compared to 43 for the SmRC strain.  Also, five more ribosomal proteins were 
able to be identified for the SmRC strain in the bottom-up analysis.  These observed 
differences in the two strains could be due to the compensation that was allowed to occur 
for the SmRC strain.  The acquired resistance to streptomycin by E.coli has an associated 
fitness cost resulting in slowed growth.  The compensated derivative strain (SmRC) was 
obtained by evolving an isolate of the original streptomycin resistant strain (SmR) 
through repeated serial passage, in the laboratory, until it had “compensated” for the 
reduced fitness and recovered a wild type comparable growth rate.  This “compensation” 
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process in the SmRC strain may allow for higher protein expression providing, a greater 
number of identifiable proteins.  This compensation within the SmRC strain is thought to 
come from intra- or extra-genic mutations and differential post translational 
modifications that stabilize the resistance phenotype in the population. However, a 
process of differentially post translationally modifying ribosomal proteins to compensate 
fitness is thought to occur, what these modifications are have been difficult to obtain by 
traditional molecular techniques.  Using top-down mass spectrometry, differentially 
expressed modifications could be examined for the SmR and SmRC strains.  An example 
of these differential post translational modifications is the S21 and L16 ribosomal 
proteins.  The S21 ribosomal protein is present in the SmRC strain with 7 methylations 
and a N-terminal methionine truncation (Figure 4.2), whereas in the SmR strain S21 only 
contains the N-terminal methionine truncation and no identified methylations.  The L16 
ribosomal protein was also identified with a differential post translation modification 
within the SmRC strain and not in the SmR strain.  The L16 protein was identified with 
two acetylations in the SmRC strain, which were not identified in the SmR strain.  The 
use of top-down mass spectrometry provided, for the first time, a way of examining 
differential post translational modifications in “compensated” streptomycin resistant 
strains of E. coli.   
 Streptomycin resistance within E. coli is thought to occur from point mutations 
within the ribosomal proteins. One such previously identified point mutation is the lysine 
42 to threonine in ribosomal protein S12. The S12 protein is known as the “hinge” 
protein in the ribosomal complex, and plays an important role in the structural 
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conformation [95]. Therefore, it is understandable why this protein would be an 
important target for antibiotic resistance. 
The integrated top-down and bottom-up method identified the S12 protein with a 
N-terminal methionine truncation, β-methythioaltion, as well as a lysine 42 to a threonine 
point mutation in the SmR and SmRC strains.  The identification of the S12 ribosomal 
protein with the lysine to threonine point mutation only within the SmR and SmRC 
strains, and not the WT strain, provides further conformation toward its role in 
streptomycin resistance.   
Conclusions 
 Employing the integrated top-down and bottom-up approach, first allowed for a 
comprehensive evaluation of ribosomal proteins from R. palustris and second of 
antibiotic resistant strains of E. coli. The analysis of component proteins of the 70S 
ribosome from R. palustris enhanced several aspects of the analysis. The intact protein 
measurements include the aggregate contribution of all modifications to the protein, 
allowing for the discrimination of isoforms with different molecular masses, while the 
peptide data provided the location of the modification in many instances. 
Not only was this method useful in the analysis of R. palustris ribosomes; the use 
of integrated top-down and bottom-up mass spectrometry approaches provided insight 
into the role of ribosomal proteins in streptomycin resistance in E. coli.  The 
identification of differential modifications may provide starting points for future 
biological analysis of antibiotic resistance within bacterial species.  
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Chapter 5 
Evaluation of PTMs and Isoforms in Protein Complexes from 
Rhodopseudomonas palustris for Key Regulation Sites 
All of the data presented below is accepted for publication Heather M. Connelly, Dale A. 
Pelletier, Tse-Yuan Lu, Patricia K. Lankford, and Robert L. Hettich. Characterization of 
pII Family (GlnK1, GlnK2, GlnB) Protein Uridylylation in Response to Nitrogen 
Availability for Rhodopseudomonas palustris. Analytical Biochemistry, Accepted, In 
Press (2006). All MS sample preparation, experiments and data analysis were performed 
by Heather M. Connelly. 
 
Introduction 
The analysis of protein complexes, and their associated PTMs, that play a key role 
in regulation was an important aspect in the development of this dissertation work. This 
analysis allowed for the improved identification of PTMs and protein complexes that was 
need for future work in the analysis of multiple growth states from R. palustris (Chapter 
7). 
The movement of ammonium across biological membranes is a process that is 
conserved throughout all domains of life from bacteria to man [96]. In bacteria, the pII 
family generally plays a pivotal role in nitrogen metabolism regulation due to its ability 
to sense internal cellular ammonium concentrations [96,97,98]. This protein family is 
able to sense and transduce an ammonium signal, via protein-protein interactions, to a 
variety of enzymes involved in nitrogen metabolism [99,100,101]. The pII proteins GlnK 
and GlnB in Escherichia coli are trimers that functions as small signal transduction 
proteins and are able to sense the status of cellular nitrogen within prokaryotic cells 
[102].  The crystal structure of GlnK in E. coli has a compact barrel structure around 50Å 
in diameter and 30Å high, with an unstructured T-loop protruding from the upper surface 
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[96,103]. Residue tyrosine-51 at the apex of the T-loop is uridylylated in nitrogen starved 
cells, with the process being reversed when nitrogen is sufficient [96]. 
The general nitrogen regulation system (ntr), which has been most extensively 
studied in E. coli, controls the transcriptional activity of a number of genes involved in 
nitrogen regulation and assimilation, such as glnA (encoding glutamine synthetase) and 
nifA (encoding the transcriptional activator for the other nif genes) [104,105]. In E. coli, 
there are two levels of regulation involving the uridylylation of both the GlnB and GlnK 
proteins.  The first level within the cascade is the uridylylation (under low ammonium 
conditions) and de-uridylylation (under high ammonium conditions) of the GlnK protein 
in direct response to the intracellular nitrogen concentration, which in turn regulates the 
AmtB ammonium transporter’s movement of ammonium across the cell membrane 
[96,106,107]. This regulation of AmtB occurs when the cellular nitrogen status reaches a 
certain level, and de-uridylylation of GlnK allows for the direct binding of AmtB and 
sequestration to inhibit further ammonium transport [96,108,109].  The second level in 
the cascade is the uridylylation of the GlnB pII functional protein, which is thought to 
play a role in regulating enzymatic activity of glutamine synthetase (GlnA), which 
catalyzes the conversion of glutamate to glutamine, by controlling the level of 
adenylylation on tyrosine-397. Adenylytransferase (AT) is the enzyme that adenylylates 
and deadenylylates GlnA. Regulation as to which reaction the adenylytransferase 
catalyzes is determined by either unmodified GlnB (which stimulates adenylylation of 
glutamine synthetase) or uridylylated GlnB (which stimulates deadenylylation of 
glutamine synthetase) [110,111,112] (Figure 5.1).   
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Figure 5.1: Proposed model for glutamine synthetase (GS) regulation in R. palustris 
based on known models in E. coli.  Two metabolic states were interrogated in this study.  
The growth state shown on the left is anaerobic, grown in the light without oxygen 
(photoheterotrophic) with no ammonium present (nitrogen fixing conditions).  The 
growth state shown on the right is photoheterotrophic growth with ammonium sulfate 
present in the growth media (non-nitrogen fixing).  The tagged GlnK and GlnB proteins 
are suspected to be uridylylated on Tyr-51 under nitrogen-fixing conditions which in turn 
activates the adenylytransferase (AT) to deadenylylate glutamine synthetase (GS), Under 
non-nitrogen fixing growth the lack of uridylylation on Tyr-51 leads to the inactive form 
of GS .  Figure adapted from Larimer et al. Nature Biotechnology, 2004. 
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In the purple non-sulfur anoxygenic phototrophic bacterium Rhodopseudomonas 
palustris, the GlnK proteins also are expected to function as a primary regulator point in 
ammonium sensing and thus regulation of the glutamine synthetase pathway. However, 
R. palustris has unique metabolic versatility in its modes of energy generation and carbon 
metabolism, and unlike E. coli, it is able to thrive under severe nitrogen limiting 
conditions by fixing atmospheric nitrogen.  As such, it is possible that R. palustris may 
utilize a nitrogen-ammonium regulation system that varies from other commonly studied 
bacteria such as E. coli [13, 11].  In R. palustris there are three encoded forms of pII 
proteins; GlnK1 (RPA0272), GlnK2 (RPA0274), and GlnB (RPA2966). Also unique in R. 
palustris is the encoding of two AmtB transporters within the same operon as GlnK1 and 
GlnK2, with each transporter corresponding to one of the two GlnK proteins (Figure 5.2). 
Based on information from other bacteria, it is likely that uridylylation of these proteins 
is a key aspect of controlling the glutamine synthetase pathway.  Figure 5.1 outlines a 
proposed pathway in which GlnK2 is the uridylylation target protein that is sensitive to 
the availability of nitrogen, and the uridylylation of GlnB activates glutamine synthetase. 
Traditionally, nitrogen-ammonium regulation has been evaluated with 
immunoblotting and native gel analysis for a number of organisms, such as Escherichia 
coli, Gluconacetobacter diazotrophicus, Rhodospirillum rubrum, and Rhodobacter 
capsulatus [96, 97, 110, 111,113].  In this methodology, a series of plasmids are created 
to evaluate the effects of removing or altering a gene, or series of genes, to look at protein 
expression and modification levels. Once the protein or proteins are isolated, there are 
two common approaches employed, including Western blotting using antibodies or native 
gels to look at the migration differences of modified or unmodified proteins of interest.   
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Figure 5.2:  Artemis view and sequence alignment for GlnK1, GlnK2, and GlnB.  (2A) 
The Artemis view showing R.palustris genome, with the bold box highlighting the 
GlnK1, GlnK2 as well as both AmtB transporters located within the same operon. 
(2B)The sequence alignment and homology comparison of the R. palustris (labeled Rp) 
GlnB, GlnK1, GlnK2 proteins, along with the E. coli (labeled Ec) GlnK protein as a 
comparison are shown. 
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While these methodologies are informative, they are also very labor intensive and 
sometimes difficult to reproducibly perform. Therefore, using these methods in tandem 
with mass spectrometry is able to provide a comprehensive technique for the examination 
of protein modifications quickly and accurately in most cases.   
Mass spectrometry is a rapidly emerging tool for protein identification and 
characterization.  Intact protein or top-down mass spectrometry can be used to 
characterize the GlnK and GlnB proteins, as well as their modification state, to ascertain 
the level of regulation in the glutamine synthetase pathway of R. palustris.  This powerful 
method can provide information on the natural state of intact proteins, including details 
about post-translational modifications (PTM’s), truncations, mutations, signal peptides, 
and isoforms, due to top-down mass spectrometry’s ability to measure the molecular 
weight of a protein very accurately and detect any covalent modifications that alter the 
mass of a protein [114].  This information is often difficult to obtain by the more 
common peptide or “bottom-up” mass spectrometry methods, where intact proteins are 
digested with a protease such as trypsin or Glu-C and the resulting peptide mixtures are 
analyzed by MS or MS/MS methods. The top-down mass spectrometry approach was 
first introduced with electrospray-Fourier transform ion cyclotron resonance mass 
spectrometry (ESI-FTICR-MS) [22, 23, 24].  The dynamic range, sensitivity, and mass 
accuracy offered by high performance FTICR-MS afford not only unambiguous protein 
identification in many cases, but also detailed information about protein modifications. 
In this report, we will focus on the investigation of the GlnK and GlnB proteins 
modification state for R. palustris as a function of nitrogen availability to the growing 
bacterial cultures, and ultimately glutamine synthetase activation or inactivation.  This 
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will be achieved by isolating affinity-tagged GlnK2, GlnK1, and GlnB complexes under 
nitrogen-fixing and non-nitrogen fixing growth conditions.  Using this method in 
conjunction with an integrated high resolution top-down and bottom-up mass 
spectrometry approach should reveal detailed information about the presence and 
isoforms of GlnK and GlnB proteins.  In particular, uridylylation of GlnK is suspected to 
be a key regulatory aspect of nitrogen availability, while the uridylylation of GlnB is 
thought to play a key role in the regulatory aspect of glutamine synthetase. Both of these 
modifications states of GlnK and GlnB should be identifiable in the different growth 
samples.  The experimental section can be found in Chapter 2. 
Results 
Characterization of GlnK1, GlnK2, and GlnB Under Non- Nitrogen Fixing Conditions 
GlnK2 
  Affinity purifications of the GlnK2 protein complex from R. palustris under non-
nitrogen fixing growth conditions were performed in order to examine the baseline 
modification state of the complex and associated proteins. A Western blot was obtained 
for the GlnK2 protein complex after affinity purification using antibodies to the 6X his-
tag present within the GlnK2 protein. This immunoblot shows only the GlnK2 protein 
band at approximately 13 kDa present on the gel (Figure 5.3). Lane one of the 
immunoblot is the whole cell extract, followed by lane three which contains protein 
extract obtained after the nickel purification step and finally lane five contains the final 
V5 antibody purification extract from the affinity purification (Figure 5.3).  
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Figure 5.3: Western Blot of GlnK2 complex at approximately 13 kDa. Lane one of the 
immunoblot is the whole cell extract, followed by lane three which contains protein 
extract obtained after the nickel purification step and finally lane five contains the final 
V5 antibody purification extract from the affinity purification. Lanes two and four 
contain the bypass wash elute. 
1 3 5
GlnK213 kDa
200 kDa
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50 kDa
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Lanes two and four are bypass wash steps that are tested as a control to ensure no protein 
loss is occurring in the wash steps.  The Western analysis provides another way of 
visualizing and confirming the protein tagging procedures and affinity purifications for 
the GlnK2 protein.   
Under these growth conditions, the affinity purification procedure for tagged 
GlnK2 yielded abundant proteins corresponding to the unmodified GlnK1 and 
unmodified, tagged GlnK2, as determined by top-down ESI-FTICR-MS measurements 
(Figure 4A). The m/z values for both the unmodified GlnK1 and tagged GlnK2 are 
present within the FTICR mass spectra, with GlnK1 having a higher intensity than the 
tagged GlnK2. GlnK1 is seen with a charge state package ranging from +12 to +15 with 
the two most abundant m/z values of 883.9309 and 951.8519, while the tagged GlnK2 
charge state package ranges from +17 to +20 with the two most abundant m/z values 
being 859.9071 and 907.6828, providing a distinguishing charge state series for both 
proteins.  The measured and theoretical molecular mass values of unmodified GlnK1 
(measured 12,360.824 Da, calculated 12,360.776 Da, 4 ppm mass error) and unmodified 
tagged GlnK2 (measured 16,318.980 Da, calculated 16,318.859 Da, 7 ppm mass error) 
agree very well, and demonstrate the power of this high-resolution mass spectrometric 
technique.  To demonstrate the ability and considerations of high-resolution top-down 
mass spectrometry for directly identifying R. palustris proteins, the entire R. palustris 
proteome database was queried with the measured molecular mass of 12,360.824 Da.  
The closest match, as illustrated above, was the unmodified GlnK1 protein; the only other 
protein within a window of 5 Da was the RPA4690 hypothetical protein at 12, 360.828 
Da.   Since the focus of this work is to examine modified proteins, this search then was 
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expanded to include a range of common post-translational modifications.  In particular, 
this measured molecular mass of 12,360.824 Da was searched against the entire R. 
palustris proteome database, this time including methionine truncation, as well as any 
possible combination of 0-5 methylations, acetylations, oxidations, and disulfide bonds.  
This search yielded only six possible proteins within a 2 Da window.  Obviously, the 
availability of peptide or MS/MS data for intact proteins would greatly help limit the 
search space.   
 The experimental determination of only unmodified GlnK1 and GlnK2 is 
consistent with the expectation that under non-nitrogen fixing growth conditions, the high 
ammonium levels within the cell leads to an inactive form of AmtB, and thus there is no 
need to modify the GlnK2, since it is only expressed endogenously at a very low level 
[102].  The forced over-expression of this tagged GlnK2 under non-nitrogen fixing 
conditions explains why this affinity purification yields only the tagged version of this 
protein. 
 The same sample used to generate Figure 5.4 was examined by the bottom-up MS 
technique, in which proteolytic digestion was used to generate peptides for LC-MS/MS 
interrogation.  The bottom-up experimental results confirmed the top-down data.  Under 
these non-nitrogen fixing conditions, the peptide MS results verified the presence of 
unmodified GlnK1 at 89.3% sequence coverage with 16 unique peptides and unmodified, 
tagged GlnK2 at 94.6% sequence coverage with 25 unique peptides.  The bottom-up MS 
measurements often are more extensive than the top-down, and indicate the presence of 
some other minor components in this sample.   
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Figure 5.4: ESI-FTICR mass spectrum of GlnK2 affinity purification from R. palustris 
grown under non-nitrogen fixing conditions. Only unmodified GlnK1 and unmodified 
tagged (tag refers to 6X His-tag and V5 antibody tag) GlnK2 proteins are present in the 
growth state. 
GlnK2 + Tag
GlnK1
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A possible DNA-binding protein Hu-alpha (RPA 2953) and the GlnB regulatory protein 
were each observed with 2-peptide hits and sequence coverage’s of about 30%.  The low 
abundance of the GlnB protein not observed in the LC-MS/MS experiments could be due 
to the weak affinity of GlnB associated with GlnK2 in the affinity purification. A few 
other species were detected with single peptide hits, but were not considered to be 
significant enough for confident identification. 
GlnK1 
Also performed, were affinity purifications of the tagged GlnK1 protein complex 
from R. palustris under non-nitrogen fixing growth conditions, in order to examine the 
baseline modification state of the complex and associated proteins. As determined by top-
down ESI-FTICR measurements for the GlnK1 affinity purifications, two forms of 
GlnK1 were identified [Figure 5.5].  These two isoforms of GlnK1 correspond to the 
tagged and untagged forms of GlnK1. Both of these proteins were identified with a 5-10 
ppm mass accuracy.  It is important to remember that the 6X His tag and V5 antibody tag 
used for affinity purifications are inserted within the plasmid DNA. Therefore, the 
untagged version of the protein is coming from the bacterial chromosomal DNA. The 
experimental determination of only unmodified GlnK1 in both the tagged and un-tagged 
versions is consistent with the expectation that under non-nitrogen fixing growth 
conditions, the high ammonium levels within the cell leads to an inactive form of the 
AmtB transporter, and thus there is no need to modify the GlnK1, since there is no need 
for the cell to transport ammonium.  
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Figure 5.5: ESI-FTICR mass spectrum of GlnK1 affinity purification from R. palustris 
grown under non-nitrogen fixing conditions. The tagged and un-tagged versions of the 
protein are present. 
GlnK1
GlnK1+ Tag
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The expression of GlnK1 under non-nitrogen fixing growth conditions will yield both 
tagged and untagged versions of this protein due to GlnK1 existing as a multimeric form, 
which interacts with both GlnK2 and GlnB [102].  Within the non-nitrogen fixing growth 
state, GlnK2 is expected to be expressed at a significantly lower level in the cell as 
compared to GlnK1.  This observation is supported by bottom-up data, where GlnK1 is 
present at 35.7% and 7 unique peptides, while GlnK2 has only one unique peptide and 
21.4% sequence coverage. 
GlnB 
Affinity purifications of the GlnB protein complex from R. palustris under non-
nitrogen fixing growth conditions were also performed.  Using top-down ESI-FTICR-MS 
to examine the GlnB affinity purifications reveals two isoforms of GlnB present within 
the non-nitrogen fixing growth state [Figure 5.6].  The two isoforms of GlnB identified 
correspond to the tagged and untagged versions of GlnB. The experimental determination 
of only unmodified GlnB is consistent with the expectation that under non-nitrogen fixing 
growth conditions, the high ammonium levels within the cell leads to an inactive form of 
glutamine synthetase, and thus there is no need to modify the GlnB. Again it is not 
surprising to see the un-tagged version of GlnB since it is coming from the chromosomal 
DNA of R. palustris.  Bottom-up data indicates that GlnB is present at 30% sequence 
coverage and 4 unique peptides.  
 The top-down data shown in Figures 5.4-5.6, along with the bottom-up 
information, indicate that the expression of the tagged, GlnK1, GlnK2, and GlnB proteins 
and subsequent affinity purification procedures are effective in enriching the targeted 
sample for mass spectrometric characterization.   
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Figure 5.6: ESI-FTICR mass spectrum of GlnB affinity purification from R. palustris 
grown under non-nitrogen fixing conditions. The tagged and un-tagged versions of the 
protein are present. 
GlnB GlnB + Tag
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Thus, this approach can be used for in-vivo studies of GlnK1, GlnK2, and GlnB 
modifications as a function of growth state.  The observation of GlnK1 in the affinity 
purification of the tagged GlnK2 verifies the robustness of this method.  The absence of 
significant quantities of other proteins (i.e. non-specific binding) also attests to the 
potential of this affinity method. 
Characterization of GlnK1, GlnK2, and GlnB Under Nitrogen Fixing Conditions 
GlnK2 
Affinity purifications of GlnK2 from R. palustris grown under nitrogen fixing 
conditions revealed the presence of four isoforms of expressed GlnK2, as shown in 
Figure 5.7.  As expected, the unmodified tagged version of GlnK2 is present; however, it 
also is accompanied by the uridylylated version of the tagged protein, as well as the 
untagged GlnK2 and the uridylylated untagged version of this protein.  While the 
presence of untagged GlnK2 initially may be surprising, it is important to remember that 
GlnK2 is thought to exist in a trimeric form, which interacts with both GlnK1 and GlnB 
[97].  Thus, the expression of GlnK2 under these growth conditions will yield both 
tagged and untagged versions of this protein.  The affinity purification targets the tagged 
GlnK2, which will bring-down the other components of the protein complex.  Once 
again, the high mass accuracy of 3-5 ppm afforded by the ESI-FTICR-MS provides the 
ability to confirm the molecular masses of all four isoforms by comparing them with the 
calculated masses.  
In the direct infusion ESI-FTICR-MS experiments of the GlnK2 affinity 
purification shown in Figure 5.7, GlnK1 was not observed, even though it was detected 
under non-nitrogen fixing conditions (Figure 5.4).   
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Figure 5.7: ESI-FTICR mass spectrum of GlnK2 affinity purification from R. palustris 
grown under nitrogen fixing conditions. Four different isoforms of the GlnK2 protein are 
present within the growth state, including the tagged and untagged isoforms of the protein 
as well as the modified and unmodified isoforms. 
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This absence of GlnK1 in Figure 5.7 most likely is due to the overwhelming 
amount of uridylylated untagged GlnK2 at similar molecular mass.  This ionization 
suppression effect in direct infusion ESI-MS experiments is not uncommon, and is one of 
the major reasons for performing LC-MS measurements (i.e. to provide spatial separation 
of proteins prior to measurement). 
In order to evaluate whether ionization suppression was a factor in GlnK1 
detection, samples of GlnK2 affinity purifications from the nitrogen fixing and non-
nitrogen fixing growth conditions (confirmed to contain GlnK1) were mixed at a 1:1 
ratio. Even though GlnK1 was observed in Figure 5.4, in this set of experiments from the 
mixed sample, GlnK1 was not observed, therefore supporting the ionization suppression 
postulation. To alleviate this problem, an online liquid chromatography ESI-FTICR-MS 
experiment was performed to search for GlnK1 in the associated affinity purification 
complex of the nitrogen fixing sample.  This LC-FTICR-MS experiment allowed for 
partial chromatographic separation of the GlnK2 (all isoforms) from GlnK1, and 
provided evidence that GlnK1 was present in this sample (Figure 5.8).  Even though the 
chromatographic separation of GlnK1 was incomplete from GlnK2, there was distinct 
evidence for unmodified GlnK1, as well as all four isoforms of GlnK2 in this sample.  
The GlnB protein was not observed in the LC-FTICR-MS or ESI-FTICR-MS 
experiments; this could be due to the low abundance or weak affinity of GlnB associated 
with GlnK2 in the affinity purification.  The first peak eluting in the chromatogram is 
ubiquitin, added as an internal standard. 
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Figure 5.8: LC-FTICR-MS total ion chromatogram of GlnK2 affinity isolation showing 
the GlnK1 protein as well as all four forms of the GlnK2 protein. The first peak in the 
chromatogram (tr = 4.5min) is ubiquitin which was used as an internal standard for the 
chromatography. 
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Bottom-up MS characterization of this nitrogen-fixing sample confirmed the 
overwhelming presence of GlnK2 (100% sequence coverage with 20 unique peptides) 
and GlnK1 (92.9% sequence coverage with 15 unique peptides).  As before, the bottom-
up MS measurements indicated the presence of some other minor components in this 
sample.  The same DNA-binding protein Hu-alpha (RPA 2953) and the GlnB regulatory 
protein were each detected at a fairly low level. A few other species, primarily ribosomal 
proteins, were detected with single peptide hits, but were not considered to be definitive 
enough for identification. Bottom-up analysis also confirmed the presence of two unique 
uridylylated peptides from the GlnK2 complex under nitrogen fixing growth conditions. 
Each of these two peptides contains tyrosine- 51, which was suspected to be the 
uridylylation site in GlnK2.  Peptides 48-GAEY*AVSFLPK-58 and 48-
GAEY*AVSFLPKIK-60 were present with high DBDigger scores, of 58.9 for a +2 and 
34.0 for a +1, and abundant ion intensities. The MS/MS spectrum of peptide 48-
GAEYAVSFLPK-58 is shown in Figure 5.9, with the b and y fragmentation ion series 
labeled within the mass spectrum. This MS/MS spectrum shows unambiguously that the 
tyrosine residue within the peptide contains the uridylylation, which adds a mass shift of 
306.02 Da.  Inspection of all the other peptides failed to reveal a tyrosine uridylylation at 
any other position.  Also present in the MS/MS were GlnK2 peptides containing tyrosine-
51 that were not modified with the uridylylation.  These finding are consistent with the 
observation of the unmodified form of GlnK2 in the top-down mass spectra. There were 
no uridylylated peptides found for GlnK1 within the GlnK2 affinity purification, 
verifying the top-down data that this protein is unmodified.   
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Figure 5.9: MS/MS spectrum of uridylylated peptide 48-GAEY*AVSFLPK-58. The 
spectrum has the b and y ions labeled showing the uridylylation on tyrosine 51 (y8 and b4 
ions).   
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Even though the bottom-up MS measurements verified the presence of both 
uridylylated Y-51 and non-uridylylated Y-51 peptides for GlnK2, this technique did not 
provide further details about which of the four isoforms was present or whether all were 
present. Top-down analysis of the GlnK2 modification state proved to be the most 
valuable and efficient way of confirming the presence of the multiple isoforms.   
By combining the top-down and bottom-up mass spectrometry approaches, it was 
possible to determine not only the unique site of uridylylation in GlnK2, but also the 
range of isoforms present under nitrogen-fixing growth conditions. 
In both the LC-FTICR-MS and ESI-FTICR-MS experiments of the GlnK2 affinity 
purification, GlnK2 under nitrogen fixing growth conditions was observed to be 
uridylylated in this affinity purification. Therefore, GlnK2 seems to play a key role in the 
regulation of nitrogen availability in R. palustris and activation of the AmtB ammonium 
transporter.  This mechanism of AmtB regulation is different from other well 
characterized systems such as E. coli where the primary regulation site is GlnK1.  Also R. 
palustris differs from other bacterial species in that it encodes three pII proteins 
providing additional regulation sites for the bacteria within the glutamine synthetase 
pathway.   
GlnK1 
Affinity purifications of GlnK1 from R. palustris, grown under nitrogen fixing 
conditions, revealed the presence of two isoforms for both GlnK1 and GlnK2, as shown 
in Figure 5.10. As expected, the unmodified tagged version of GlnK1 is present; 
however, it also is accompanied by the uridylylated version of the tagged protein, as well 
as the unmodified GlnK2 and the uridylylated untagged version of this protein.   
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Figure 5.10: ESI-FTICR mass spectrum of GlnK1 affinity purification from R. palustris 
grown under nitrogen fixing conditions. The unmodified and modified tagged (tag refers 
to 6X His-tag and V5 antibody tag) GlnK1 isoforms are present in the growth state as 
well as the unmodified and modified isoforms of GlnK2. 
GlnK2 + Uridylylation
GlnK2
GlnK1 + Tag +Uridylylation
GlnK1 + Tag
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The presence of untagged and modified GlnK2 again is due to the multimeric form of the 
complex [102].  Thus, the expression of GlnK1 under these growth conditions will yield 
both tagged and untagged versions of this protein.  The affinity purification targets the 
tagged GlnK1, which will bring down the other components of the multimer. This 
mixture of GlnK1 and GlnK2 isoforms from this affinity purification may indicate that 
under nitrogen fixing conditions GlnK2 plays a more primary role in the regulation of 
AmtB. This is also supported by the lower abundance of GlnK1 in the GlnK2 affinity 
purification under nitrogen fixing conditions.  Once again, the high mass accuracy 
afforded by the ESI-FTICR-MS provides the ability to confirm the molecular masses of 
all the GlnK1 and GlnK2 isoforms by comparing them with the calculated masses. 
Bottom-up data further confirms the top-down data with GlnK1 present at 73.2% 
sequence coverage and 14 unique peptides. The GlnK2 protein is present at 92.0% 
sequence coverage and 19 unique peptides within the same affinity purification. Bottom-
up analysis also confirmed the presence of two unique uridylylated peptides (48-
GAEY*IVNFLPK-58  and 41-GHTEIYRGAEY*IVNFLPK-58)  for GlnK1 as well as 
the unique uridylylated peptide 48-GAEY*AVSFLPK-58 from GlnK2. 
GlnB 
Affinity purifications of GlnB from R. palustris, grown under nitrogen fixing 
conditions, revealed the presence of four isoforms of expressed GlnB, as shown in Figure 
5.11.  This affinity purification yields the unmodified tagged version of GlnB which is 
also accompanied by the uridylylated version of the tagged protein, as well as the 
untagged GlnB and the uridylylated untagged version of this protein.  
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Figure 5.11:  ESI-FTICR mass spectrum of GlnB affinity purification from R. palustris 
grown under nitrogen fixing conditions. Four different isoforms of GlnB proteins are 
present in the growth state, including the tagged and untagged isoforms of the protein as 
well as the modified and unmodified isoforms. 
GlnB
GlnB + Uridylylation GlnB + Tag + Uridylylation
GlnB + Tag
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It is again important to remember that GlnB exist in a trimeric form, therefore yielding all 
four isoforms of the GlnB protein. Bottom-up MS data identifies GlnB at 50.7% 
sequence coverage and 11 unique peptides. In the ESI-FTICR-MS experiments of the 
GlnB affinity purification, only GlnB under nitrogen fixing growth conditions was 
observed to be uridylylated. Therefore, GlnB may be a key regulation site of glutamine 
synthetase in R. palustris.  This mechanism of glutamine synthetase regulation is similar 
to other well characterized systems such as E. coli where the primary regulation site is 
GlnB.   
Wild Type R. palustris GlnK1, GlnK2, and GlnB Analysis 
In order to examine if the plasmid constructs that forced over-expression of 
GlnK1, GlnK2, and GlnB would alter the normal state of the proteins, wild type R. 
palustris cells were analyzed for the presence and modification state of the GlnK1, 
GlnK2, and GlnB proteins.  Wild type cells were grown under both photoheterotrophic 
conditions as well as nitrogen fixing conditions, the cells were lysed and total protein was 
extracted, FPLC anion exchange fractionation performed, and the resulting fractions were 
analyzed by LC-FTICR-MS and LC-MS/MS.  GlnK1and GlnB proteins were detected in 
the cells grown under photoheterotrophic conditions, both in the unmodified forms.  
GlnK2 was not observed under these conditions.  For this growth condition, the most 
abundant protein was GlnB, which may be indicative of endogenous expression under 
non-nitrogen fixing conditions.  The absence of GlnK2 expression and modification is 
consistent with the growth state of the cells, which is anaerobic non-nitrogen fixing.  The 
bottom-up experimental results for the non-nitrogen fixing growth conditions revealed 
GlnK1 at 38.4% sequence coverage and 3 unique peptides, and GlnB at 51.8% sequence 
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coverage and 7 unique peptides.  No peptides were observed for GlnK2, in accord with 
the top-down MS results. 
Under nitrogen fixing growth conditions, the GlnK2 and GlnB proteins were 
identified in both the unmodified and modified states. The GlnK1 protein was not 
observed under nitrogen fixing conditions.  This observation is consistent with the 
observations in the affinity purifications of higher GlnK2 expression under nitrogen 
fixing conditions.  These results provide evidence that plasmid constructs did not alter the 
natural state of the complex.   
Conclusions 
The pII proteins, GlnK1, GlnK2, and GlnB, all appear to play an essential role in 
ammonium and nitrogen regulation for R. palustris.  Affinity purifications, in conjunction 
with top-down mass spectrometry, permitted the isolation and characterization of the 
functional state and isoforms for these proteins as a function of nitrogen availability.  
Under non-nitrogen fixing conditions, all of these pII proteins are unmodified.  Under 
endogenous growth conditions, GlnB and GlnK1 are abundant, whereas GlnK2 was not 
observed.  Under nitrogen fixing conditions, all of these pII proteins are uridylylated, all 
on the Tyr-51 positions.  Thus, pII protein uridylylation appears to be tightly coordinated 
with nitrogen availability.  The presence of tagged and untagged protein isoforms also 
provided evidence for the multimeric conformations of these species, thereby supporting 
results obtained from E. coli that these proteins exist in trimers. 
From this work, we conclude the GlnK2 is predominantly expressed and 
uridylylated in R. palustris under nitrogen limited conditions, presumably to regulate the 
AmtB transporter.  Unmodified GlnK1 is abundant in non-nitrogen fixing conditions, but 
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also is uridylylated under nitrogen-fixing conditions.  As expected, GlnB is expressed as 
an unmodified protein under non-nitrogen fixing conditions, while it also is uridylylated 
under nitrogen-fixing conditions, likely regulating glutamine synthetase.  By comparing 
endogenous growth vs. affinity labeling conditions, we determined that the plasmid 
construction did not alter the normal state of the proteins, suggesting that this 
experimental protocol can be used to probe the natural modification conditions of such 
proteins. 
In this study, top-down mass spectrometry using FTICR-MS was found to be an 
invaluable tool for determining the post translational modifications on the pII family 
proteins, GlnK1, GlnK2, and GlnB, in Rhodopseudomonas palustris.  By using a 
combined technique of protein affinity purifications and mass spectrometry it was 
determined, for the first time, that GlnK2, GlnK1 and GlnB proteins possess an 
uridylylation under nitrogen fixing growth conditions in R. palustris.  This information 
allowed for a previously un-afforded glimpse into the modifications and isoforms of the 
proteins that regulate the AmtB transporter and glutamine synthetase in R. palustris. 
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Chapter 6 
Computational Searching Algorithms Developed for Integrated Top-down and 
Bottom-up Data for the Identification of PTMs 
 
All of the data presented below is in preparation for submission Heather M. Connelly, 
Robert L. Hettich, Chandrasegaran Narasimhan, Gary J. VanBerkel, Vilmos Kertesz. 
Integrated Top-down and Bottom-up Protein and PTM searching: “PTMSearch Plus” 
Analytical Chemistry (2006) All MS sample preparation, experiments, biological 
knowledge behind programming, and final data analysis were performed by Heather M. 
Connelly. Programming was performed by Vilmos Kertesz, post doc in OBMS group. 
 
Introduction 
One of the largest challenges in developing a top-down proteomics platform was 
the development of a functional proteome informatics capability. At the start of this 
dissertation, the ProSight [115] and PROCLAME [116] algorithms had been available for 
the analysis of intact protein and their MS/MS spectra against protein databases as well as 
PTM prediction. But no major effort had been made to integrate top-down analysis with 
traditional enzymatic bottom-up analysis for protein identification and PTM analysis.  
Integrating “top-down” and “bottom-up” MS-based proteomic strategies provides 
a powerful tool to examine complex protein mixtures, such as proteins in multi-
component complexes or even complete proteomes. An integrated top-down and bottom-
up approach allows for a more comprehensive characterization of protein complexes due 
to the unique strength of each technique. In an integrated approach, intact protein masses 
from the top-down analysis corresponding to a particular PTM or isoform are able to be 
compared to the comprehensive list of proteins provided by the bottom-up analysis. This 
correlation between the two methods can provide PTM location and identity with more 
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certainty.  The comprehensiveness of this technique has been previously demonstrated in 
studies of the Shewanella oneidensis proteome as well as the 70S ribosomal complex 
from Rhodopseudomonas palustris [54, 35]. 
Current software searching tools can provide very good identifications from top-
down protein data, as well as make predictions of possible PTMs on a protein. Examples 
of these tools are ProSight PTM [115] and PROCLAME [116].  ProSight PTM [115] 
combines a number of search engines and browser environments into a web application 
that allows the user to analyze top-down data from proteins in the >10kDa size range. 
This program uses intact protein masses and fragmentation masses from the intact 
proteins to provide protein and PTM identifications.  This method works well, although, 
it requires the use of top-down dissociation methods such as infrared multiphoton 
dissociation (IRMPD) and electron capture dissociation (ECD) that are not available to 
all labs and may not be as comprehensive for complex mixtures as bottom-up methods 
employing an enzymatic digestion. The PROCLAME algorithm uses intact protein mass 
measurements to determine sets of putative protein cleavage and modification events to 
account for the measured protein masses observed [116].  PROCLAME provide a good 
prediction algorithm but is unable to incorporate mass spectrometry (MS/MS) data within 
the process. 
Our ORNL developed algorithm PTMSearch Plus is the first software providing a 
comprehensive search method that allows for the integration of top-down protein 
identification with the bottom-up peptide data to identify proteins and their associated 
PTMs [Figure 6.1].  The software is built around multiple instrumentation platforms and 
data inputs. These multiple instrumentation and data platforms include bottom-up ion  
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Figure 6.1: Screen shot of PTMSearch Plus main data input screen.
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trap data, as well as top-down high resolution data such as FT-ICR data. The software 
can perform independent top-down or bottom-up searches, as well as these two parts of 
the program being able to interact. By combining these two search capabilities, the results 
from the top-down search can limit the number of the proteins that are used to generate 
the database used for the bottom-up search (search time decrease) and in return, the 
results of the bottom-up search can be used as a confirmation for the proteins with 
associated PTMs found in the top-down search. This integration reduces the search time 
dramatically, allowing the user to search for more PTMs on proteins and peptides during 
a reasonable time frame.   The power of this integrated search method is demonstrated 
using data from analysis of a protein standard mixture and a complex Rhodopseudomonas 
palustris ribosomal protein mixture. 
Methods and Software 
System Requirements.   
PTMSearch Plus was developed using Delphi 3 computer language (Borland 
Software Corp., Scotts Valley, CA) under Microsoft© Windows XP Home Edition 
(Microsoft Corp., Redmond, WA) operation system and can be run in any 32-bit 
Windows environment with at least 256 MB RAM.  Currently, the program is free to use 
for any government or educational institute. 
Methodology.  
PTMSearch Plus currently supports seven search options allowing the user to 
perform: 
• a standalone “top-down” search 
• a standalone internal “bottom-up” search 
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• MASPIC [117], “bottom-up” search 
• an integrated “top-down” and “top-down predicted” internal “bottom-up” search 
with PTM/peptide limitation 
• an integrated “top-down” and “top-down predicted” MASPIC “bottom-up” search 
with PTM/peptide limitation 
• an integrated “top-down” and “top-down predicted” external “bottom-up” search 
(e.g. accomplished by DBDigger [118] or Sequest, etc.) 
• integration of “top-down” search results with already-made DTASelect [61] 
“bottom-up” search result files 
These search options are discussed in details below. 
Defining a PTM.  
 PTMSearch Plus allows for the user to define any number and kind of PTMs 
without any restrictions. When a PTM is defined, the following parameters must/can be 
specified: (a) a 3-letter unique ID that is used to identify the PTM; (b) maximum number 
of the specific PTM that a protein can have; (c) average mass of the PTM (used in top-
down search); (d) exact mass of the PTM (used in bottom-up search); (e) if the PTM is 
used in the bottom-up search (e.g. disulfide bond formation is not used in bottom-up 
search); (f) "offset": if the specific PTM should be used when calculating the precursor 
ion's mass but should be removed when calculating the mass of the fragment ions (e.g. it 
allows the user to search for labile PTMs such as phosphorylation that is removed from 
tyrosine, histidine, and serine in the ion trap prior/during fragmentation); (g) location of 
amino acid that is modified (C-, N-terminal or any location on the peptide); (h) number of 
amino acids that can have the specific PTM; (i) amino acids that can have the specific 
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PTM; (j) maximum number of the PTM that the amino acids can have (e.g. in the case of 
methylation; it can be 3 for arginine and lysine, or set to less) and (k) if the C- or N-
terminal amino acid can have the PTM independent from the type of the amino acid (e.g. 
acetylation can occur on the N-terminal amino acid beside every arginine and lysine 
residues).  The user may define and save many PTMs into a dataset and is still able to 
select a sub-group of PTMs that are used in the actual search. 
Standalone “Top-Down” Search   
Prior to performing a standalone “top-down” search (Figure 6.2), the user has to 
generate a peak list for each spectra from the raw experimental data. A Visual Basic 
script was written that extracts out all the average mass peaks (calculated by the IonSpec 
software) from across a selected region of the ion chromatogram, and saves them to a file 
with DCP extension (deconvoluted peaks).  From the DCP files that have been generated, 
the user is able to select the DCP files to be searched through.  The user is able to 
accomplish searching using the same searching conditions on an unlimited number of 
DCP files in one software run without user intervention by selecting a directory 
containing the DCP files of interest.  Also needed, prior to starting the top-down search, 
is a specified FASTA protein database; giving the user the ability to search against any 
annotated organism, combination of organisms or subset of proteins.  The user also has 
the ability to limit the top-down search to the deconvoluted peaks which meet certain 
criteria: (a) the m/z of a deconvoluted peak must be larger than the preset threshold value 
(3000 Da by default); (b) minimum number of isotopic peaks deriving a deconvoluted 
peak (3 by default);  
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Figure 6.2: Flow chart of the top-down searching method within PTMSearch Plus. 
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(c) FFT size and (d) apodization settings used to generate the spectra resulting in the 
deconvoluted peak must be selected in the program. Also, the user has the ability to 
specify the conditions for a match to the deconvoluted peak found in a top-down 
spectrum: (a) maximum difference between the m/z of a deconvoluted peak and that of 
the calculated m/z of the PTM protein, and (b) maximum number of PTMs on the protein.   
Standalone "Bottom-Up" Search  
Built into the PTMSearch Plus program is a simple internal bottom-up searching 
algorithm that is based on the presence and intensity of b- and y-ions in the spectrum.  
The scoring mechanism is not discussed here in more detail as it was implemented only 
to demonstrate the power of the integrated top-down and bottom-up searches, such as 
how limiting the number of peptides to search against in a bottom-up run can drastically 
reduce search time.  PTMSearch plus is designed to allow for the user to use a scoring 
algorithm of their choice at any time.  To demonstrate the ability to implement different 
scoring algorithms, we implemented the MASPIC scoring algorithm [117] within the 
software.  When using either the internal or the MASPIC standalone bottom-up search, 
the user must (a) define the number of missed tryptic cleavages; (b) maximum number of 
PTM a peptide can have (see below); (c) minimum and (d) maximum mass of the tryptic 
peptide; (e) minimum number of amino acid residue a peptide must have (to exclude 
short peptides from the search that are normally not unique for a protein); (f) the 
maximum difference between the peptide and the precursor ion's mass to search the 
corresponding MS/MS spectra against the b and y fragment ions of the peptide, and (g) 
the maximum difference between the m/z of a peak in the MS/MS spectrum and that of 
the b and y ions of the peptide to be used in the scoring. 
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Integrated "Top-Down" and "Bottom-Up" Search   
Figure 6.3 shows the simplest approach to integrate "top-down" and "bottom-up" 
searching algorithms in general.  In this case, "top-down" and "bottom-up" data are 
searched independently and the results are compared.  This approach is considered to be a 
complete search, as all proteins (and their possible PTMs) are checked against the two 
different datasets.  Figure 6.4 shows a different approach, that is implemented in 
PTMSearch Plus to integrate "top-down" and internal or MASPIC "bottom-up" search 
algorithms.  First, a "top-down" search is accomplished, followed by assigning all 
combination of possible PTMs found to that particular protein. E.g. if protein 1 was 
found with three different PTMs in the "top-down" search: 2 methylations; 4 
methylations and a β-methythiolation; then all possible combinations of these PTMs are 
assigned to protein 1.  The assigned PTM represents the most complex set of PTMs that a 
single peptide of the given protein can have.  At this point the user has two options: I.) 
creating peptide sequences exclusively from the proteins found in the "top-down" search 
using their individually assigned PTMs, or II.) creating peptide sequences from the 
proteins found in the "top-down" search using their individually assigned PTMs as well 
as from proteins not found in the "top-down" search using their intact (non-modified) 
sequence.  Each method may drastically decrease the number of peptide sequences used 
in the "top-down predicted" (i.e. peptide sequences are generated based on the results of 
the "top-down" search) "bottom-up" search.  
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Figure 6.3: Flow chart of simple integration of independent "top-down" and "bottom-up" 
searching algorithms. 
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Figure 6.4: Integrated approach of PTMSearch Plus that is able to combine "top-down" 
and "bottom-up" searching algorithms. 
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Current "bottom-up" search engines (e.g. Sequest, DBDigger etc.) don't have the 
possibility to limit the number of PTMs in a single peptide to a reasonable level that 
could be considered acceptable from a chemical viewpoint [62, 118].  If a peptide has 
nX=4 arginines, and arginines can have mono-, di- or tri-methylation (pX=3), then it 
results in 256 peptide candidates each with different PTMs.  Generally, peptides with 0, 1 
or 2 PTMs could be found.  For this reason, it seemed to be practical to let the user limit 
the number of possible PTMs on a single peptide (m) in the software to reduce the 
searching time.  Using the example above, (nX=4, pX=3) the number of the different 
peptide candidates is 13 or 67, using m=1 or m=2, respectively.  This simple example 
clearly demonstrates that the number of PTM peptide candidates, and the time necessary 
to search them against the experimental "bottom-up" data, can be (drastically) reduced by 
limiting the number of PTMs that a single peptide can have based on simple chemical 
viewpoint and our experimental experience.  The reduction in the number of peptide 
candidates, by limiting the maximum PTM/peptide, is even more drastic when different 
PTMs are assigned to different amino acids (e.g. methylations to arginine and lysines, β-
methythiolation to aspartic acid, etc.). Bottom-up inputs are also available for Sequest 
[62], DBDigger[118], and DTASelect[61] text files, however, the advantages of "top-
down" predicted "bottom-up" search cannot be utilized in these cases. 
Methods 
All proteins, salts, and buffers were obtained from Sigma Chemical Co. (St. 
Louis, MO).  Sequencing grade trypsin was purchased from Promega (Madison, WI).  
Formic acid was obtained from EM Science (affiliate of Merck KGaA, Darmstadt, 
Germany).  HPLC-grade acetonitrile and water were used for all LC-MS-MS analyses 
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(Burdick and Jackson, Muskegon, MI).  Ultrapure 18 MΩ water used for sample buffers 
was obtained from Millipore Milli-Q system (Bedford, MA).  Fused silica capillary 
tubing was purchased from Polymicro Technologies (Phoenix, AZ). 
Preparation of Protein Standard Mixture and Rhodopseudomonas palustris Ribosomal 
Proteins 
In this study, all prepared samples were divided into two portions. One portion 
was examined by 1D LC-MS-MS bottom-up mass spectrometry and the other portion of 
the sample was examined using LC-FT-ICR-MS for top-down mass spectrometry.  By 
correlating the two data sets, using PTMSearch Plus with the same sample, it was 
possible to identify the proteins, but also to characterize PTMs on the proteins. 
Five proteins were used in a five protein mixture: ubiquitin (MW 8 kDa), chicken 
lysozyme C (MW 14 kDa), bovine ribonuclease A (MW 13 kDa), bovine carbonic 
anhydrase II (MW 29 kDa), and bovine beta lactoglobulin-B (MW 18 kDa).  The proteins 
were dissolved in HPLC grade water to give a final concentration of 1 mg/mL of each 
protein, and diluted as required for the analysis.  The PSM mixture was digested for 
bottom-up analysis with sequencing grade trypsin added at 1:20 (wt/wt) of enzyme to 
protein.  The digestions were run with gentle shaking at 37 °C for 12 hours.  Samples 
were immediately desalted with an Omics 100 µl solid phase extraction pipette tip 
(Phenomenex, Torrance, CA).  All samples were frozen at   -80°C until LC-MS/MS 
analysis.   
70S ribosomes from R. palustris were purified and fractionated using a high salt 
sucrose cushion and sucrose density fractionation as previously described [119].  For 
bottom-up analysis acid extracted [120] ribosomal proteins were denatured and reduced 
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in 6M guanidine HCl, 50 mM Tris-HCl (pH 7.6), with 10 mM DTT at 60 °C for 45 
minutes.  Afterward, the proteins were digested with 1 µg trypsin overnight at 37 °C.  
Remaining disulfides were reduced with 10 mM DTT at 60 °C for 45 minutes.  To 
perform top-down analysis the ribosomal samples were neither reduced nor digested. 
Results and Discussion 
Protein Standard Mixture 
 A five protein standard mixture consisting of ubiquitin, lysozyme, ribonuclease A, 
β-lactoglobulin B, and carbonic anhydrase was evaluated with PTMSearch Plus. The 
protein standard mixture served as a training set to evaluate the performance of the 
program with an initial simple mixture. To begin the search of the five protein standard, 
using PTMSearch Plus, a combined top-down and bottom-up search was selected using 
both the built in simple bottom-up searching method, as well as the top-down and 
external search option using the DBDigger program as described above [118].  Both 
programs were used in order to validate the simple built in bottom-up searching method 
with a known external bottom-up search algorithm to ensure both data sets corresponded. 
 A directory comprising text files from the top-down data obtained from scripting 
methods by selecting data rich regions across the total ion chromatogram, as well as a 
directory of the MS2 files generated from the raw bottom-up MS/MS data files, was input 
for the five protein search.  These data directories can be selected from browser tab at the 
input sites within the software main screen.  Once the appropriate data directories were 
loaded, a list of PTMs to be searched was input. Within all searches of the protein 
standard mixture, the only specified PTMs were disulfide bonds and methionine 
truncation. These two PTMs were selected due to the intact proteins used containing 
 147
these modifications.  A feature of the PTM function within PTMSearch Plus is the ability 
to perform certain smart PTM searches (Figure 6.3). For example, the program looks for 
the number of cystines within a protein and will not allow for more disulfide bonds to be 
formed than there are cystines to support.  
 All searching was performed with a database composed of the five proteins, as 
well as common contaminants to give a total of 43 proteins within the database. Top-
down specifications included a maximum mass difference of one dalton and a minimum 
of three peaks within the isotopic package. Also used in the top-down search 
specifications were all three FFT data sizes (128, 256, 1024K), and apodization both on 
and off. For the bottom-up search parameters, a peptide can have a maximum of two 
missed cleavages, a maximum of two PTMs on a peptide, a minimum of 5 amino acids 
within a peptide, and a minimum mass of 400 Da and maximum mass of  6000 Da.   
Of the five proteins searched for within the mixture, four could be identified both from 
the intact protein data, as well as having supporting peptide data from both bottom-up 
search types. The identified four proteins with corresponding top-down and bottom-up 
data included ubiquitin, lysozyme, ribonuclease A, and β-lactoglobulin-B.  Carbonic 
anhydrase is a 29 kDA protein that is difficult to elute from the C4 reverse phase column 
used in the top-down analysis.  Therefore, carbonic anhydrase was identified in the 
bottom-up searching but not in the top-down data.   
Post translational modifications in the form of disulfide bonds were identified on 
three of the proteins in the integrated search.  These included lysozyme with two 
disulfide bonds, β-lactoglobulin B with two disulfides, as well as ribonuclease A with 
multiple isoforms and disulfide bonds.  Also identified was ubiquitin with a methionine 
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truncation. All of these modifications were expected due to the use of purchased protein 
stocks with these known modifications. These modifications were previously known, 
however,  PTMSearch Plus was able to identify them without any prior inputs into the 
software indicating their presence.    
Rhodopseudomonas palustris Ribosomal Proteins 
In a recent study by Strader et al. top-down and bottom-up characterization of the 
ribosome from R. palustris was performed.  In this study 53 of the 54 orthologs to the E. 
coli ribosomal proteins were identified by bottom-up analysis, and 42 intact protein 
identifications were obtained by the top-down approach [54]. Following top-down mass 
measurement, the authors used a manually created intact protein look-up table that 
contained intact molecular masses, methionine truncated molecular masses, and all 
possible combinations of methionine truncation with single acetylation and multiple 
methylations, up to 9, for the entire suit of 54 possible ribosomal proteins. After bottom-
up measurement, the authors used SEQUEST [62] to identify peptides with no 
modifications. Next, numerous single searches of the data using SEQUEST with 
individual possible PTMs was performed.   Once the identifications from both the top-
down and bottom-up approach were generated, they were then compared to one another 
manually to provide conformation of both methods.  This manually inspected data set 
yielded a test set for PTMSearch Plus to test the program with a complex mixture.  Since 
PTMSearch Plus is able to take the top-down intact protein data and the bottom-up 
MS/MS data and combine them into one single search, thereby eliminating the time 
consuming manual search and conversion of data, the time to search both raw data sets 
took only minutes as compared to months for the manual conversion.    
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When performing the searches with PTMSearch Plus, a combined top-down and 
bottom-up search was performed, using both the built in simple bottom-up searching, as 
well as the top-down and external search option using the DBDigger program.  Top-down 
search specifications included a maximum mass difference of one dalton and a minimum 
of three peaks within the isotopic package. Also used in the top-down search 
specifications was all three FFT data sizes (128, 256, 1024K), and apodization both on 
and off. For the bottom-up search parameters, a peptide can have a maximum of two 
missed cleavages, a maximum of two PTMs on a peptide, a minimum of 5 amino acids 
within a peptide, and a minimum mass of 400 Da and maximum mass of  6000 Da.  
Within all searches of the complex ribosomal mixture, the only specified PTMs were 
methylations, acetylations, and methionine truncation. These PTMs were selected due to 
the initial study using these modifications, therefore, our search results could be directly 
compared to the manual results published in the study.   
 Using PTMSearch Plus, we were able to identify all of the 53 identified by 
bottom-up analysis, and 42 intact protein identified by the top-down approach within the 
Strader et al. study [54].  PTMSearch Plus is able to output the proteins identified by 
bottom-up only, top-down only, and a list of measured intact proteins, with or without 
PTMs, that have confirming bottom-up data. The examine matches interactive output 
selection, loads a graphical display showing the identified protein with its corresponding 
identified peptide and PTMs. This function is able to filter the results with a number of 
different options to show only the top-down matches that have confirmation with bottom-
up data, delete duplicate proteins with the same PTMs, and delete duplicate peptides that 
confirm the protein plus PTM. Once the results have been filtered, the user is able to view 
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the identified proteins with their associated PTMs and peptides. Within the results view, 
the protein name is shown, sequence of the peptides, the PTMs on the protein and the 
peptides, as well as the b and y ion labeled ms/ms spectra of the peptide.   These results 
interfaces allow for the quick and easy viewing of results.  When looking at the proteins 
that contain supporting peptide data we find a total of 41 R. palustris ribosomal proteins. 
This is consistent with the individual top-down and bottom-up data due to there only 
being 42 identified top-down peaks to match peptides.  The one unidentified top-down 
peak is L36 where bottom-up could not provide any supporting peptides.  These results 
are consistent with what was seen in the Strader et al. study [54].  Figure 6.4 shows the 
top-down and bottom-up data for ribosomal protein L33 as out put by PTMSearch Plus. 
The L33 protein was identified with a methylation of the peptide AK*AVTIKIK by 
bottom-up analysis. The mass of L33 with a methionine truncation and a methylation was 
identified in the top-down searching. When PTMSearch Plus output the proteins that 
have confirming peptide data L33 was shown [Figure 6.5].    
 151
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.5:  Integrated top-down and bottom-up results for the R. palustris L33 protein.  
(A) Shown are the results lists from PTMSearch Plus with the labeled confirming 
MS/MS spectrum from the bottom-up analysis.  The sequence of the peptide is given 
with the methylation labeled as MET within the sequence. (B) Shown is the top-down 
spectrum of the intact protein with the de-methionation and a methylation. 
 
(A)
(B)
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Conclusions 
PTMSearch Plus provides a novel software for the integration of top-down and 
bottom-up protein and PTM identification.  The software allows for the use of multiple 
data and instrument platforms to be combined.  This methodology provides an integrated 
top-down and bottom-up searching algorithm that is not only fast but accurate. The 
software was demonstrated with a protein standard mixture and complex ribosomal 
protein mixture. All proteins from the protein standard mixture, which was used as a 
training set, could be identified using PTMSearch Plus.  The R. palustris complex 
ribosomal mixture was previously examined in an integrated fashion by manual 
comparison. Using PTMSearch Plus all of the identified ribosomal proteins identified in 
the previous study were identified in a fraction of the time. Both of these test cases 
showed the power of the integrated approach, as well as demonstrating the accuracy and 
speed of PTMSearch Plus.   
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Chapter 7 
 
Identification of PTMs and Isoforms from the Versatile Microbe 
Rhodopseudomonas palustris Under Three Metabolic States 
All of the data presented below are in preparation for submission Heather M. Connelly, 
Dale A. Pelletier, Vilmos Kertesz, Melissa Thompson, W. Judson Hervey, Tse-Yuan Lu, 
Patricia K. Lankford, Gregory B. Hurst, Frank W. Larimer, and Robert L. Hettich Top-
down Characterization of the Versatile Rhodopseudomonas palustris Microbe Under 
Three Growth Conditions to Identify PTMs and Isoforms. Journal of Proteome Research 
(2006). Judson Hervey a graduate student in the genome science and technology 
program provided signal peptide database. All MS sample preparation, experiments and 
data analysis were performed by Heather M. Connelly. 
 
Introduction 
Rhodopseudomonas palustris belongs to the α-proteobacteria, and is a purple 
nonsulfur anoxygenic phototrophic bacterium found in diverse environments from fresh 
water to soil. One of the unique features of R. palustris is its ability to grow and function 
under many metabolic states. These states include: photoheterotrophic where energy is 
obtained from light and carbon from organic carbon sources, photoautotrophic where 
energy is from light and the main source of carbon is from carbon dioxide, 
chemoheterotrophic where carbon and energy are from organic compounds, and finally 
chemoautotrophic where energy is from inorganic compounds and carbon from carbon 
dioxide [10, 11, 12, 13] (Figure 7.1).  R. palustris has the ability to be a biofuel producer 
by producing hydrogen gas as a byproduct of nitrogen fixation, as well as a greenhouse 
gas sink by converting carbon dioxide into cell mass.  Since most of these metabolic 
states can easily be attained in laboratory settings, R. palustris is an ideal model system 
for the study of diverse metabolic modes and their control within a single organism.  
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Figure 7.1: Graphical representation of the core metabolic states of Rhodopseudomonas 
palustris interrogated in this study. The top figure illustrates the basic anaerobic state for 
photoheterotrophic growth in light without oxygen. The bottom figure illustrates the basic 
aerobic state for chemoheterotrophic growth in the dark with oxygen present. The circle 
in the center of the cell represents central metabolism. This figure was adapted from 
Larimer et al. Nat. Biotechnol.2004, 22, 55-60. 
Photoheterotrophic
growth
Succinate
Anaerobic States
Chemoheterotrophic
growth
Succinate
Aerobic States
Light = Energy
Organic Carbon = Cell Material
Organic Carbon = Energy
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Recently, R. palustris has been sequenced revealing a 5.4 Mb genome with 4836 
potential protein encoding regions [13]. This sequencing and annotation effort other 
along with proteome profiling, protein-protein interaction studies, global gene knockouts 
[14], and transcriptome profiling [15], will provide a detailed systems biology 
characterization of this microbe.  A study of the baseline proteome of an R. palustris 
wild-type strain under phototrophic and chemotrophic growth conditions, including 
variants of each state, was recently completed providing a starting point for 
understanding this microbe’s protein diversity [121]. 
The goal of this study was to provide the first comprehensive intact protein or 
“top-down” characterization of R. palustris.  Intact protein or Top-down mass 
spectrometry can be used to provide intact protein identification as well as insight into 
protein modification states, to ascertain the role individual proteins play in the complex 
metabolism states of R. palustris. This powerful method can provide information on the 
natural state of intact proteins, including details about post-translational modifications 
(PTM’s), truncations, mutations, signal peptides, and isoforms due to top-down mass 
spectrometry’s ability to measure the molecular weight of a protein very accurately and 
detect any covalent modifications that alters the mass of a protein.  
The more common peptide or “bottom-up” mass spectrometric approach involves 
enzymatic digestion of intact proteins with a protease to generate a peptide mixture. 
However, bottom-up methods provide a comprehensive list of proteins, vital information 
about post translational modifications may be missed if the peptides containing the 
particular modification escape detection.   Furthermore, identifying peptides that come 
from a complex protein mixture may not provide information on the presence of different 
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isoforms (variations of a protein that may include different states of PTMs) that may exist 
for a particular protein. 
An integrated top-down and bottom-up approach allows for a more complete 
characterization of proteins due to the unique strengths of each technique. In an 
integrated approach, intact protein masses from the top-down analysis corresponding to a 
particular PTM or isoform are compared to the comprehensive list of proteins provided 
by the bottom-up analysis. This correlation between the two methods can provide 
information on PTM location and identity, as well as verifying gene start sites within the 
genome annotation with more certainty.  The comprehensiveness of this technique has 
been previously demonstrated in studies of the Shewanella oneidensis proteome as well 
as the 70S ribosomal complex from Rhodopseudomonas palustris [54, 35]. Combing the 
strengths of two important mass spectrometric techniques such as “top-down” and 
“bottom-up”, proteomic strategies provides a powerful tool to examine proteins from 
selected growth states of R. palustris. 
Three growth states of R. palustris were interrogated with this integrated top-
down and bottom-up approach.  These three growth states consist of two categories: 
aerobic growth in the dark (chemotrophic) and anaerobic growth in light (phototrophic).  
The main growth state was the anaerobic photoheterotrophic growth mode, with light 
providing the energy, organic carbon in the form of succinate providing the carbon source 
for cell material, and ammonia serving as the nitrogen source. The second growth state 
examined was a variant of the photoheterotrophic growth mode in which nitrogen 
fixation is performed. In this state, nitrogen gas was substituted for ammonia as the 
nitrogen source forcing the cells to fix nitrogen.  The final growth state examined was the 
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aerobic state or chemoheterotrophic growth state, in which cells were grown aerobically 
in the dark, with succinate as both the carbon and energy source, and nitrogen serving as 
the ammonia source.  These three growth conditions provided an opportunity to examine 
both intact proteins and how post translational modifications (PTMs) from R. palustris 
play a role in the complex metabolic processes carried out by this organism.   
This study provides the first large-scale characterization of these three growth 
states of R. palustris by an integrated top-down and bottom-up approach. This global 
measurement strategy can provide information on intact proteins, including PTMs, 
isoforms, and signal peptides from a given growth state. This technological approach 
provides information on the function and location of proteins, as well as providing 
confirming peptide MS/MS data. This tool is especially powerful when determining what 
modification states play a role in the switch between different growth conditions, 
characterizing known and unknown proteins, and determining trends within protein 
expression across the chosen metabolic states.   
Material and Methods 
Chemicals and Reagents 
All salts, buffers, dithiothreitol (DTT), guanidine HCl, trifluoroacetic acid, phenyl methyl 
sulfonyl fluoride (PMSF), were obtained from Sigma Chemical Co. (St. Louis, MO).  
Sequencing-grade trypsin was purchased from Promega (Madison, WI).  Formic acid was 
obtained from EM Science (Affiliate of Merck KgaA, Darmstadt, Germany).  HPLC 
grade acetonitrile and water were used for all LC-MS analyses (Burdick & Jackson, 
Muskegon, MI).  Ultrapure 18 MΩ water used for sample buffers was obtained from a 
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Millipore Milli-Q system (Bedford, MA).  Fused silica capillary tubing was purchased 
from Polymicro Technologies (Phoenix, AZ). 
Cell Growth and Protein Fractionation 
R. palustris strain CGA010, a hydrogen-utilizing derivative of the sequenced 
strain (unpublished C. S. Harwood) and referred to here as the wild-type strain, was 
grown under the three conditions outlined in the Introduction section. Wild type R. 
palustris cells were grown anaerobically in light or aerobically in dark on defined mineral 
medium at 30 °C to mid-log phase (OD 660 nm = 0.6). Carbon sources were added to a 
final concentration of 10 mM succinate, 10 mM sodium bicarbonate. For the 
photoheterotrophic N2 fixing cultures, ammonium sulfate was replaced by sodium sulfate 
in the culture medium and N2 gas was supplied in the headspace. Chemoheterotrophic 
cells were grown aerobically in the dark with shaking at 200 rpm; phototrophic cells were 
grown anaerobically in the light with mixing with a stir bar. All anaerobic cultures were 
illuminated with 40 or 60 W incandescent light bulbs from multiple directions. 4-5 liters 
of cells were grown for all three states and pooled together for each state. The cell pellet, 
obtained by centrifugation at 1000 X g for 10 minutes, from each growth state was 
French Pressed to yield 60-120 mg of protein for each of the three growth states. Cell 
extract was centrifuged at 10,000g for 35 minutes in a Sorvall centrifuge to remove all 
unbroken cells. Protein extract was used for off-line anion exchange FPLC fractionation. 
To perform off-line anion exchange chromatography 60 mg of protein was injected onto 
a 5 ml HiTrap (HiTrap SP HP, Amersham Pharmacia) ion exchange column connected to 
an AKTA (Amersham Pharmacia) FPLC system. After protein injection, a 30 minute 
ammonium acetate gradient was run from 0.2 M to 2 M. Twenty fractions from each 
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growth state (total of 60 from 3 growth states) were determined to have sufficient protein 
concentrations (400 µg) by a Bradford protein assay. Each FPLC fraction obtained was 
then divided into two equal protein concentration portions. One portion was examined by 
1D LC-MS-MS bottom-up mass spectrometry and the other portion of the sample was 
examined using LC-FTICR-MS for top-down mass spectrometry. All fractions were 
analyzed with 1X coverage with top-down methods due to the proteins precipitating upon 
freezing.  Bottom-up analysis was performed with 2X coverage on all fractions.  
Data Analysis 
All resulting top-down and bottom-up data sets were analyzed with two methods. 
In the first method, the SEQUEST algorithm was used to identify MS-MS spectra with 
their counterparts predicted from a protein sequence database [62].  For all database 
searches, an R. palustris proteome database was used, which contained 4,833 proteins 
and 36 common contaminants. All resultant output files from SEQUEST were filtered by 
DTASelect [61] at the 1-peptide, 2-peptides and 3-peptides level with the following 
parameters:  SEQUEST, delCN of at least 0.08 and cross-correlation scores (Xcorrs) of at 
least 1.8 (+1), 2.5 (+2) and 3.5 (+3). Once filtered the results were analyzed by Contrast 
[61] for comparison.  In the second method, integrated top-down and bottom-up 
searching was performed with the PTMSearch Plus software developed at Oak Ridge 
National Laboratory. Output files containing bottom-up data from PTMsearch Plus were 
filtered by DTASelect [61] at the 2-peptides level with the following parameters:  
MASPIC [118], scores of at least 23 (+1), 28 (+2) and 43 (+3).  The output files 
containing top-down data were filtered with at least three peaks within the isotopic 
package, a 3000 Da mass cutoff and a relative abundance of at least 10%.   The 
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PTMSearch Plus program allows for the combined searching of both the top-down and 
bottom-up data sets, as well as allowing for the searching of a defined set of PTMs.  In 
the integrated top-down and bottom-up data searches a standard set of PTMs were 
searched for including: methylation, acetylation, de-methionation, and disulfide bonds 
(restricted to top-down data). Less common PTMs such as uridylylation were searched 
individually. All data outputs generated were manually inspected and then compared 
using Microsoft Access (Microsoft Corp., Redmond, WA). 
Results and Discussion 
Approximately twenty fractions were obtained from the off line FPLC separation 
of the protein lysate from each of the three anaerobic, nitrogen fixing, and aerobic growth 
states.  Off line FPLC was used to separate the large complex mixtures of proteins from 
the three growth states for top-down analysis, due to its proven ability to reduce down the 
complexity of the mixture.  Therefore, by reducing the complexity of the protein mixture, 
this method allowed for better separation from the on-line HPLC methods employed, as 
well as more comprehensive protein identifications. Top-down methodologies are a 
powerful tool, but some limitations do exist such as on-line chromatography of intact 
proteins is difficult due to the wide range of protein sizes and hydrophobicities within the 
complex mixtures used.  This method of off line FPLC fractionation followed by on line 
HPLC takes a large amount of protein starting material (in the milligram range), 
although,  this is not of great concern due to the ability to produce more than enough 
material (~120 mg) from the 4 liters of culture from each growth state. Another area of 
concern using this strategy is the loss of protein during the off line separation. This 
problem is unavoidable, due to the need to have a prior separation of the complex protein 
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mixture before the top-down analysis. By providing this initial separation step with 
FPLC, we increase the overall ability to analyze and identify more proteins than with no 
initial separation. We have found this technique of off line fractionation followed by on 
line HPLC, to be highly reproducible and simple to implement for a large-scale study of 
multiple samples [35].  
Each data set generated with the integrated top-down bottom-up approach was 
searched with PTMSearch Plus, which combined the top-down and bottom-up data set 
searches to provide positive identifications of both proteins and their associated PTMs. 
PTMSearch Plus is a new search algorithm developed at Oak Ridge National Laboratory 
(ORNL), which provides the first integrated top-down and bottom-up searching 
algorithm that allows the user to select the number and types of PTMs they wish to search 
for. As well as the integrated searching approach, all bottom-up MS/MS data sets were 
searched with SEQUEST [62], filtered with DTASelect [61], and compared with Contrast 
[61]. Since SEQUEST is a proven search tool within the community; the search results 
from SEQUEST were used to manually verify the outputs from PTMSearch Plus were 
accurate.  The results from the integrated top-down and bottom-up searches for all three 
growth states allowing up to 10 methylations, 2 acetylations, N-terminal methionine 
truncation, and disulfide bonds on the intact proteins are shown in Table 7.1.  These 
PTMs and amounts were used for searching due to biological constrains and to keep the 
search space and results manageable. For example, only one N-terminal methionine 
truncation can be present on a protein and the number of disulfide bonds is restricted to 
the number of cysteines present within the protein sequence. Also shown in Table 7.1 are 
the results for the SEQUEST searches of the bottom-up MS/MS data with no specified  
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Table 7.1: Number of identified proteins from all three searching methods. 
Growth Condition 
PTMSearch Plus 
TDBU PTM a  
PTMSearch Plus 
BU PTMs b 
SEQUEST BU 
no PTM c 
Anaerobic 119 853 465 
Nitrogen Fixing 214 785 295 
Aerobic 426 1373 512 
Total Non-Redundant Proteins Identified 599 1908 713 
a Top-down and bottom-up searching with PTMs performed with PTMSearch Plus  
b Bottom-up searching with PTMs performed with PTMSearch Plus  
c Bottom-up searching performed with SEQUEST and no PTMS 
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PTMs and the PTMSearch Plus bottom-up results allowing for the PTMs listed above. 
There were more proteins identified using the bottom-up searching containing PTMs. The 
identification of more proteins with the PTMSearch Plus program is due to the ability to 
confidently identify MS/MS spectra from a peptide containing PTMs.  These MS/MS 
spectrum would have been unidentified in the SEQUEST program. This is due to the 
inability of SEQUEST to perform searches with multiple modifications specified. 
Therefore, using PTMSearch Plus provides more comprehensive identifications for the 
data set.  One method used to ensure our searches were identifying proteins correctly was 
to examine some of the common proteins that one would expect to find, such as 
elongation factors, chaperonin GroES, and nitrogen regulatory proteins. Table 7.2 
provides a list of these expected proteins found in both the top-down and bottom-up data 
sets.  The percent sequence coverage of the protein from the bottom-up data is provided 
in Table 7.2 as well as the ppm error from the top-down data.  
Both the top-down and bottom-up data sets were evaluated separately and in an 
integrated approach within this study.  Tthe bottom-up method provides a confident list 
of proteins, using MS/MS data, but there are instances where bottom-up is unable to 
provide identifications. These proteins missed with the bottom-up method are generally 
very amenable to the top-down approach, due to the proteins being within a size range 
that works well for top-down measurements (3-15 kDa). Generally, the unidentifiable 
proteins from bottom-up are small in size or have very few tryptic sites. Small proteins 
when digested form peptides that are too small to be seen within the mass spectrometer 
(less than 400 Da).  
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Table 7.2: Expected proteins and their percent sequence coverage and mass accuracy. 
Gene 
Number Category Product 
% 
Sequence 
Coverage 
Mass 
Accuracy 
RPA3053 Transcription Cold Shock Protein 73.1 1.2 
RPA3672 Transcription Cold Shock Protein 52.4 12 
RPA2513 Translation Elongation Factor P 41 28.1 
RPA1141 Cellular Processes Chaperonin GroES1 49 11.1 
RPA2165 Cellular Processes Chaperonin GroES2 58.7 1.7 
RPA2966 Signal Transduction 
GlnB Nitrogen Regulatory Protein 
PII 51.8 -4.1 
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Also, proteins with few tryptic sites generate peptides that are to large to be measured 
with the mass spectrometers employed in bottom-up.  Table 7.3 provides examples of 
some of these proteins, where the tryptic peptides used are outside the 400-6000 Da range 
generally seen in the bottom-up method, but were identified by top-down.  Also, within 
this study, positive protein identifications from bottom-up searching require two unique 
peptides.  In the cases presented in Table 7.3, some of these proteins do not have the 
required two unique peptides for a positive identification.  Therefore, top-down methods 
alone are able to add another level of information above the identification of PTMs and 
isoforms generally considered.  Contained within the top-down data sets are proteins with 
good isotopic resolution and mass accuracy, but are unidentified. These unidentified 
proteins may be from degradation and truncation products or the result of missed start 
sites within the protein annotation process.        
Due to the focus of this research being to confidently identify intact proteins and 
their associated PTMs, all data we will focus our biological analysis on will be from the 
integrated TDBU data obtained for the PTMSearch Plus program. From the integrated 
Top-down and bottom-up searching, a total of 599 non-redundant proteins were identified 
from all three growth states [Table 7.4]. Table 7.4 shows all 599 proteins identified, 
organized by functional categories. These 599 proteins include both proteins identified 
with and without PTMs and all have bottom-up MS/MS confirmation.     
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Table 7.3: Proteins not identified by bottom-up analysis that were identified by top-
down. 
 
Protein Intact Mass Peptides Mass Peptide
RPA0214 8651.6691 1-MALGEPQEVPNDPGPVTPPPEVPPSTPGTPTEPPLEQPPGN 7929.859
PNPDIPPPEEPGAPPQPNELPGQMPAEVPMQSPGR-77
78-SVPNPGVA-85 739.827
RPA1952 7593.1835 1-TAELNILGVFVPTILICAAAAFILTSLVSR-30 3117.788
31-LLVWLNFYHLVWHHTLFNLTIFVVIVFVALGLVSGWPQ-68 4493.411
RPA1773 11366.5634 1-MK-2 277.388
3-WLYLLIAIVAEVVGTSALK-21 2059.521
22-ASQGFTVLLPSVLVVVGYGAAFYFLSLTLSSISVGIAYA 9065.685
 WSGIGIVLISAVGWLWFGQALDTAAIIGIAFIIAGVGIINFFSNVSAH-109
RPA1085 14242.7461 1-MK-2 277.388
3-YAGILAAFALGASVAGADAGSLVYTPTNPAFGGS 5297.859
PLNGSWQMQQATAGNHFNR-55
56-AAPTSGPQQLTQSQIFAQQLQSQLYASLANQVT 6108.735
QAIFGANAQQSGTFSFQGTTISFAK-113
114-VDGQTNITINDGSTVTQISLPTVTH-138 2611.847
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Table 7.4: All 599 proteins identified from the three growth states of R. palustris 
 
Gene 
Number 
Aerobic Anaerobic Nitrogen 
Fixing 
PTMs BU 
Seq. 
Cov.e 
Protein Annotation 
10127.686a, S   1xDEM-3xMETRPA0008 
 10086.001, Wd  1xDEM 
30 circadian clock protein 
RPA0010 18760.967, Sb   4xMET  transcriptional regulator, 
probable glutamate 
RPA0036 17908.472, W     conserved unknown 
protein 
RPA0038  13314.382, Mc  1xMET 70 ribosomal protein L20  
RPA0039  7457.667, S  1xDEM-3xMET 27 50S ribosomal protein 
L35 
RPA0040 21979.05, S   4xMET 21 translation initiation 
factor IF-3  
RPA0052  16447.565, M  1xDEM-4xMET  putative nitrogen 
regulatory IIA 
protein(enzyme 
RPA0054   15894.144, W 1xDEM-3xMET 12 putative small heat shock 
protein  
RPA0059  43156.031, M  1xDEM-1xMET 51 L-carnitine 
dehydratase/bile acid-
inducible 
RPA0090 15149.266, W   1xDEM 82 hypothetical protein 
RPA0092 10019.455, W   1xDEM-2xMET 50 conserved hypothetical 
protein 
RPA0155  16656.413, M  6xMET 10 putative tolR/exbD 
protein  
13359.566, S   1xDEM RPA0158 
  13359.564, M 1xDEM 
42 putative ribosomal 
protein L21  
9477.775, S   1xDEM-2xMETRPA0159 
  9463.792, S 1xDEM-1xMET
40 ribosomal protein L27  
RPA0160   22277.636, S 1xDEM-3xMET 9 possible 
acetyltransferases. 
RPA0177 32018.782, W   6xMET 9 putative H+-transporting 
ATP synthase gamma 
RPA0179 19541.781, W   2xMET 13 putative H+-transporting 
ATP synthase delta 
RPA0203 20990.138, M   1xDEM-3xMET 78 heme exporter protein A 
(heme ABC transporter 
13656.301, S   1xDEM-3xMETRPA0207 
  13699.846, M 1xDEM-6xMET
28 unknown protein 
RPA0222  19744.263, M  1xDEM-8xMET 61 Beta-Ig-H3/Fasciclin 
domain 
RPA0224 28876.763, S   1xDIS-6xMET 9 similar to eukaryotic 
molybdopterin 
RPA0233 31223.309, S   1xDEM-3xMET 73 putative Citrate lyase 
beta chain (acyl lyase 
22365.940, M   3xMET 
 22366.559, M  3xMET 
RPA0235 
  22366.103, S 3xMET 
15 3-isopropylmalate 
dehydratase small 
subunit  
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Table 7.4: Continued 
Gene 
Number 
Aerobic Anaerobic Nitrogen 
Fixing 
PTMs BU 
Seq. 
Cov.e 
Protein Annotation 
RPA0241 14297.711, S 14297.834, S 14297.470, S  32 50s ribosomal protein L19 
12017.821, S   1xDEM RPA0244 
  12017.633, S 1xDEM 
14 ribosomal protein S16  
RPA0246 13472.790, W    14 PilT protein, N-terminal 
RPA0263 15891.873, M   1xDEM-4xMET 27 Protein of unknown 
function UPF0047 
RPA0267 32750.676, M   1xDEM-5xMET 4 possible thioredoxin 
RPA0272  12360.825, M   17 GlnK, nitrogen regulatory 
protein P-II  
RPA0274   12367.542, M 1xURY 13 GlnK, nitrogen regulatory 
protein P-II  
RPA0276 12559.245, S   2-4xMET 17 PAP/25A core 
domain:DNA polymerase, 
beta-like 
RPA0282 16018.135, W   1xDEM 8 possible transcriptional 
regulator 
RPA0283 24983.847, S   1xDEM 9 putative two-component 
response regulator  
RPA0285 23538.857, W   1xDIS-9xMET 6 Protein of unknown 
function UPF0001 
RPA0292 30801.005, W   1xDEM-1xDIS-
3xMET 
6 chromosome partitioning 
protein, ParA  
RPA0298 30818.180, W   1xDEM-6xMET 17 DUF299 
RPA0301 25755.166, W   1xDEM-1xDIS-
4xMET 
5 putative DNA polymerase 
III epsilon chain  
23669.290, W   1xDIS-3xMET RPA0311 
 23669.449, M  1xDIS-3xMET 
8 imidazoleglycerol-
phosphate synthase, 
RPA0323 14372.435, M   8xMET 7 Protein of unknown 
function UPF0102 
13489.857, W   1xDEM-9xMETRPA0326 
  13490.434, M 1xDEM-9xMET
12 DUF24, predicted 
transcriptional regulator, 
RPA0329 26017.808, S   2xDIS-3xMET 4 ribonuclease PH  
22173.571, M   1xDEM-7xMETRPA0331 
  22305.627, M 7xMET 
15 possible heat shock 
protein  
22366.393, M   1xDEM-8xMETRPA0335 
  22366.586, M 1xDEM-8xMET
9 putative phospholipid N-
methyltransferase  
16176.801, S   9xMET 
 16176.339, S  9xMET 
RPA0350 
  16119.958, M 5xMET 
13 putative patch repair 
protein 
RPA0354 11347.234, S   1xDEM-5xMET 22 putative pts system 
phosphocarrier protein 
HPr  
RPA0356 15924.889, M   3xMET 9 conserved hypothetical 
protein 
26896.572, S   5xMET RPA0359 
 26866.940, W  3xMET 
5 conserved unknown 
protein 
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Table 7.4: Continued 
Gene 
Number 
Aerobic Anaerobic Nitrogen 
Fixing 
PTMs BU 
Seq. 
Cov.e 
Protein Annotation 
RPA0366 12741.565, S   1xDEM-3-
4xMET 
11 unknown protein 
16027.073, W   2xDIS-8xMET RPA0373 
  16027.527, W 2xDIS-8xMET 
13 thioredoxin  
RPA0377 30252.460, W   1xDIS-7xMET 4 conserved unknown 
protein 
RPA0384 20438.524, W   1xDIS-8xMET 8 conserved unknown 
protein 
RPA0395 21641.686, M   1xDIS-2xMET 10 Metal dependent 
phosphohydrolase, HD 
region 
RPA0403 14135.043, W   9xMET 9 conserved hypothetical 
protein 
 11855.153, M  4xMET RPA0414 
  11870.371, M 5xMET 
16 DUF167 
10011.569, S   1xDEM 
 10011.231, M  1xDEM 
RPA0433 
  10011.035, M 1xDEM 
28 ribosomal protein S15  
RPA0435   15379.549, S 1xDEM-2xMET 12 putative ribosome-binding 
factor A  
RPA0443 15004.785, W   1xDEM-3xMET 10 possible transcriptional 
regulator  
16585.565, M   1xDEM-1xDIS RPA0450 
  16644.153, S 1xDEM-4xMET
20 ferric uptake regulation 
protein  
RPA0453   20348.108, M 4xMET 57 possible NifU-like 
domain (residues 119-
187) 
RPA0489   12526.718, M 1xDIS-1xMET 9 ferredoxin II  
RPA0490   8068.031, M 1xDEM-9xMET 25 conserved hypothetical 
protein 
10848.394, S   1xDEM RPA0493 
  10876.330, S 1xDEM-2xMET
28 50S ribosomal protein 
L28  
RPA0501 9422.580, S   1xDEM 13 BolA-like protein 
RPA0511  33493.706, W  10xMET 8 PpiC-type peptidyl-prolyl 
cis-trans isomerase 
RPA0517 17835.864, W   1xDEM-8xMET 15 putative transcriptional 
regulator (Fur family) 
RPA0526      50S ribosomal protein 
L32  
RPA0532  25590.320, M  1xDIS-9xMET 13 beta-ketothiolase, 
acetoacetyl-CoA 
reductase  
RPA0543 18434.769, S   1xDEM-1xDIS-
6xMET 
13 unknown protein 
20007.852, S   1xDEM RPA0571 
  20105.929, S 1xDEM-7xMET
49 two-component, response 
regulator  
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Table 7.4: Continued 
Gene 
Number 
Aerobic Anaerobic Nitrogen 
Fixing 
PTMs BU 
Seq. 
Cov.e 
Protein Annotation 
RPA0578 9423.369, S   1xDIS-1xMET 17 unknown protein 
RPA0594 14966.448, S   1xDEM-1xDIS-
7xMET 
17 putative mutator protein 
mutT  
RPA0598 9622.031, W   1xDEM-1xDIS 22 putative glutaredoxin 
RPA0600  18099.337, S  1xDEM-7xMET 16 conserved hypothetical 
protein 
RPA0607 30498.225, S   1xDEM-2xDIS-
3xMET 
7 putative 
protoporphyrinogen 
oxidase, hemK 
RPA0609   29001.611, S 1xDEM-3xMET 4 conserved hypothetical 
protein 
RPA0616 11188.397, S 11188.089, M 11188.397, M  22 Uncharacterized BCR 
RPA0617   21259.868, S 7xMET 9 putative recombination 
protein recR  
RPA0618 14793.278, S   1xDIS-4xMET 10 unknown protein 
RPA0626  29733.197, W   6 2,3,4,5-
tetrahydropyridine-2-
carboxylate 
RPA0629  31499.295, W  1xMET 5 putative acetylglutamate 
kinase 
RPA0633   12907.673, M 2xMET 7 probable ribonuclease p 
protein component 
RPA0643 13969.928, W   1xDEM-3xMET 13 conserved hypothetical 
protein 
RPA0646 9413.638, M   1xDEM-4xMET 39 conserved hypothetical 
protein 
RPA0650 27433.140, S   2xDIS-4xMET 8 cyclohex-1-ene-1-
carboxyl-CoA hydratase 
RPA0653 28669.548, S   2xDIS-7xMET 30 2-
ketocyclohexanecarboxyl-
CoA hydrolase 
RPA0662   8848.975, S 1xDEM-4xDIS-
3xMET 
19 ferredoxin  
RPA0663 17079.605, S   1xMET 60 transcriptional regulator  
RPA0673 25777.576, S   1xDEM-9xMET 50 transcriptional activator  
RPA0687 23830.531, M   6xMET 40 conserved hypothetical 
protein 
RPA0688 20543.116, M   5xMET 60 ATP-binding component, 
PhnN protein, possible 
RPA0702  43081.468, S  3xMET 30 possible phosphonate 
ABC transporter, 
permease 
RPA0703   25979.575, S 1xDIS-4xMET 30 conserved hypothetical 
protein 
RPA0704 35909.585, W   7xMET 40 conserved unknown 
protein 
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Table 7.4: Continued 
Gene 
Number 
Aerobic Anaerobic Nitrogen 
Fixing 
PTMs BU 
Seq. 
Cov.e 
Protein Annotation 
RPA0707   11958.916, M 7xMET 11 putative periplasmic 
divalent cation resistance
RPA0714 18760.967, S   1xDEM-9xMET 70 bifunctional cobinamide 
kinase, cobinamide 
RPA0717   23441.430, S 9xMET 80 putative cob(I)alamin 
adenosyltransferase 
20656.598, M   4xMET RPA0729 
 20627.654, S  2xMET 
40 conserved hypothetical 
protein 
RPA0739 21203.439, S   2xDIS-4xMET 12 putative cytochrome c 
RPA0767 34867.931, W   1xDEM-3xMET 40 PAS 
domain:GGDEF:PAC 
motif 
RPA0771 10002.695, M   4xMET 
   9926.698, M 1xDEM-8xMET
13 possible protein 
commonly found in 
insertion 
RPA0775 19030.859, M   4xMET 80 hypothetical protein 
RPA0791 30019.876, W   1xDEM-2xDIS-
7xMET 
60 similar to Staphylococcus 
nuclease (SNase-like) 
RPA0795 22822.941, S   1xDEM-8xMET 70 possible SOS-response 
transcriptional repressor 
RPA0830   23441.430, S 5xMET 47 conserved unknown 
protein 
RPA0843 17712.212, M   9xMET 98 putative Fo ATP synthase 
B chain  
RPA0844 19203.863, M   1xMET 12 putative FoF1 ATP 
synthase, subunit B' 
RPA0855  39499.553, M  1xDEM-1xMET 37 Beta-lactamase-like 
RPA0866 14264.828, W   1xDEM-6xMET 12 putative nucleoside 
diphosphate kinase 
regulator 
RPA0868 6011.702, S   1xDEM-5xMET 33 hypothetical protein 
RPA0885   10254.021, W 1xDEM-4xMET 10 conserved hypothetical 
protein 
RPA0893 15051.893, W   8xMET 53 
   14893.115, S 1xDEM-6xMET  
conserved hypothetical 
protein 
RPA0903 20630.974, S   4xMET 35 putative transcriptional 
regulator  
RPA0907 13450.536, M   8xMET 18 possible response 
regulator receiver domain
RPA0917   18515.305, M 1xDEM-6xMET 12 Transcriptional Regulator, 
AraC Family 
RPA0918  8566.680, M    20 possible 50S ribosomal 
protein L31  
RPA0920 17135.907, S   5xMET 11 GCN5-related N-
acetyltransferase 
RPA0927    7731.168, W 1xDEM-1xDIS-
4xMET 
28 probable transcriptional 
regulator  
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Table 7.4: Continued 
Gene 
Number 
Aerobic Anaerobic Nitrogen 
Fixing 
PTMs BU 
Seq. 
Cov.e 
Protein Annotation 
RPA0930 21414.056, M   1xDEM-1xDIS-
5xMET 
45 possible 3-octaprenyl-4-
hydroxybenzoate 
RPA0932 19542.010, S   1xDEM-3xMET 13 conserved unknown 
protein 
RPA0941 11384.043, W   1xDEM-4xMET 21 conserved hypothetical 
protein 
RPA0942 10806.326, W   9xMET 11 conserved hypothetical 
protein 
RPA0953 9142.316, S   1xDEM 26 
   9286.551, W 1xMET  
possible 
exodeoxyribonuclease 
small subunit 
RPA0956   17064.368, W 1xDIS-7xMET 44 hypothetical protein 
RPA0973 12572.113, S   2xDIS-3xMET 17 hydrogenase 
formation/expression 
protein hypA 
RPA0977  41253.600, S  7xMET 32 hydrogenase 
expression/formation 
protein hypD 
RPA0993 20540.812, W   1xDEM-4xMET 13 possible alpha-ribazole-
5`-phosphate phosphatase
RPA0999  22495.358, M  9xMET 54 conserved hypothetical 
protein 
RPA1000 14479.792, M   1xDIS-3xMET 11 Nitrogenase-associated 
protein:Arsenate 
RPA1017   13746.840, M 1xDEM-1xDIS-
8xMET 
78 Nitrogen fixation-related 
protein 
RPA1019  12257.701, S  1xDEM-1xDIS-
5xMET 
11 possible transcriptional 
activator HlyU 
RPA1025   13455.728, M 1xDIS-9xMET 74 possible 
Ectothiorhodospira 
Vacuolata 
RPA1030 26939.380, S    15 possible CoA transferase, 
subunit B  
RPA1061 31284.422, S   2xMET 46 possible polyketide 
synthesis protein  
RPA1064   18078.781, S  60 conserved hypothetical 
protein 
RPA1066 10119.106, W   6xMET 22 hypothetical protein 
RPA1088   12590.446, M 1xDEM-8xMET 14 hypothetical protein 
RPA1090 23792.666, S   1xDEM-1xMET 15 possible nitrogen 
regulator  
RPA1097 26941.767, S    52 DUF28 
RPA1100 21697.417, S   5xMET 73 RuvA; Holliday branch 
migration protein 
RPA1106  18345.992, W  1xDEM-6xMET 11 conserved hypothetical 
protein 
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RPA1107   19521.468, S 1xDEM-6xMET 90 possible transcriptional 
regulator  
RPA1108 14415.533, W   1xDEM-1xDIS-
4xMET 
17 Myb DNA-binding 
domain:DGPF domain 
RPA1111 9426.774, W   1xDIS-7xMET 12 hypothetical protein 
RPA1141 10493.013, S   1xDEM 40 
  10492.701, S  1xDEM  
   10493.154, S 1xDEM  
chaperonin GroES1, 
cpn10 
RPA1152  18166.729, M  4xMET 23 hypothetical protein 
RPA1157    9553.862, S 8xMET 73 conserved unknown 
protein 
RPA1160 12698.756, W   5xMET 11 conserved unknown 
protein 
RPA1168 17026.930, W   1xDEM-2xMET 15 
   17027.435, M 1xDEM-2xMET  
molybdopterin converting 
factor, subunit 2  
RPA1173 9369.198, S   5xMET 13 possible cold shock 
protein  
RPA1175 14420.772, W   1xDEM-8xMET 24 chemotaxis protein 
CheY4 
RPA1191 17028.760, S   7xMET 73 putative RNA 
methyltransferase  
RPA1228   19751.976, S 1xDEM-9xMET 59 putative 2-oxoglutarate 
ferredoxin 
RPA1263   10369.363, M 6xMET 27 putative II.1 protein 
RPA1271 16026.872, M   8xMET 63 conserved hypothetical 
protein 
RPA1278 16179.437, M   1xDEM-6xMET 18 
  16135.775, W  1xDEM-3xMET  
GatB/Yqey 
RPA1279   10911.295, M 1xDEM-7xMET 79 hypothetical protein 
RPA1289 12010.505, M   1xDEM-6xMET 11 hypothetical protein 
RPA1291 11431.413, W   8xMET 32 putative proteic killer 
suppression protein  
RPA1302   12590.586, M 1xDEM-2xMET 90 unknown protein 
RPA1333 22674.886, M    73 conserved hypothetical 
protein 
RPA1342   9999.405, M 1xDEM-4xMET 21 hypothetical protein 
RPA1344 17028.852, S   6xMET 14 hypothetical protein 
RPA1361   7132.965, M 9xMET 24 hypothetical protein 
RPA1366 12350.218, S   8xMET 20 putative sulfur oxidation 
protein 
RPA1390 24811.042, M   2xDIS-5xMET 69 conserved hypothetical 
protein 
RPA1392 19630.240, M   1xDEM 77 nitroreductase family 
proteins 
RPA1414 31284.422, S   9xMET 11 MaoC-like dehydratase 
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RPA1416 25863.037, S   1xDIS-9xMET 54 putative branched-chain 
amino acid transport 
RPA1441 28744.987, M   2xMET 77 
  28829.754, S  8xMET  
possible uridylate kinase 
RPA1442 28899.592, M   7xMET 85 
   28885.179, S 6xMET  
possible uridine 
monophosphate kinase 
RPA1454   9368.408, W 1xDEM-4xMET 22 hypothetical protein 
RPA1455   16811.588, S 1xDIS-5xMET 40 nitric-oxide reductase 
subunit C 
RPA1475 8778.512, W   9xMET 17 hypothetical protein 
RPA1500 21499.481, M   1xDIS-4xMET 11 unknown protein 
RPA1535 14599.861, W   1xDEM-7xMET 80 
   14514.801, M 1xDEM-1xMET  
cytochrome c2 
RPA1551  11037.662, W  1xDEM-8xMET 18 
   11084.940, W 2xMET  
hypothetical protein 
RPA1578 28900.136, S   8xMET 97 ferredoxin--NADP+ 
reductase 
RPA1586 27968.897, S   1xDEM-1xDIS-
1xMET 
85 putative short-chain 
dehydrogenase/reductase 
RPA1587 9927.322, M   3xMET 22 hypothetical protein 
RPA1589   23442.195, S 1xDEM-1xMET 12 30S ribosomal protein S4 
RPA1591   13697.058, M 3xMET 15 conserved unknown 
protein 
RPA1593 18006.889, S   1xDEM-7xMET 50 Thioesterase superfamily 
RPA1600 8272.686, S   1xDEM-1xMET 30 
  8273.949, S  1xDEM-1xMET  
   8301.483, S 1xDEM-3xMET  
BolA-like protein 
RPA1606  14218.167, M  8xMET 79 
   14245.615, M 10xMET  
conserved unknown 
protein 
RPA1615 28867.609, M   1xDEM-4xMET 61 putative methyltransferase
RPA1617   21315.981, M 8xMET 52 ErfK/YbiS/YcfS/YnhG 
RPA1620   11417.855, M 1xDEM-1xMET 25 unknown protein 
RPA1629   13456.672, M 1xDEM-6xMET 58 chemotaxis response 
regulator  
RPA1634 16381.157, M   4xMET 12 conserved unknown 
protein 
RPA1645 8065.034, W   4xMET 33 unknown protein 
RPA1659   22884.739, S 1xDEM 25 conserved unknown 
protein 
RPA1661   10306.118, W 1xDIS-3xMET 24 DUF156 
RPA1682 22620.915, W   6xMET 72 putative two component 
response regulator  
RPA1693 22557.316, W   3xMET 86 superoxide dismutase  
RPA1697 19054.936, S   1xDEM-6xMET 84 Competence-damaged 
protein 
RPA1717   14245.615, S 1xDEM-7xMET 17 hypothetical protein 
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RPA1719 11861.782, W   5xDIS-3xMET 23 Protein of unknown 
function UPF0153 
RPA1726 35298.166, S   1xDEM-1xDIS-
6xMET 
56 putative oxidoreductase  
RPA1757   26980.102, M 1xDEM-1xDIS-
7xMET 
31 possible oxoacyl carrier 
protein reductase 
RPA1777 15295.070, M   1xDEM-2xMET 11 DUF35 
RPA1788 15964.473, M   1xDIS-8xMET 23 
   15894.144, M 1xDIS-3xMET  
possible 4-
hydroxybenzoyl-CoA 
thioesterase  
RPA1812  24467.277, W  1xDEM-9xMET 66 conserved hypothetical 
protein 
RPA1824 17461.560, M   1xDEM-1xMET 32 unknown protein 
RPA1825 9003.751, M   6xMET 11 conserved hypothetical 
protein 
RPA1827 9668.191, M   1xDEM-3xMET 19 hypothetical protein 
RPA1831 9577.858, S   1xDIS-2xMET 20 conserved hypothetical 
protein 
RPA1839 13292.780, W   6xMET 25 putative dihydroneopterin 
aldolase 
RPA1842 12496.787, M   1xDEM-4xMET 14 conserved unknown 
protein 
RPA1855 22351.107, M   1xDIS-5xMET 74 conserved hypothetical 
protein 
RPA1870   18515.305, M 1xDEM-7xMET 82 possible transcriptional 
regulator (MarR/EmrR 
RPA1872 11267.049, M   7xMET 11 Rhodocoxin 
RPA1896  19940.857, M  7xMET 38 homologue of 
Rhodobacter capsulatus 
gene 
RPA1900  10669.437, M  6xMET 95 
   10697.929, S 8xMET  
homologue of 
Rhodobacter capsulatus 
gene 
RPA1905  31763.171, M  1xDEM-2xDIS-
3xMET 
50 homologue of 
Rhodobacter capsulatus 
gene 
RPA1908 16820.322, M   4xMET 77 hypothetical protein 
RPA1909  17137.601, M  1xMET 11 putative transcriptional 
regulator, MarR family 
RPA1915 24984.711, M   1xDEM-9xMET 58 FeuP  two-component 
system, regulatory protein
RPA1928 33099.112, M   2xDIS-6xMET 76 ferredoxin-like protein 
[2Fe-2S] 
RPA1964   19754.608, M 1xDEM-4xMET 14 hypothetical protein 
RPA1978  37839.176, S  1xDEM-1xDIS-
8xMET 
29 molybdenum biosynthetic 
protein A  
       
 176
Table 7.4: Continued 
Gene 
Number 
Aerobic Anaerobic Nitrogen 
Fixing 
PTMs BU 
Seq. 
Cov.e 
Protein Annotation 
RPA1982 20026.946, S   8xMET 15 
   19882.199, W 1xDEM-7xMET  
conserved unknown 
protein 
RPA1985 12722.134, M   1xDEM-3xMET 12 probable diacylglycerol 
kinase 
RPA1992 15165.192, M   2xMET 88 possible NtrR protein  
RPA1993 9832.024, M   1xDEM-3xMET 14 possible virulence-
associated protein  
RPA1996   10698.920, M 2xDIS-6xMET 16 hypothetical protein 
RPA2004 22567.353, W   1xDIS-8xMET 95 conserved hypothetical 
protein 
RPA2006 26621.810, S   1xDEM-8xMET 74 putative 
phosphatidylserine 
decarboxylase  
RPA2012 11188.935, S   1xDEM-5xMET 36 
  11118.798179, 
M 
 1xDEM  
conserved unknown 
protein 
RPA2028 21793.511, S   1xDEM-4xMET 73 conserved hypothetical 
protein 
RPA2032 19942.040, M    89 acetolactate synthase 
(small subunit) 
RPA2036 26939.380, S   1xDIS-2xMET 41 possible transcriptional 
regulator (GntR family) 
RPA2040 22362.657, M   4xMET 74 possible choline ABC 
transporter ATP-binding 
RPA2044 27086.658, M   1xDIS-7xMET 55 conserved unknown 
protein 
RPA2045  36322.528, S  1xDEM-3xDIS-
1xMET 
51 biotin synthetase  
RPA2057 12463.311, W   1xDEM-4xMET 19 hypothetical protein 
RPA2066   35090.978, M 1xDEM-4xMET 60 putative nosX 
RPA2068 10674.355, M   1xMET 14 conserved unknown 
protein 
RPA2082 25774.205, W   1xDEM-6xMET 22 putative uroporphyrin III 
methylase  
RPA2084 27462.806, M   1xDEM 13 precorrin 3 or 4 methylase
RPA2085 12941.148, W   2xMET 14 cobalamin biosynthesis 
protein G; CbiG 
RPA2125   12587.776, M  24 conserved unknown 
protein 
RPA2136 11243.957, M   1xDIS-1xMET 18 
   11115.419, W 1xDEM-1xMET  
possible cytochrome C 
precursor 
RPA2145 28029.307, S   1xDIS-6xMET 54 putative enoyl-CoA 
hydratase/isomerase 
RPA2158 11824.846, S   1xDEM-2xDIS-
3xMET 
11 hypothetical protein 
RPA2159 11346.894, W   1xDIS-3xMET 13 hypothetical protein 
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RPA2165 11164.094, S 11163.802, S 11164.046, S  27 chaperonin GroES2, 
cpn10 
RPA2179   20109.335, M  87 xanthine-guanine 
phosphoribosyltransferase 
RPA2188   11659.550, M 1xDIS-6xMET 11 hypothetical protein 
RPA2196   25015.256, M  89 conserved hypothetical 
protein 
RPA2197  25380.431, M  1xDEM-9xMET 47 cell division protein FtsJ 
RPA2205 13441.281,M    11 hypothetical protein 
RPA2239 22823.257, M   1xDEM-3xMET 10 putative partition protein 
RPA2241  17775.413, M  1xDEM-3xMET 11 conserved hypothetical 
protein 
RPA2243 9127.186, M   5xMET 16 putative transcriptional 
regulator  
RPA2264 17948.706, S   6xMET 85 conserved hypothetical 
protein 
RPA2265  35913.907, W  1xDEM-1xDIS-
2xMET 
33 conserved hypothetical 
protein 
RPA2274 13462.515, W   9xMET 11 hypothetical protein 
10475.250, S   1xDEM-4xMETRPA2283 
 10517.445, W  1xDEM-7xMET
14 putative proteic killer 
suppression protein 
RPA2313   19275.381, M 5xMET 11 unknown protein 
RPA2314   15152.212, M 1xDEM-1xDIS-
6xMET 
13 cytochrome c556  
RPA2334  11959.120, M  1xDEM  
   11959.120, M 1xDEM  
unknown protein 
RPA2335  11442.593, S  NATIVE, 1-
4xMET  
76 
   11442.593, S NATIVE, 1-
4xMET 
 
unknown protein 
 10908.894,S  NATIVE, 
1xMET 
RPA2336 
  10921.606, M NATIVE, 
1xMET 
47 unknown protein 
RPA2338  17752.529  1xDEM 52 unknown protein 
RPA2359 30819.670, W   4xMET 52 putative periplasmic 
protein  
RPA2368 8395.593, S   2xMET 17 possible transcriptional 
regulatory protein  
RPA2401 12335.292, S    19 conserved unknown 
protein 
RPA2407 12113.494, W   1xDEM-3xMET 12 hypothetical protein 
RPA2409  24359.957, S  1xDIS-6xMET 32 possible AmiR 
antitermination protein 
RPA2421 15886.364, M   4xMET 16 NADH:ubiquinone 
oxidoreductase 17.2 k 
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RPA2433 16394.228, W   4xMET 12 possible two-component 
response regulator  
RPA2437 15964.473, M   1xDEM-1xDIS-
6xMET 
12 3-dehydroquinate 
dehydratase type 2 
RPA2442 27754.376, M   1xDIS-5xMET 78 putative outer membrane 
protein  
RPA2443  25651.912, W  1xDEM-3xMET 24 probable antioxidant 
protein 
RPA2446  43113.781, S  4xMET 33 putative aminotransferase
RPA2453  35496.288, S  1xDEM-9xMET 37 translation peptide 
releasing factor RF-2  
RPA2456 23830.531, S    31 possible bacterioferritin 
co-migratory protein 
RPA2465 27433.140, S   2xMET 56 sufC, related to ABC 
transporter ATP-binding 
RPA2470 13365.283, M    13 Protein of unknown 
function, 
HesB/YadR/YfhF 
RPA2492  22366.559, M  1xDEM-1xDIS-
2xMET 
79 Conserved hypothetical 
protein 
RPA2513 20843.685, S   9xMET 41 
   20843.911, M 9xMET  
elongation factor P  
RPA2520 20568.489, M   2xMET 32 hypothetical protein 
RPA2521 7939.293, S   1xDEM-8xMET 21 hypothetical protein 
RPA2522 9477.775, S   3xMET 22 hypothetical protein 
RPA2523 17028.379, S   1xDEM-1xDIS 81 
   17028.555, S 1xDEM-1xDIS  
putative 
lactoylglutathione lyase  
RPA2528 19053.121, S   2xDIS-1xMET 71 hypothetical protein 
RPA2531 10302.373, W   7xMET 10 hypothetical protein 
RPA2533 15410.303, M   1xDEM-6xMET 11 unknown protein 
RPA2540 31329.289, S   1xDEM-3xDIS-
4xMET 
43 3-hydroxy-3-
methylglutaryl-CoA lyase 
RPA2546 15869.205, M   3xMET 15 
   15966.401, W 10xMET  
FKBP-type peptidyl-
prolyl cis-trans isomerase
RPA2549   16217.439, M 1xDIS-6xMET 10 conserved hypothetical 
protein 
RPA2552 11779.037, S   8xMET 15 unknown protein 
RPA2556  30215.805, M  1xDEM-4xMET 36 PA-phosphatase related 
phosphoesterase 
RPA2589 21640.620, M   1xDIS-2xMET 78 possible competence-
damaged protein 
RPA2601 17688.403, M   1xMET 83 
  17771.338, S  7xMET  
phosphopantetheine 
adenylyltransferase 
RPA2603 16010.780, M   2xMET 88 conserved hypothetical 
protein 
RPA2604 16795.230, M   1xDEM 11 peptidyl prolyl cis-trans 
isomerase 
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RPA2639 17915.266, M   2xMET 13 probable L-2-amino-
thiazoline-4-carboxylic 
acid 
RPA2640   25979.119, S 5xMET 71 Isochorismatase hydrolase 
family 
RPA2648 27758.256, M   1xDEM-5xMET 39 unknown protein 
RPA2649 12888.806, M   1xDEM-7xMET 15 conserved unknown 
protein 
RPA2652  7178.843, W    unknown protein 
RPA2667 26252.611, W   1xDEM-1xDIS-
7xMET 
81 conserved unknown 
protein 
RPA2687   17032.969, S 2xMET 82 large-conductance 
mechanosensitive channel 
RPA2688 18258.432, M 18114.023, M  8xMET 83 small protein B  
    1xDEM-7xMET   
RPA2690  24467.277, W  1xDEM-3xDIS-
5xMET 
40 possible uracil-DNA 
glycosylase 
RPA2692   14368.256, M  20 RNA polymerase omega 
subunit  
RPA2695 15655.277, M   1xDEM 15 
   15813.404, W 2xMET  
acyl carrier protein 
synthase  
RPA2702 18944.166, M   8xMET 94 DUF24, predicted 
transcriptional regulator, 
RPA2715 19653.464, M    16 possible transcriptional 
regulator, MarR family 
RPA2717 7852.327, M   1xDEM-6xMET 29 conserved hypothetical 
protein 
RPA2718 21067.252, M   1xDEM-5xMET 14 hypothetical protein 
RPA2721 9921.998, M   2xDIS-3xMET 22 hypothetical protein 
RPA2728  17040.698, W  1xDEM-6xMET 56 
   17026.731, M 1xDEM-5xMET  
riboflavin synthase, beta 
chain  
RPA2729 19691.488, M   5xMET 86 putative N-utilization 
substance protein B  
RPA2732 8397.260, W   1xDEM 48 
   8397.280, M 1xDEM  
conserved hypothetical 
protein 
RPA2734 32102.932, S   4xMET 31 possible epoxide 
hydrolase-related protein 
RPA2742 12862.989, M   2xMET 22 
   12904.490, M 5xMET  
integration host factor 
alpha subunit  
RPA2744  7862.194, S  1xDEM-2xMET 95 hypothetical protein 
RPA2748 34871.554, W   3xDIS-3xMET 53 possible short-chain 
dehydrogenase  
RPA2755   18260.081, M 1xMET 13 possible DNA-binding 
stress protein 
RPA2766 15132.167, W   1xDEM-4xMET 85 Phenylacetic acid 
degradation-related 
RPA2783 21797.403, M   1xDIS-8xMET 11 hypothetical protein 
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RPA2795   28838.153, M 1xDIS-7xMET 10 Protein of unknown 
function UPF0001 
RPA2801 15572.265, M   1xDIS-1xMET 33 
   15571.851, M 1xDIS-1xMET  
Collagen triple helix 
repeat 
RPA2814 17696.443, S   1xDEM 46 
   17696.403, S 1xDEM  
single-strand DNA-
binding protein  
RPA2823 10207.451, M    45 conserved hypothetical 
protein 
RPA2848 17799.324, M   1xDEM-5xMET 13 possible sec-independent 
protein secretion 
RPA2852  35915.053, W  1xDEM-5xMET 32 putative sugar hydrolase  
RPA2856 11421.239, W   1xDEM-1xDIS-
5xMET 
83 Protein of unknown 
function, 
HesB/YadR/YfhF 
RPA2868 11896.347, W   2xMET 14 Septum formation 
initiator 
RPA2869   20102.175, S 1xDEM-1xDIS-
6xMET 
92 possible flavin-dependent 
oxidoreductase 
RPA2892 18214.481, M   3xMET 57 molybdenum cofactor 
biosynthesis protein C  
RPA2896 8985.992, W   1xDEM-1xDIS-
8xMET 
13 
  8986.770, W  1xDEM-1xDIS-
8xMET 
 
   8986.950, M 1xDEM-1xDIS-
8xMET 
 
hypothetical protein 
RPA2899 18139.023, M   3xMET 99 
  18139.454, W  3xMET  
conserved hypothetical 
protein 
RPA2919 20660.667, M   1xDEM-2xMET 22 
  20660.757, M  1xDEM-2xMET  
ribosome releasing factor
RPA2932   14258.256, S 2xDIS-1xMET 11 hypothetical protein 
RPA2933 9923.460, M   1xDEM 22 
   9923.086, M 1xDEM  
conserved hypothetical 
protein 
RPA2934 14212.615, W   1xDEM-1xMET 13 conserved unknown 
protein 
RPA2940  11024.113, W  1xDEM-8xMET 12 NADH-ubiquinone 
dehydrogenase chain K 
RPA2942 18761.236, M   8xMET 86 
   18685.995,W 3xDIS-3xMET  
NADH-ubiquinone 
dehydrogenase chain I 
RPA2953 11116.797, S   1xDEM-2xMET 33 
   11145.405, S 1xDEM-4xMET  
possible DNA-binding 
protein hu-alpha (NS2) 
RPA2966  12335.167, M 12335.891, M  98 nitrogen regulatory 
protein P-II  
RPA2973   20173.446, M 1xDEM 12 hypothetical protein 
RPA2982 10002.695, M   4xMET 13 possible insertion element 
ISR1 hypothetical 10 
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RPA2985   24851.053, M 1xDEM-5xMET 93 conserved unknownl 
protein 
RPA2998 32018.782, W   7xMET 49 putative 
dihydrodipicolinate 
synthase 
RPA3005 10219.565, M   4xMET 19 hypothetical protein 
RPA3021 21125.201, M   3xMET 24 
  21139.221, M  4xMET  
transcriptional regulator 
RPA3024   14141.632, W 1xDEM-1xDIS-
6xMET 
17 unknown protein 
RPA3034  9212.003, M  1xDEM-2xMET  
   9212.352, M 1xDEM-2xMET  
unknown protein 
RPA3035 15363.893, M   5xMET 87 
   15307.924, M 1xMET  
hypothetical protein 
RPA3037   21369.003, S 7xMET 63 conserved unknown 
protein 
RPA3053 7525.886, S 7526.470, S   65 cold shock protein  
RPA3056 15289.620, W   5xMET 33 
  15289.332, M  5xMET  
   15289.489,M 5xMET  
nucleoside-diphosphate-
kinase  
RPA3073   8567.662, S 1xDEM-9xMET 16 constitutive acyl carrier 
protein 
RPA3074  25406.064, M  4xMET 57 3-oxoacyl-acyl carrier 
protein reductase fabG 
RPA3077 17932.594, M  17932.615, M  18 possible 30S ribosomal 
protein S6  
RPA3078 9046.970, S   1xDEM-6xMET 13 30S ribosomal protein 
S18  
RPA3080   21178.830, S  31 putative 50S ribosomal 
protein L9, cultivar 
RPA3086 9397.898, S   3xMET 17 hypothetical protein 
RPA3101 17232.381, W   1xDEM-7xMET 88 conserved unknown 
protein 
RPA3103 7088.891, W   8xMET 13 
  7088.003, W  8xMET  
hypothetical protein 
RPA3109   10697.310, M 9xMET 64 conserved hypothetical 
protein 
RPA3113   17140.300, M 4xMET 10 conserved hypothetical 
protein 
RPA3123 11112.651, W   1xDEM-8xMET 83 
   11056.853, S 1xDEM-4xMET  
hypothetical protein 
RPA3126 15994.192, M   5xMET 10 conserved hypothetical 
protein 
RPA3129 6249.313, S   1xDEM-1xMET 30 
  6249.333, S  1xDEM-1xMET  
   6249.462, S 1xDEM-1xMET  
50S ribosomal protein 
L33  
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RPA3130 14169.554, S   1xDEM-3xMET 79 Helix-turn-helix motif 
RPA3134 10997.690, S   9xMET 16 
  10998.578, M  9xMET  
   10997.732, S 9xMET  
conserved unknown 
protein 
RPA3148   14709.646, W 1xDEM-7xMET 69 DUF174 
RPA3152   25980.423, S 1xDIS-3xMET 57 hypothetical protein 
RPA3162 13284.110, M   7xMET 16 
  13312.971, W  9xMET  
possible helix-turn-helix 
RPA3168 8804.559, S   1xDEM-7xMET 21 possible flgaellar switch 
protein FliN 
RPA3180 11166.904, S   9xMET 11 
  11139.519, S  7xMET  
hypothetical protein 
RPA3212 15955.683, M   7xMET 14 unknown protein 
RPA3213   8030.265, S  1xDEM-6xMET 18 hypothetical protein 
RPA3215 25048.560, S   1xDEM-5xMET 80 putative nitroreductase 
RPA3223   35934.629, S 1xDEM-7xMET 68 putative alginate lyase 
RPA3225 15717.489, S   3xMET 21 
   15717.933, S 3xMET  
50S ribosomal protein 
L17 
RPA3227 13761.002, M   1xDEM-1xMET 22 
  13761.158, M  1xDEM-1xMET  
   13761.287, M 1xDEM-1xMET  
30S ribosomal protein 
S11 
RPA3228 14357.764, M   1xDEM-3xMET 79 
  14357.709, M  1xDEM-3xMET  
   14384.163, M 1xDEM-5xMET  
30S ribosomal protein 
S13 
RPA3231 16837.254, S 16836.541, S 16836.630, S  87 50S ribosomal protein 
L15 
RPA3232 7093.155, S   1xDEM 20 
  7092.929, S  1xDEM  
   7092.861, S 1xDEM  
ribosomal protein L30 
RPA3234   12905.679, S 1xDEM 26 50S ribosomal protein 
L18 
RPA3235 19273.207, S   1xDEM 41 
  19273.083, S  1xDEM  
   19273.221, S 1xDEM  
50S ribosomal protein L6
RPA3236 14576.761, S   1xDEM-7xMET 27 
   14576.574, S 1xDEM-7xMET  
30S ribosomal protein S8
RPA3238 21122.037, M   6xMET 12 50S ribosomal protein L5
RPA3239 11012.697, S   1xDEM-1xMET 21 
  11012.444, S  1xDEM-1xMET  
   11012.821, S 1xDEM-1xMET  
50S ribosomal protein 
L24 
RPA3240 13489.094, M 13488.674, M 13489.187, M  22 50S ribosomal protein 
L14 
RPA3242 7849.937, S   1xDEM 24 
  7849.874, S  1xDEM  
   7849.864, S 1xDEM  
50S ribosomal protein 
L29 
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RPA3243 15296.048, S   1xMET 23 
   15296.084, S 1xMET  
50S ribosomal protein 
L16 
RPA3244 26178.851, W   1xDEM-1xDIS-
3xMET 
60 30S ribosomal protein S3
RPA3246 10088.469, S   1xDEM 27 
  10088.391, S  1xDEM  
   10088.778, S 1xDEM  
30S ribosomal protein 
S19 
RPA3248 10908.765, S 10908.483, S 10908.697, S  31 50S ribosomal protein 
L23 
RPA3251 11668.941, S 11668.783, S 11668.568, S  40 30S ribosomal protein 
S10 
RPA3254   17556.347, M 1xDEM 27 30S ribosomal protein S7
RPA3261 15004.785, W   1xDIS-1xMET 91 
   14902.234, M 1xDEM-1xDIS-
3xMET 
 
transcriptional regulator  
12754.760, S   1xDEM-3xMET
 12754.702, S  1xDEM-3xMET
RPA3269 
  12754.772, S 1xDEM-3xMET
47 50S ribosomal protein 
L7/L12  
RPA3270 19054.936, M   1xDEM-1xMET 28 50S ribosomal protein 
L10 
RPA3272 23878.783, S   1xDEM 12 50S ribosomal protein L1 
20026.946, S   9xMET RPA3274 
 20026.860, S  9xMET 
39 transcription 
antitermination protein  
RPA3275   9402.074, M 5xMET 84 preprotein translocase, 
SecE subunit 
RPA3290 23849.470, S   1xDEM-1xDIS-
3xMET 
32 possible transcriptional 
regulator, TetR family 
RPA3300 27834.970, S   2xMET 73 possible transcriptional 
regulator, TetR family 
15533.356, W   7xMET 
 15560.493, S  9xMET 
RPA3319 
  15532.882, S 7xMET 
58 hypothetical protein 
RPA3327 10062.561, W   1xDEM-4xMET 16 hypothetical protein 
RPA3328   15602.023, W 5xMET 13 conserved hypothetical 
protein 
RPA3373 10271.970, M   7xMET 27 hypothetical protein 
16873.403, M   1xDIS-8xMET- 
 16789.906, M  1xDIS-2xMET 
RPA3390 
  16672.650, M 1xDEM-1xDIS-
3xMET 
16 phosphoribosyl c-AMP 
cyclohydrolase  
RPA3394  17200.646, S  1xDEM-1xDIS-
3xMET 
93 DUF37 
RPA3397  16658.898, M  6xMET 11 hypothetical protein 
RPA3402 15218.140, W   1xDEM-2xDIS-
5xMET 
15 conserved hypothetical 
protein 
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RPA3434 22791.311, M   1xDIS-6xMET 47 Universal stress protein 
(Usp) 
RPA3436 18900.382, M   1xDEM-2xMET 13 GCN5-related N-
acetyltransferase 
29567.345, M   1xDIS-2xMET RPA3446 
  29595.953, M 1xDIS-4xMET 
51 3-hydroxyisobutyrate 
dehydrogenase  
RPA3457   7429.588, S 1xDEM-5xMET 20 Biotin/lipoyl 
attachment:Biotin-
requiring 
RPA3476 28083.780, S   1xDEM-2xMET 84 possible energy 
transducer TonB 
RPA3481 9215.385, S   7xMET 23 hypothetical protein 
10149.437, W   1xDEM-7xMETRPA3501 
 10163.493, W  1xDEM-8xMET
67 conserved unknown 
protein 
RPA3518 11231.845, W   4xMET 95 Excinuclease ABC, C 
subunit, N-terminal 
RPA3524  36319.974, S  1xDEM-6xMET 43 putative cell division 
protein FtsQ  
RPA3537 14096.695, M   1xMET 11 conserved hypothetical 
protein 
RPA3555 18816.879, S   1xDEM-2xMET 92 arsenate reductase  
RPA3561  13124.930, S  1xDIS-8xMET 14 possible arsenate 
reduction regulatory 
protein 
6883.790, M   1xDEM-4xMETRPA3574 
 6897.073, M  1xDEM-5xMET
32 putative thiamin 
biosynthesis ThiG  
10002.695, W   4xMET RPA3579 
 10030.489, W  6xMET 
13 possible insertion element 
ISR1 hypothetical 10 
RPA3583 12099.680, W  12127.793, M 1xDEM-5xMET 22 conserved hypothetical 
protein 
RPA3589 RPA3589   1xDEM-7xMET  conserved hypothetical 
protein 
RPA3602   9716.998, W 1xDIS-4xMET 25 unknown protein 
RPA3606 10500.755, W   1xDIS-1xMET 13 hypothetical protein 
RPA3626   9293.434, M 1xDEM 27 conserved unknown 
protein 
RPA3652   13698.826, S 1xDEM-2xMET 69 conserved hypothetical 
protein 
RPA3653   9296.464, W 4xMET 26 Protein of unknown 
function UPF0033 
RPA3662 11279.887, W   6xMET 14 urease beta subunit 
10999.640, S   1xDEM-3xMETRPA3663 
 10998.597, S  1xDEM-3xMET
20 urease gamma subunit  
10459.920, S   1xDEM-1xMET
 10460.115, S  1xDEM-1xMET
RPA3671 
  10459.441, S 1xDEM-1xMET
59 translation initiation 
factor if-1 (infA)  
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8970.250, S   1xDEM-2xMET
 8969.587, M  1xDEM-2xMET
RPA3672 
  9012.829, M 1xDEM-5xMET
47 cold shock protein  
RPA3673 22674.886, M   8xMET 82 conserved unknown 
protein 
RPA3676   18594.783, M 1xDEM-1xDIS-
1xMET 
35 putative type IV prepilin 
peptidase, cpaA  
RPA3719 28867.609, S   1xDEM-6xMET 64 putative high-affinity 
branched-chain amino 
acid 
RPA3721  30808.822, W  1xDEM-7xMET 45 possible ABC transporter, 
permease protein  
RPA3726 18517.400, M   6xMET 90 conserved unknown 
protein 
RPA3745 17028.339, S   5xMET 90 unknown protein 
RPA3759   14695.257, M 1xDEM-7xMET 31 putative 5-
carboxymethyl-2-
hydroxymuconate 
RPA3770 17958.517, M   1xDEM-3xMET 13 conserved unknown 
protein 
RPA3786 9335.393, S 9335.064, S   57 unknown protein 
RPA3790 28964.617, M   1xDIS-9xMET 56 putative efflux protein 
RPA3794 11869.466, S   4xDIS-4xMET 17 conserved hypothetical 
protein 
RPA3798 24649.796, M    34 conserved unknown 
protein 
11347.234, S   1xDIS-4xMET RPA3799 
 11347.449, M  1xDIS-4xMET 
16 DUF182 
RPA3803 17136.725, S   1xDEM-1xDIS-
8xMET 
50 carbon-monoxide 
dehydrogenase small 
subunit  
16026.165, S  16083.263, M PTM:1xDIS RPA3804 
   1xDIS-4xMET 
35 conserved unknown 
protein 
RPA3820 8418.840, M  8419.307, M  29 Protein of unknown 
function UPF0062 
RPA3822 12010.648, W   5xMET 13 conserved unknown 
protein 
RPA3824 12572.842, M   1xDEM 13 conserved hypothetical 
protein 
RPA3826   13316.091, M 9xMET 12 conserved hypothetical 
protein 
RPA3827   11761.786, M 3xMET 11 conserved hypothetical 
protein 
RPA3828   7145.348, M 1xDEM-2xMET 25 Helix-turn-helix motif 
10002.695, W   4xMET RPA3837 
 10030.489, W  6xMET 
13 possible insertion element 
ISR1 
RPA3852 20592.106, M   1xDEM-8xMET 86 hypothetical protein 
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RPA3864 9463.912, S 9463.471, S   19 unknown protein 
RPA3865  19743.894, S  2xMET 68 Thioesterase superfamily 
RPA3871   26980.102, S 1xDIS-8xMET 29 Nuclear protein SET 
9961.592, M   1xDEM 
 9961.076, M  1xDEM 
RPA3875 
  9961.140, M 1xDEM 
76 conserved unknown 
protein 
RPA3878 17694.943, S   1xDEM-5xMET 74 conserved unknown 
protein 
RPA3886   10475.058, W 5xMET 12 Flagellar hook-basal body 
complex protein FliE 
RPA3887 15471.115, M   5xMET 78 flagellar basal-body rod 
protein flgC  
RPA3895 28030.834, M   6xMET 59 conserved hypothetical 
protein 
RPA3896   15002.200, W 1xDEM-3xMET 10 hypothetical protein 
RPA3898 18030.359, M   3xMET 11 Flagellar basal body-
associated protein FliL 
RPA3907 16930.802, M   9xMET 14 DnaK suppressor protein 
DksA 
RPA3908 14169.336, S   8xMET 88 conserved unknown 
protein 
12130.745, S   1xMET 
 12130.782, M  1xMET 
RPA3910 
  12186.408, W 5xMET 
20 conserved hypothetical 
protein 
RPA3913 13458.449, S   1xDEM-7xMET 74 conserved hypothetical 
protein 
RPA3914 14420.772, M   1xDEM-1xMET 12 putative flbT protein 
RPA3923  34837.447, W  1xDEM-2xDIS-
3xMET 
56 putative acetoin 
dehydrogenase (TPP-
dependent) 
RPA3924 24964.302, S   1xDEM-5xMET 87 conserved hypothetical 
protein 
RPA3939 19601.710, S   1xDIS-7xMET 97 conserved unknown 
protein 
11442.106, S   1xDEM-6xMETRPA3956 
  11442.720, S 1xDEM-6xMET
30 ferredoxin  
RPA3957  12561.372, M  2xMET 84 Hpt domain 
RPA3970 23794.943, S   1xDEM-1xMET 69 putative 
RPA3988 19992.661, S   1xDEM-3xMET 95 putative phosphatase 
RPA4005 10845.866, S   1xMET 12 possible ribosomal protein 
S21  
RPA4006  17769.328, S  1xDEM-5xMET 12 hypothetical protein 
RPA4010  14013.813, M  3xMET 13 putative response 
regulator  
RPA4030 13980.157, W   4xMET 13 hypothetical protein 
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RPA4047  25162.285, W  2xDIS-6xMET 59 Haloacid dehalogenase-
like hydrolase 
29896.503, S   1xDEM-3xMETRPA4050 
  29896.082, S 1xDEM-3xMET
25 unknown protein 
RPA4067 11526.438, S   1xDEM-3xMET 13 hypothetical protein 
RPA4070 21755.278, M   1xDEM-3xMET 50 possible peptide 
methionine sulfoxide 
reductase 
17029.108, S   1xDEM 
 17029.156, S  1xDEM 
RPA4072 
  17029.160, S 1xDEM 
61 transcriptional elongation 
factor greA 
17903.487, S   1xDIS-3xMET RPA4074 
 17987.102, M  1xDIS-9xMET 
69 putative leucine regulon 
transcriptional 
RPA4076 34867.931, W   4xMET 49 putative transcriptional 
regulator, lysR family 
RPA4077 23944.810, M   1xDEM-1xDIS-
7xMET 
76 ATPase, ParA type 
RPA4093   9159.405, M 1xDEM-3xMET 14 hypothetical protein 
17031.513, M   1xDEM-1xMETRPA4102 
 17086.813, S  1xDEM-5xMET
12 putative transcriptional 
regulator  
RPA4104 22887.971, M   7xMET 66 hypothetical protein 
 11913.973, S  7xMET RPA4109 
  11913.701, M 7xMET 
67 conserved hypothetical 
protein 
RPA4122 9250.851, M   5xMET 12 Conjugal transfer protein 
TrbD 
12832.671, S   9xMET 
 12832.592, S  9xMET 
RPA4129 
  12832.545, S 9xMET 
30 putative transcriptional 
regulator 
RPA4135  18385.213, S  5xMET 14 GCN5-related N-
acetyltransferase 
RPA4137  13892.225, S  1xDEM 20 conserved unknown 
protein 
RPA4138 13905.092, S   1xDEM-1xMET 28 conserved unknown 
protein 
RPA4151  31499.295, W  2xDIS-2xMET 34 possible transcriptional 
regulator of NADH 
12340.401, W   3xMET 
 12341.050, M  3xMET 
RPA4171 
  12326.933, W 2xMET 
19 conserved unknown 
protein 
RPA4176 10077.843, M   1xMET 12 ribosomal protein S21 
RPA4179  13333.444, S  1xDEM-5xMET 57 conserved unknown 
protein 
RPA4191 11212.504, S   1xDEM-7xMET 28 conserved unknown 
protein 
RPA4206 27433.140, S   1xDEM-2xMET 77 D-beta-hydroxybutyrate 
dehydrogenase  
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RPA4210   9267.744, W 4xMET 20 hypothetical protein 
RPA4214 10761.067, M   4xMET 14 conserved hypothetical 
protein 
RPA4217   7991.877, S  35 conserved unknown 
protein 
RPA4224 10459.824, S   6xMET 35 unknown protein 
RPA4227 22384.074, S   1xDIS-4xMET 67 urease accessory protein 
UreG  
RPA4228 12550.962, W   1xDEM-4xMET 15 hypothetical protein 
10046.148, S   1xDEM-1xMETRPA4230 
  10073.371, M 1xDEM-3xMET
13 conserved unknown 
protein 
RPA4241  15050.666, S  1xDEM-6xMET 70 CBS domain 
RPA4257 19545.573, M   2xDIS-4xMET 46 NADH-ubiquinone 
dehydrogenase chain I 
RPA4272   25979.575, S 1xDEM 15 conserved unknown 
protein 
RPA4277 23149.083, S   1xDEM-3xMET 48 conserved hypothetical 
protein 
RPA4282 18029.260, W   6xMET 70 possible activator of 
photopigment and puc 
RPA4297 30057.486, W   1xDEM-1xDIS-
5xMET 
60 putative aldose reductase 
RPA4298 22791.264, S   2xMET 68 ATP/GTP-binding site 
motif A (P-loop) 
RPA4305 12110.554, M   1xDEM-5xMET 10 hypothetical protein 
RPA4319 5806.499, W   4xMET 25 hypothetical protein 
RPA4330 17933.468, S   2xMET 13 conserved unknown 
protein 
RPA4331  44426.051, S   46 aspartate 
aminotransferase A  
RPA4344 8492.921, M   1xDEM-6xMET 22 hypothetical protein 
RPA4348  16278.313, M  1xDEM-5xMET 70 conserved hypothetical 
protein 
18866.714, S   1xDEM-1xMETRPA4349 
  18851.297, M 1xDEM-1xDIS 
20 conserved unknown 
protein 
RPA4357 10095.787, M   1xDEM-1xMET 11 conserved unknown 
protein 
RPA4365   15801.209, M 1xDEM-1xDIS 13 GCN5-related N-
acetyltransferase 
RPA4372 15491.980, M   4xMET 10 Class I peptide chain 
release factor domain 
RPA4381 16826.447, M   1xDIS-6xMET 59 conserved unknown 
protein 
18847.915, M   1xDEM-6xMET  RPA4383 
 18804.927, M  1xDEM-3xMET  
conserved unknown 
protein 
RPA4393   7991.020, M 4xMET 20 unknown protein 
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RPA4418   7110.894, W 1xDEM-9xMET 22 conserved unknown 
protein 
RPA4457 13639.667, M   1xDEM 20 putative sulfide 
dehydrogenase 
RPA4458 17466.002, W   5xMET 51 hypothetical protein 
12125.648, M   1xDEM RPA4466 
 12125.666, M  1xDEM 
15 putative sulfur oxidation 
protein soxZ 
RPA4467 16177.138, M   1xDEM-2xMET 98 putative sulfur oxidation 
protein soxY 
RPA4470 16387.876, W   1xDEM-3xMET 12 DUF336 
RPA4473 11040.704, S   4xMET 27 conserved hypothetical 
protein 
14375.557, S   7xMET RPA4474 
  14316.966, W 1xDIS-3xMET 
12 possible transcriptional 
activator  
10792.071, S   1xMET RPA4478 
 10805.846, M  2xMET 
13 conserved hypothetical 
protein 
RPA4483  43079.763, S  1xDEM-1xDIS-
7xMET 
29 possible signal transducer 
RPA4500 7526.018, S   1xDEM-1xDIS-
5xMET 
32 hypothetical protein 
RPA4501  7962.293, M  2xMET 20 phnA-like protein  
RPA4503 9513.824, M   1xDIS-7xMET 14 conserved hypothetical 
protein 
RPA4505  26141.064, M  1xMET 56 TPR repeat 
RPA4518 11898.625, M   2xMET 20 hypothetical protein 
RPA4529 17419.338, M   1xDEM-5xMET 10 putative arsenate 
reductase  
RPA4541 19273.064, S   1xDEM-2xMET 73 DNA invertase gene rlgA
RPA4542   11244.156, M 1xDEM-4xMET 18 unknown protein 
RPA4543 15054.561, W   8xMET 12 conserved hypothetical 
protein 
RPA4544 21753.512, M   1xDEM-4xMET 61 conserved unknown 
protein 
RPA4548   12793.518, W 6xMET 52 hypothetical protein 
RPA4573  16639.503, M  1xDIS-6xMET 12 conserved unknown 
protein 
RPA4574   9800.818, S 1xDEM-5xMET 26 hypothetical protein 
RPA4600 16584.872, M   1xDEM-2xDIS-
5xMET 
15 conserved unknown 
protein 
RPA4602   10657.886, S 1xDEM-2xDIS-
4xMET 
11 ferredoxin like protein, 
fixX 
RPA4605   30483.750, S 1xDEM-1xDIS-
8xMET 
46 electron trnasfer 
flavoprotein beta chain 
fixA  
RPA4610 10830.525, S   1xDEM-6xMET 18 Protein of unknown 
function, 
HesB/YadR/YfhF 
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RPA4612   11212.001, S  16 ferredoxin 2[4Fe-4S] III, 
fdxB  
RPA4615   14719.802, S 7xMET 25 nitrogenase molybdenum-
iron protein nifX  
RPA4634  30215.805, M  1xDEM-6xMET 28 hypothetical protein 
16786.288, S   1xDIS-4xMET RPA4666 
 16786.506, M  1xDIS-4xMET 
51 carbon-monoxide 
dehydrogenase small 
subunit  
18896.116, S   1xDEM-1xDIS-
7xMET 
RPA4676 
 18987.873, S  4xMET 
55 putative transcriptional 
regulator  
RPA4678  22847.204, S  1xDEM-8xMET 13 possible outer membrane 
protein OprF (AF117972)
RPA4686 28332.691, W   1xDEM-9xMET 68 possible ABC transporter, 
periplasmic amino 
RPA4689  16547.471, M  1xDEM-1xDIS-
4xMET 
40 conserved hypothetical 
protein 
RPA4701 14599.861, W   1xDEM-4xMET 13 Protocatechuate 4,5-
dioxygenase, alpha chain 
RPA4703   35090.978, M 2xDIS-6xMET 94 4-carboxy-2-
hydroxymuconate-6-
semialdehyde 
14571.402, M   1xDEM-7xMETRPA4705 
 14530.074, M  1xDEM-4xMET
13 phosphoribosyl-AMP 
cyclohydrolase / 
RPA4707 23061.022, M   4xMET 76 conserved hypothetical 
protein 
RPA4724 19977.214, S   1xDEM-3xMET 75 putative uridine 5-
monophosphate synthase 
13453.223, S   1xDEM-7xMETRPA4738 
  13467.290, M 1xDEM-8xMET
18 possible two-component 
system reponse regulator 
RPA4740   14258.256, S 1xDIS-8xMET 11 putative 4-
carboxymuconolactone 
decarboxylase 
RPA4744   24159.019, W 7xMET 53 possible thioredoxin-like 
protein  
RPA4748  31898.837, S  5xMET 38 3-hydroxybutyryl-CoA 
dehydrogenase  
RPA4760 18312.327, S   1xDEM 14 unknown protein 
28138.586, S   3xMET RPA4768 
 28138.352, M  3xMET 
39 conserved hypothetical 
protein 
RPA4770 14601.733, M   1xDEM-3xMET 13 DUF525 
RPA4774  23446.932, W  1xDIS-5xMET 10 conserved unknown 
protein 
RPA4775  26963.040, W  2xMET 6 phosphate regulatory 
protein, PhoB  
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RPA4777 30253.206, M   1xDIS-1xMET 13 phosphate ABC 
transporter ATP-binding 
protein, 
RPA4804 10400.837, M   5xMET 20 conserved hypothetical 
protein 
RPA4818 12907.825, M   3xMET 80 conserved hypothetical 
protein 
RPA4825 13087.366, W   2xMET 11 putative transcriptional 
regulator, MerR family 
8356.579, M   1xDIS-4xMET RPA4827 
  8355.656, M 1xDIS-4xMET 
20 conserved hypothetical 
protein 
RPA4836 9578.187, S     1xDEM 19 30S ribosomal protein 
S20  
 
aAverage molecular weight (Da) 
bS = Significant signal within the mass spectrum  
cM = Moderate signal within the mass spectrum 
dW = Weal signal within the mass spectrum 
ePercent bottom-up sequence coverage 
DEM = N-terminal methionine truncation 
ACE = acetylation 
MET = Methylation 
DIS = Disulfide Bond 
URY = Uridylylation 
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Functional Categories 
The use of protein identifications that have only top-down and bottom-up 
identification limits the results to only the overlapping regions of the two data sets. For 
example, the top-down analysis will be able to see proteins ≤ 40-60 kDa in size due to the 
limitation of on line C4 reverse phase chromatography employed and the ability to elute 
larger proteins off the column. In the bottom-up analysis smaller proteins will be missed, 
because when the tryptic digest is performed smaller proteins will generate small peptides 
that are not seen within the mass spectrometer.  Therefore, we have a subset of 599 
proteins containing both top-down and bottom-up confirmations.  
These 599 proteins range in functional categories they belong to.  The functional 
categories for the identified proteins are shown in Table 7.5 (these functional categories 
are based on the ORNL annotation scheme for bacteria 
(http://genome.ornl.gov/microbial/).  Table 7.5 depicts proteins identified from each 
category, the total number of proteins predicted in each category from the genome, and 
the percent of the predicted genome identified from each category. A total of 599 proteins 
were confidently identified representing 12.44% of the genome predictions.  Most of the 
identified proteins fall into the unknowns and unclassified functional category in Table 
7.5.  This category contains two sub-groups that includes hypothetical and conserved 
hypothetical proteins, as well as unknown and conserved unknown.  Most of the 
identified proteins were hypothetical and conserved hypothetical proteins, 141 in total 
being followed by 100 proteins in the unknown function category.
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Table 7.5: Functional categories of identified proteins. 
Category Proteins Genome Prediction % Identified
Unknowns and Unclassified 241 1407 17.13
Replication Repair 17 126 13.49
Energy Metabolism 35 306 11.44
Carbon and Carbohydrate metabolism 6 107 5.61
Lipid Metabolism 9 158 5.70
Transcription 54 283 19.08
Translation 56 168 33.33
Cellular Processes 59 524 11.26
Amino Acid Metabolism 17 181 9.39
 General Function Prediction 44 420 10.48
Metabolism of Cofactors and Vitamins 16 150 10.67
Transport 17 699 2.43
Signal Transduction 21 231 9.09
Purine and Pyrimidine Metabolism 7 56 12.50
Total 599 4816 12.44  
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In our classification scheme, protein names are changed from hypothetical and conserved 
hypothetical to unknown and conserved unknown when they are confidently identified 
with at least two unique peptides [121]. Another category with numerous identifications 
includes proteins involved in cellular processes such as chaperones, flagellar proteins, 
stress proteins, and proteases.  This category contained 59 proteins.  The R. palustris 
genome contains two separate copies of GroEL (RPA1140 and RPA2164) and GroES 
(RPA1141 and RPA2165). We identified each of the two predicted GroES proteins 
encoded by the RPA1141 and RPA2165 genes at high confidence. The two GroEL 
proteins were not found due to the larger size of these proteins at 57626 Da for GroEL-1 
and 57796 Da for GroEL-2.  These larger molecular masses will prevent them from being 
identified in the top-down analysis and therefore excluded from our combined top-down 
and bottom-up data set. 
 The categories of transcription and translation make up two of the largest 
percentages of proteins identified based on genome predictions and were identified in all 
three growth states. This is to be expected since many of the proteins in these categories 
are necessary under all metabolic modes. The large number of ribosomal proteins 
provides most of the identifications in the translation functional category.  In a previous 
study of the purified 70S ribosome from R. palustris, we identified 53 of the 54 predicted 
ribosomal proteins [54]. In the present study, we identified 45 of the 54 predicted 
ribosomal proteins without prior purification. The missed ribosomal proteins are all small 
and rich in lysine residues, which suggest that they were digested into peptides too small 
for confident bottom-up identification. The larger ribosomal proteins were likely missed 
by the top-down analysis due to the inability to elute them from the reverse phase C4 
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column. This problem was also encountered in the previous study by Strader et al [54]. 
The transcription functional category mainly consisted of transcriptional regulators with a 
total of 24 of these proteins comprising the 54 total identified proteins.   
 Proteins from the functional categories of, replication and repair, energy 
metabolism, and purine and pyrimidine metabolism comprise some of the larger 
percentages of the genome predictions based on the integrated top-down and bottom-up 
data set.  The category of replication and repair was detected with 17 proteins. In a 
previous study baseline proteomics study performed in our laboratory, replication and 
repair was found to be the category with the lowest abundance at 17% and 22 identified 
proteins [121].  Howerver, in this study using the integrated top-down and bottom-up 
method, the category of replication and repair was one of the higher percentage 
categories with 17 proteins identified. This total is within the same range as identified in 
the baseline bottom-up proteomics study. The identification of 17 proteins from this 
category may be due to the size and ability of these proteins to be eluted from the C4 
reverse phase column to be identified by top-down analysis well.  In the category of 
energy metabolism 35 proteins were identified. Most of these identifications include 
proteins involved in photosynthesis and oxidative phosphorylation. One set of proteins 
identified of particular interest are the NADH-ubiquinone dehydrogenase complexes. 
Within this complex two operons (RPA2937-RPA2952 and RPA4252-RPA4264) are 
each predicted to encode complete NADH-ubiquinone dehydrogenase proteins. It has 
been theorized, the structure of each operon and the degree of divergence of the 
individual proteins within these operons have different evolutionary lineages, possibly 
from lateral transfer instead of duplication and divergence within the genome [13, 121]. 
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A total of 3 proteins were identified from the first operon and 1 protein from the second 
operon. These proteins were found across all metabolic states indicating expression under 
all metabolic states. Isoforms of this protein were also identified which will be discussed 
in greater detail later. 
 The categories of general function, metabolism of cofactors and vitamins, signal 
transduction, amino acid metabolism, carbon and carbohydrate metabolism, and lipid 
metabolism were identified with some of the smallest numbers of proteins predicted by 
the genome sequence.   From the signal transduction category 21 proteins were identified 
with some of these identifications coming from nitrogen regulation proteins such as the 
GlnK proteins and GlnB (RPA0272, RPA0274, and RPA2966) as well as the chemotaxis 
proteins.  Proteins from the categories of metabolism of cofactors and vitamins, amino 
acid metabolism, carbon and carbohydrate metabolism, and lipid metabolism contained 
proteins expected in metabolism of the individual products from the associated pathways 
and in most cases represented across all growth states.   
 The transport category was identified with 17 proteins. This category should be 
fairly abundant within the proteome. Originally, this was the case in the baseline study of 
R. palustris; the integrated top-down and bottom-up method employed here provides a 
low percentage of these proteins [121]. This is again due to the large size of the proteins 
within this category at 30-50 kDa which would prevent the elution during the LC-FT-ICR 
experiments off the C4 reverse phase column.    
Comparison of Growth States 
One goal of this study was to identify protein differences between the three growth 
conditions (aerobic, anaerobic, and nitrogen fixing) employed for R. palustris.   This 
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comparison was first done by binary comparisons of related metabolic states as illustrated 
in Figure 7.1. Proteins identified as showing expression differences between metabolic 
states were then compared across all metabolic states to determine global trends in 
protein expression. These differences were based on the presence or absence of the 
protein in one state as compared to the closest metabolic state. For example, the 
chemoheterotropic growth state (aerobic) was compared to the photoheterotrophic growth 
state (anaerobic) as a baseline comparison. Also compared were the photoheterotrophic 
growth state (anaerobic) and the photoheterotrophic nitrogen fixing growth state. It 
should be noted that this technique is only useful in determining proteins presence or 
absence between growth states and generating hypotheses about these proteins for future 
testing. 
Chemoheterotrophic Growth State Compared to the Photoheterotrophic Growth State 
The chemoheterotrophic and photoheterotrophic states are the base states for this 
study, as shown in Figure 7.1. The initial expectation is that the protein profiles of cells 
grown under these two conditions would be quite different due to the cells obtaining 
energy from the oxidation of succinate during chemoheterotrophic growth and energy 
from light during photoheterotrophic growth. Most importantly, chemoheterotrophic cells 
were grown aerobically whereas photoheterotrophic cells were grown anaerobically.  
Succinate was the source of carbon for both growth modes. Interestingly, the hallmark R. 
palustris phenotype of photosynthesis, the red coloring of the cell membranes, was 
observed for every metabolic state, though the red coloring was much more prominent 
under anaerobic states. This is due to R. palustris inability to turn off its photosynthetic 
machinery completely, no matter what growth condition it is in. Therefore, certain 
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photosystem proteins would be expected throughout all growth conditions.  The 
photosystem proteins are generally large in size and not amenable to the liquid 
chromatography separations used in the top-down measurements and therefore, not listed 
in the total 599 proteins identified. However, certain photosystem proteins, such as 
RPA1548 which encodes for the H subunit of the photosynthetic reaction center, were 
identified in the bottom-up analysis across all three growth states.  Nonetheless, 
differences were found at the protein level between these two growth states. The BolA-
like protein (RPA0501) and chemotaxis protein CheY4 proteins (R1175) showed strong 
correlation with the aerobic states with no expression under any of the anaerobic states. 
In contrast, the anaerobic proteins unknown proteins RPA1495, RPA1620, RPA2333, 
RPA2334, RPA2335, RPA2336, and RPA2338 all showed strong correlation with the 
anaerobic states and no expression under the aerobic state. The operon of genes encoding 
unknown proteins, from RPA2333 to RPA2338, is a unique operon that was previously 
identified in a baseline proteomics study performed on R. palustris [121]. As in the 
previous study, this entire operon, except RPA2337, was found to show relatively strong 
expression under anaerobic states but no expression in the aerobic state.  In the case of 
RPA2337 it was not detected, even though it does not have any predicted transmembrane 
domains which should make it detectable in both the peptide and protein form [121]. 
Photoheterotrophic Growth State Compared to Nitrogen-Fixing Growth State 
 In this study the evaluation of protein differences between with nitrogen fixation 
in the photoheterotrophic state was a logical step in testing our methodology, due to 
many of the proteins expressed during nitrogen fixation should be present when this 
process is undertaken by the cell [121, 122]. As expected, a number of proteins expressed 
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only under nitrogen fixing conditions were identified.  Some of the proteins thought to be 
involved in nitrogen fixation were found only under nitrogen-fixing conditions and not 
detected to under any of the other growth conditions. These include RPA4209, glutamine 
synthetase; and certain proteins within the nif regulon (RPA4602-4632) including 
RPA4605, electron trnasfer flavoprotein beta chain fixA; RPA4612, the ferredoxin 
2[4Fe-4S] III, fdxB; as well as RPA4615 nitrogenase molybdenum-iron protein nifX.  
The protein RPA4209, glutamine synthetase, is involved in nitrogen fixation in concert 
with the GlnK and GlnB proteins, which are regulated by a unique PTM under nitrogen 
fixing conditions.   
Post Translational Modifications 
 Of the 599 proteins identified by top-down and bottom-up most of these were identified 
with some varying degree of PTMs; whether it is an N-terminal methionine truncation, 
methylation, or acetylation. Nearly all proteins undergo some form of post translational 
modification [1].  These post translational modifications are important to provide protein 
heterogeneity; thereby allowing the protein to exists in multiple isoforms. Within this 
study, the common PTMs of methylation, acetylation, N-terminal methionine truncation, 
and disulfide bonds were examined. By far the most common PTM identified was N-
terminal methionine truncation. Of the 599 proteins identified in this study 267 have a 
methionine truncation. The truncation of the N-terminal methionine depends on the 
charge and size of the amino acid side chain occupying the next position from the N-
terminal methionine. According to the “N-end rule”, residues bearing small uncharged 
side chains (stabilizing), such as alanine, allow docking of methionine peptidases that 
cleave the N-terminal methionine.  Within the 267 N-terminal truncated proteins 
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identified, 184 have a stabilizing amino acid according to the “N-end rule”. Shown in 
Table 7.6 are all of the N-terminal methionine truncated proteins identified and the 
amino. acid occupying the second position.  The proteins that do not follow the “N-end 
rule” would make good candidates for further study. Also the proteins that do not adhere 
to the rule may be the result of annotation errors and bear further analysis of the gene 
start site calls. 
 Phosphorylation is a common PTM, although, most of the phosphorylation in R. 
palustris is performed by a histidine kinase, which provides a very fleeting interaction as 
well as being acid labile that posses problems during mass spectrometry analysis.  Due to 
these reasons, phosphorylation was not searched for within this study. Other specialized 
PTMs such as uridylylation were searched for and identified within the top-down and 
bottom-up data sets. 
A number of proteins were identified with PTMs from the anaerobic growth state. 
Of the 119 proteins identified by the integrated top-down and bottom-up analysis 90 of 
these proteins from the anaerobic growth were identified with a form of a PTM. The most 
abundant of the PTMs seen on the 90 proteins are N-terminal methionine truncation, 
followed by proteins containing combinations of methylations.  Of particular interest 
were the unknown and hypothetical proteins that contain PTMs, due to the possible 
information about function and location this can provide [Table 7.7]. The unique 
hypothetical operon (RPA2333-RPA2338) was of interest because it was located in one 
operon that was previously unknown. It has also been demonstrated that none of the 
proteins in this operon have been found to have strong similarity to any genes in 
sequenced microbial genomes to date except RPA2333, which is similar to segments of a
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Table 7.6: N-Terminal Methionine Truncations 
Gene Second AA Function 
RPA0008 A circadian clock protein 
RPA0038 A ribosomal protein L20  
RPA0159 A ribosomal protein L27  
RPA0335 A putative phospholipid N-methyltransferase  
RPA0366 A unknown protein 
RPA0526 A 50S ribosomal protein L32  
RPA0662 A ferredoxin  
RPA0673 A transcriptional activator  
RPA0927 A probable transcriptional regulator  
RPA0953 A possible exodeoxyribonuclease small subunit 
RPA1088 A hypothetical protein 
RPA1090 A possible nitrogen regulator  
RPA1141 A chaperonin GroES1, cpn10 
RPA1175 A chemotaxis protein CheY4 
RPA1717 A hypothetical protein 
RPA1777 A DUF35 
RPA2012 A conserved unknown protein 
RPA2197 A cell division protein FtsJ 
RPA2334 A unknown protein 
RPA2437 A 3-dehydroquinate dehydratase type 2 
RPA2556 A PA-phosphatase related phosphoesterase 
RPA2604 A peptidyl prolyl cis-trans isomerase 
RPA2728 A riboflavin synthase, beta chain  
RPA2768 A ribosomal protein S9  
RPA2814 A single-strand DNA-binding protein  
RPA2852 A putative sugar hydrolase  
RPA2869 A possible flavin-dependent oxidoreductase 
RPA2953 A possible DNA-binding protein hu-alpha (NS2) 
RPA3078 A 30S ribosomal protein S18  
RPA3129 A 50S ribosomal protein L33  
RPA3227 A 30S ribosomal protein S11 
RPA3228 A 30S ribosomal protein S13 
RPA3232 A ribosomal protein L30 
RPA3237 A 30S ribosomal protein S14 
RPA3238 A 50S ribosomal protein L5 
RPA3239 A 50S ribosomal protein L24 
RPA3255 A 30S ribosomal protein S12 
RPA3270 A 50S ribosomal protein L10  
RPA3272 A 50S ribosomal protein L1  
RPA3273 A 50S ribosomal protein L11  
RPA3436 A GCN5-related N-acetyltransferase 
RPA3457 A Biotin/lipoyl attachment:Biotin-requiring 
RPA3583 A conserved hypothetical protein 
RPA3671 A translation initiation factor if-1 (infA)  
RPA3803 A carbon-monoxide dehydrogenase small subunit  
RPA3875 A conserved unknown protein 
RPA3956 A ferredoxin  
RPA4067 A hypothetical protein 
RPA4102 A putative transcriptional regulator  
RPA4137 A conserved unknown protein 
RPA4344 A hypothetical protein 
RPA4574 A hypothetical protein 
RPA4612 A ferredoxin 2[4Fe-4S] III, fdxB  
RPA4738 A possible two-component system reponse regulator 
RPA4836 A 30S ribosomal protein S20  
RPA1697 C Competence-damaged protein 
RPA2649 C conserved unknown protein 
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Table 7.6: Continued 
Gene Second AA Function 
RPA1279 D hypothetical protein 
RPA1615 D putative methyltransferase 
RPA1812 D conserved hypothetical protein 
RPA1824 D unknown protein 
RPA1842 D conserved unknown protein 
RPA2241 D conserved hypothetical protein 
RPA3130 D Helix-turn-helix motif 
RPA3524 D putative cell division protein FtsQ  
RPA3721 D possible ABC transporter, permease protein  
RPA4138 D conserved unknown protein 
RPA4191 D conserved unknown protein 
RPA4297 D putative aldose reductase 
RPA2533 E unknown protein 
RPA4179 F conserved unknown protein 
RPA0207 G unknown protein 
RPA0501 G BolA-like protein 
RPA0517 G putative transcriptional regulator (Fur family) 
RPA2648 G unknown protein 
RPA3244 G 30S ribosomal protein S3 
RPA3672 G cold shock protein  
RPA3924 G conserved hypothetical protein 
RPA4418 G conserved unknown protein 
RPA0855 H Beta-lactamase-like 
RPA3123 H hypothetical protein 
RPA4605 H electron transfer flavoprotein beta chain fixA  
RPA0233 I putative Citrate lyase beta chain (acyl lyase 
RPA0600 I conserved hypothetical protein 
RPA0646 I conserved hypothetical protein 
RPA0866 I putative nucleoside diphosphate kinase regulator 
RPA1064 I conserved hypothetical protein 
RPA1108 I Myb DNA-binding domain:DGPF domain 
RPA1454 I hypothetical protein 
RPA2239 I putative partition protein  
RPA2283 I putative proteic killer suppression protein 
RPA3589 I conserved hypothetical protein 
RPA3676 I putative type IV prepilin peptidase, cpaA  
RPA3828 I Helix-turn-helix motif 
RPA3878 I conserved unknown protein 
RPA4070 I possible peptide methionine sulfoxide reductase 
RPA4542 I unknown protein 
RPA4610 I Protein of unknown function, HesB/YadR/YfhF 
RPA0885 K conserved hypothetical protein 
RPA1019 K possible transcriptional activator HlyU 
RPA1107 K possible transcriptional regulator  
RPA2057 K hypothetical protein 
RPA2314 K cytochrome c556  
RPA2522 K hypothetical protein 
RPA2667 K conserved unknown protein 
RPA3223 K putative alginate lyase 
RPA3501 K conserved unknown protein 
RPA4544 K conserved unknown protein 
RPA4676 K putative transcriptional regulator  
RPA0160 L possible acetyltransferases. 
RPA0298 L DUF299 
RPA1017 L Nitrogen fixation-related protein 
RPA1278 L GatB/Yqey 
RPA1905 L homologue of Rhodobacter capsulatus gene 
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Table 7.6: Continued 
Gene Second AA Function 
RPA1985 L probable diacylglycerol kinase 
RPA2028 L conserved hypothetical protein 
RPA2603 L conserved hypothetical protein 
RPA2934 L conserved unknown protein 
RPA3101 L conserved unknown protein 
RPA3148 L DUF174 
RPA3327 L hypothetical protein 
RPA4470 L DUF336 
RPA0331 M possible heat shock protein (HSP-70 COFACTOR), 
RPA1025 M possible Ectothiorhodospira Vacuolata 
RPA2718 M hypothetical protein 
RPA2899 M conserved hypothetical protein 
RPA3719 M putative high-affinity branched-chain amino acid 
RPA4529 M putative arsenate reductase  
RPA4634 M hypothetical protein 
RPA0571 N two-component, response regulator  
RPA0594 N putative mutator protein mutT  
RPA2045 N biotin synthetase  
RPA2165 N chaperonin GroES2, cpn10 
RPA3663 N urease gamma subunit  
RPA4050 N unknown protein 
RPA4077 N ATPase, ParA type 
RPA0039 P 50S ribosomal protein L35 
RPA0283 P putative two-component response regulator  
RPA0598 P putative glutaredoxin 
RPA1302 P unknown protein 
RPA1342 P hypothetical protein 
RPA1600 P BolA-like protein 
RPA1620 P unknown protein 
RPA2456 P possible bacterioferritin co-migratory protein 
RPA2690 P possible uracil-DNA glycosylase 
RPA3168 P possible flgaellar switch protein FliN 
RPA3213 P hypothetical protein 
RPA3246 P 30S ribosomal protein S19 
RPA3254 P 30S ribosomal protein S7 
RPA3759 P putative 5-carboxymethyl-2-hydroxymuconate 
RPA4176 P ribosomal protein S21 
RPA4228 P hypothetical protein 
RPA4600 P conserved unknown protein 
RPA4686 P possible ABC transporter, periplasmic amino 
RPA4701 P Protocatechuate 4,5-dioxygenase, alpha chain  
RPA0090 Q hypothetical protein 
RPA0263 Q Protein of unknown function UPF0047 
RPA0653 Q 2-ketocyclohexanecarboxyl-CoA hydrolase 
RPA1586 Q putative short-chain dehydrogenase/reductase 
RPA1827 Q hypothetical protein 
RPA2006 Q putative phosphatidylserine decarboxylase  
RPA2453 Q translation peptide releasing factor RF-2  
RPA2717 Q conserved hypothetical protein 
RPA3215 Q putative nitroreductase 
RPA3319 Q hypothetical protein 
RPA0092 R conserved hypothetical protein 
RPA0203 R heme exporter protein A (heme ABC transporter 
RPA0301 R putative DNA polymerase III epsilon chain  
RPA0543 R unknown protein 
RPA0767 R PAS domain:GGDEF:PAC motif 
RPA0868 R hypothetical protein 
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Table 7.6: Continued 
Gene Second AA Function 
RPA1289 R hypothetical protein 
RPA1915 R FeuP  two-component system, regulatory protein 
RPA2523 R putative lactoylglutathione lyase  
RPA3024 R unknown protein 
RPA4277 R conserved hypothetical protein 
RPA4349 R conserved unknown protein 
RPA4689 R conserved hypothetical protein 
RPA0054 S putative small heat shock protein  
RPA0282 S possible transcriptional regulator 
RPA0433 S ribosomal protein S15  
RPA0435 S putative ribosome-binding factor A  
RPA0443 S possible transcriptional regulator  
RPA0450 S ferric uptake regulation protein  
RPA0493 S 50S ribosomal protein L28  
RPA0607 S putative protoporphyrinogen oxidase, hemK 
RPA0609 S conserved hypothetical protein 
RPA0714 S bifunctional cobinamide kinase, cobinamide 
RPA0917 S Transcriptional Regulator, AraC Family 
RPA0930 S possible 3-octaprenyl-4-hydroxybenzoate 
RPA0932 S conserved unknown protein 
RPA0993 S possible alpha-ribazole-5`-phosphate phosphatase 
RPA1106 S conserved hypothetical protein 
RPA1228 S putative 2-oxoglutarate ferredoxin 
RPA1659 S conserved unknown protein 
RPA1726 S putative oxidoreductase  
RPA1757 S possible oxoacyl carrier protein reductase 
RPA1964 S hypothetical protein 
RPA2066 S putative nosX 
RPA2082 S putative uroporphyrin III methylase  
RPA2732 S conserved hypothetical protein 
RPA2744 S hypothetical protein 
RPA3073 S constitutive acyl carrier protein 
RPA3235 S 50S ribosomal protein L6 
RPA3236 S 30S ribosomal protein S8 
RPA3269 S 50S ribosomal protein L7/L12  
RPA3290 S possible transcriptional regulator, TetR family 
RPA3394 S DUF37 
RPA3476 S possible energy transducer TonB 
RPA3555 S arsenate reductase  
RPA3852 S hypothetical protein 
RPA3896 S hypothetical protein 
RPA3913 S conserved hypothetical protein 
RPA4272 S conserved unknown protein 
RPA4383 S conserved unknown protein 
RPA4501 S phnA-like protein  
RPA4724 S putative uridine 5-monophosphate synthase  
RPA0052 T putative nitrogen regulatory IIA protein(enzyme 
RPA0059 T L-carnitine dehydratase/bile acid-inducible 
RPA0222 T Beta-Ig-H3/Fasciclin domain 
RPA0267 T possible thioredoxin 
RPA0292 T chromosome partitioning protein, ParA  
RPA0326 T DUF24, predicted transcriptional regulator, 
RPA0354 T putative pts system phosphocarrier protein HPr  
RPA0643 T conserved hypothetical protein 
RPA1168 T molybdopterin converting factor, subunit 2  
RPA1589 T 30S ribosomal protein S4  
RPA1593 T Thioesterase superfamily 
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Table 7.6: Continued 
Gene Second AA Function 
RPA1870 T possible transcriptional regulator (MarR/EmrR 
RPA1978 T molybdenum biosynthetic protein A  
RPA1993 T possible virulence-associated protein  
RPA2032 T acetolactate synthase (small subunit) 
RPA2084 T precorrin 3 or 4 methylase 
RPA2158 T hypothetical protein 
RPA2338 T unknown protein 
RPA2520 T hypothetical protein 
RPA2540 T 3-hydroxy-3-methylglutaryl-CoA lyase  
RPA2766 T Phenylacetic acid degradation-related 
RPA2856 T Protein of unknown function, HesB/YadR/YfhF 
RPA2973 T hypothetical protein 
RPA2985 T conserved unknownl protein 
RPA3626 T conserved unknown protein 
RPA3770 T conserved unknown protein 
RPA3970 T putative 
RPA3988 T putative phosphatase 
RPA4010 T putative response regulator  
RPA4206 T D-beta-hydroxybutyrate dehydrogenase  
RPA4241 T CBS domain 
RPA4348 T conserved hypothetical protein 
RPA4357 T conserved unknown protein 
RPA4457 T putative sulfide dehydrogenase 
RPA4500 T hypothetical protein 
RPA4541 T DNA invertase gene rlgA 
RPA4602 T ferredoxin like protein, fixX 
RPA4666 T carbon-monoxide dehydrogenase small subunit  
RPA4678 T possible outer membrane protein OprF (AF117972) 
RPA4760 T unknown protein 
RPA0490 V conserved hypothetical protein 
RPA1535 V cytochrome c2 
RPA2265 V conserved hypothetical protein 
RPA2848 V possible sec-independent protein secretion 
RPA2933 V conserved hypothetical protein 
RPA3824 V conserved hypothetical protein 
RPA4072 V transcriptional elongation factor greA 
RPA4467 V putative sulfur oxidation protein soxY 
RPA4483 V possible signal transducer  
RPA4770 Y DUF525 
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Table 7.7: Identification of unknown proteins with PTMs from the anaerobic growth 
state. 
Protein Putative PTM Function 
RPA2334 Methionine Truncation Unknown 
RPA2335 1, 2, 4 Methylations Unknown 
RPA2336 1 Methylation Unknown 
RPA2338 Methionine Truncation Unknown 
RPA1495 Methionine Truncation Unknown 
RPA1620 Methionine , 1 Methylation Unknown 
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putative cation transport ATPase but does not have the predicted transmembrane domains 
generally associated with such a transport ATPase.  
When this operon was examined with top-down methods a series of PTMs 
including methylations and N-terminal methionine truncations were identified [Table 
7.7]. The proteins RPA2334 and RPA2338 were identified with an N-terminal 
methionine truncation. Interesting though, RPA2335 was identified with a series of 1-4 
methylations as well as in its native form and RPA2336 was identified with 1 
methylation, as seen in Figure 7.2. This unique hypothetical operon with its series of 
PTMs may provide a target for future functional studies such as gene knockouts and 
protein interaction studies through tagging protocols or other biochemical enrichment 
techniques.  Also identified within the anaerobic growth state were the unknown proteins 
RPA1495 with an N-terminal methionine truncation and RPA1620 with an N-terminal 
methionine truncation as well as 1 methylation. Protein RPA1495 is found within an 
operon with light harvesting proteins which may provide a possible associated function 
for this protein.   Methylation is a common PTM found on lysine and arginine mainly. 
These two residues have very polar side chains that are positively charged.  When these 
residues are blocked by a methylation or acetylation the basic nature of that site within 
the protein can be changed, thereby making it more or less accessible to other targets.    
Within the aerobic growth state a number of proteins were identified with PTMs.  Of the 
426 proteins identified 394 of these possessed some form of a PTM.  Included in the list 
of proteins that contain PTM unknown as well as common proteins such as ribosomes 
were identified.  Two unknown proteins were of particular interest due to multiple 
isoforms being present.  
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Figure 7.2:  Mass spectra of RPA2335  and RPA2336. (A) Mass spectrum of RPA2335 
from a unique anaerobic unknown operon showing the native, 1 methylation, 2 
methylations, and 3 methylations isoforms. (B) Mass spectrum of RPA2336 from a 
unique anaerobic unknown operon showing the native protein and isoform with 1 
methylation. 
Native form
1-methylation
(A)
(B)
Native form
1-methylation
3-methylations
2-methylations
4-methylations
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The unknown protein RPA4610 (17% sequence coverage) was found to have an 
N-terminal methionine truncation with a combination of 4-8 methylations [Figure 7.3]. 
The protein was only identified in this highly modified state making it an interesting 
candidate for further functional studies.  Another unknown protein identified with 
multiple isoforms was RPA4330 which has a native form as well as a methylated version.  
Protein RPA0501 that was identified only in this growth state was shown to have an N-
terminal methionine truncation.  Two ribosomal proteins L30 and L23 also were 
identified with a native or an N-terminal methionine truncation and containing one 
methylation. 
The nitrogen fixing growth state has 214 identified proteins; of these 192 have a 
PTM.  Several of the unknown and hypothetical proteins within the nitrogen fixing 
growth state contain PTMs and multiple isoforms. Of particular interest are three of these 
conserved hypothetical proteins including, RPA2732 identified with an N-terminal 
methionine truncation form as well as an isoform with 2 acetylations and 1 methylation.  
A set of hypothetical proteins were identified within one mass spectrum from the LC-
FTICR-MS data, as seen in Figure 7.4.  Within this mass spectrum the first pair of 
proteins is RPA 1286 containing a unmodified form and a methylated isoform; the 
second pair are RPA2979 with an N-terminal methionine truncation plus 2 methylations 
and an isoform with an N-terminal methionine truncation plus 3 methylations.   
 A specialized PTM of interest associated with the nitrogen fixing growth state 
was uridylylation found on the GlnK and GlnB proteins.  The GlnK and GlnB proteins 
are members of the pII signal transduction protein family.  In R. palustris there are three 
annotated forms of pII proteins; GlnK1, GlnK2, and GlnB.
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Figure 7.3:  Mass spectrum of unknown protein RPA4610.  The unknown protein 
RPA4610 with an N-terminal methionine truncation and a combination of 4-8 
methylations from the aerobic growth state. DEM represent N-terminal methionine 
truncation within the figure.
1 DEM + 4 methylations
1 DEM + 5 methylations
1 DEM + 6 methylations
1 DEM + 7 methylations
1 DEM + 8 methylations
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Figure 7.4: A set of hypothetical proteins identified within one mass spectrum from the 
LC-FTIC-MS data.  Within the mass spectra the first pair of proteins is RPA1286 
containing a native form and a methylated isoform; the second pair is RPA2979 with an 
N-terminal methionine truncation plus 2 methylations and an isoform with an N-terminal 
methionine truncation plus 3 methylations. 
1 DEM + 2 methylations
1 DEM + 3 methylations
Native
1 methylation
RPA1286
RPA2979
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Two of these proteins were found to undergo uridylylation under ammonium starvation 
conditions (nitrogen fixing), presumably to regulate the AmtB ammonium transporter as 
well as glutamine synthetase [102]. Under nitrogen fixing growth conditions the GlnK2 
(RPA0274) and GlnB (RPA2966) proteins were identified in both the unmodified and 
modified states [123].  The GlnK2 protein was identified in the nitrogen fixing growth 
state along with GlnB, while GlnK1 was identified in the anaerobic growth states. These 
are the states the proteins should be found in according to previous research (Chapter 5). 
Signal Peptides 
Top-down mass spectrometry can provide information on the function and 
location of proteins. This is especially true when proteins containing signal peptides are 
considered. Most cell types and organisms employ several ways of targeting proteins to 
the extracellular environment or subcellular locations. Most of the proteins targeted for 
the extracellular space or subcellular locations carry specific sequence motifs (signal 
peptides) characterizing the type of secretion/targeting it undergoes. To identify potential 
amino-terminal signal peptides, primary sequence analysis of the predicted R. palustris 
proteome was performed by the SignalP NN [124], SignalP HMM [124], PrediSi [125], 
and PSORTb [126] algorithms.  A subdatabase containing R. palustris proteins with 
predicted signal peptides by all three signal peptide prediction algorithms was created by 
Judson Hervey, a graduate student in the Genome Science and Technology program.  
Amino-terminal signal peptides were removed from each protein in the subdatabase 
based upon the predicted cleavage site by the SignalP NN(2) algorithm.  Within the three 
growth states of R. palustris examined, 22 proteins with predicted signal peptides were 
identified using the database of predicted proteins containing signal peptides [Table 7.8]. 
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Table 7.8: Identified proteins with signal peptides. 
Protein 
Unprocessed 
MW 
Processed 
MW 
Measured 
Mass 
 Sequence 
Coverage Function 
RPA0088 7665.972 5687.447 5687.404  Unknown Protein 
RPA0090 15280.276 8049.5894 8048.786 7.5 Hypothetical Protein 
RPA0091 11250.928 7572.476 7572.525  Hypothetical Protein 
RPA0744 9858.252 6185.924 6186.192  
Putative High Potential 
Iron Sulfur Protein 
RPA1023 11434.053 8706.657 8706.918  Hypothetical Protein 
RPA1088 12609.711 8223.414 8223.715 13.5 Hypothetical Protein 
RPA1428 27812.97 25962.713 25962.602 19.8 Possible Lipoprotein 
RPA1454 9442.541 6067.368 6067.362 21.6 Hypothetical Protein 
RPA1824 17579.16 12571.359 12571.258 8.2 Unknown Protein 
RPA1847 9430.428 7119.5864 7120.332  
Conserved Hypothetical 
Protein 
RPA1874 7297.609 5526.5815 5526.812  Hypothetical Protein 
RPA2544 8676.271 5865.847 5865.694  
Conserved Hypothetical 
Protein 
RPA2546 15826.283 12707.527 12707.453 34.9 
FKBP-type Peptidyl-prolyl 
cis-trans Isomerase 
RPA3025 11292.242 7926.262 7926.935  Hypothetical Protein 
RPA3034 9315.853 6270.1743 6270.788 19.8 Unknown Protein 
RPA3101 17265.908 13337.184 13337.205 8.8 Unknown Protein 
RPA3362 10279.998 7755.001 7754.766  Unknown Protein 
RPA3373 10172.86 8148.3096 8149.009 15.5 Hypothetical Protein 
RPA3957 12532.322 6725.5767 6725.496  Hpt Domain 
RPA4329 15828.192 13645.581 13645.413 9 Unknown Protein 
RPA4467 16279.965 12802.759 12802.356 9.8 
SoxY2 Putative Sulfur 
Oxidation Protein  
RPA4573 16557.592 15352.109 15351.637 27.8 Unknown Protein 
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Twelve of the 22 identified proteins have some bottom-up sequence coverage. However, 
the signal peptide is not able to be identified by bottom-up methods the rest of the protein 
can provide peptide information for identification. The remaining 10 proteins identified 
that do not have bottom-up sequence coverage are generally too small to be detected, in 
bottom-up, after truncation  In the case of signal peptide searching the union of top-down 
and bottom-up identifications are shown, as well as proteins identified with only top-
down searching [Table 7.8]. 
Seventeen of the proteins identified were unknown or hypothetical proteins. The 
identification of signal peptides from these proteins provides a basis for starting to 
determine the function and location of these proteins. The putative high potential iron-
sulfur protein (RPA0744), FKBP-type peptidyl-prolyl cis-trans isomerase (RPA2546), 
and soxY2 putative sulfur oxidation protein (RPA4467) were all proteins that were 
identified with known functions. These three proteins have functions that a signal peptide 
would expect to been seen for.  For example, the putative high potential iron-sulfur 
proteins are a specific class of high-redox potential 4Fe-4S ferrodoxins that function in 
anaerobic electron transport and which occurs in photosynthetic bacteria. Also, this 
protein has been shown to have predicted signal peptides in other bacteria.  In R. palustris 
the putative high potential iron-sulfur protein (RPA0744) was identified in the anaerobic 
nitrogen fixing growth state, which correlates with its function in electron transport 
during anaerobic growth. The integrated top-down and bottom-up approach provided for 
the identification of 22 signal peptides in R. palustris, which gives an additional level of 
information about this organism.  
Conclusions 
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In this study, we have characterized the R. palustris proteome by integrated top-
down and bottom-up analysis under three major metabolic states. We confidently 
identified 599 proteins by an integrated top-down and bottom-up approach. In total, 241 
proteins classified as unknown and conserved unknown proteins were identified, 
representing 17.3% of the identified proteins. Over 500 proteins were identified 
containing some form of a PTM.  The proteome analysis of a number of metabolic states 
with their associated PTMs and isoforms is necessary to begin to understand how 
microbes change their proteome to adapt to the resources present. The conserved 
unknown and unknown proteins that were identified as containing multiple isoforms 
under the metabolic states examined here are excellent targets for future studies, because 
they may have important functions under those states. The detection of PTMs on an 
unknown operon of five proteins found to be expressed only under the phototrophic 
(anaerobic illuminated) states, with no evidence of expression under chemotrophic 
(aerobic dark) states, was an excellent example of the discovery capabilities of this 
general method to provide further information of function and location for these proteins. 
 Our data indicates that it is possible to identify large numbers of intact proteins 
with and with out PTMs and correlate this information to bottom-up ms/ms data.  By 
creating a list of common PTMs one can begin the process of imparting information 
about the natural state of the protein and how it may be functioning within the cell.  This 
is the first study of this magnitude to offer such a comprehensive list of intact identified 
proteins with their associated PTMs. This employed technique should provide a starting 
point of future work with protein complexes and functional studies within this as well as 
other microbial systems. 
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Chapter 8 
Conclusions and Impact of Integrated and Computational Platform for the Analysis 
of Intact Proteins and PTMs of Microbial Systems by Top-down Mass Spectrometry 
The overall goal of this dissertation research was to develop an integrated 
computational and experimental platform for characterizing protein isoforms and PTMs 
in microbial systems by top-down FT-ICR mass spectrometry.  We first evaluated the 
methodologies of microbial growth, intact protein and protein complex extractions, 
followed by sample preparation and then progressed to identification of the 
instrumentation needed to integrate the two methodologies used in these studies. 
Emphasis was placed on the development of integrated top-down and bottom-up 
informatics and the challenges faced in the integration of these two large data sets and 
extraction of relevant biological data. We then illustrated how these technologies can be 
applied to the analysis of complex protein mixtures, protein complexes and microbial 
proteomes. Great progress has been made through these studies, but much work is still 
needed in the areas of intact protein separations, data data-dependent MS/MS on intact 
proteins within liquid chromatography time scales, and further analysis of PTMs once 
tentatively identified.  Some avenues of research performed in this dissertation to combat 
these issues are discussed below. 
During this dissertation work, an essential need for fundamental advancements in 
the analysis of proteins and peptides was addressed.  Two areas of particular interest 
included better methods of determination of charge states for large proteins and advanced 
protein fragmentation methods with the FTICR-MS. Each of these areas was addresses in 
this dissertation work. Due to the difficulties encountered with LC-FTICR-MS 
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measurements and charge state determination, an automated method for determining 
charge states from high-resolution mass spectra was developed. Fourier transforms of 
isotope packets from high-resolution mass spectra are compared to Fourier transforms of 
modeled isotopic peak packets for a range of charge states. The charge state for the 
experimental ion packet is determined by the model isotope packet that yields the best 
match in the comparison of the Fourier transforms. Existing charge state assignment 
algorithms for FTICR-MS data appear to require centroiding before charge 
determination, and errors in this process can lead to errors in assessed charges. Use of 
Fast Fourier transforms (FFT) for charge determination does not require centroiding and 
appears to achieve superior sensitivity and noise suppression than algorithms of this type, 
especially for LC-FTICR-MS measurements. This advancement can be applied to data 
analysis in order to ensure the most accurate protein identifications during searching 
against a protein database. The second area targeted for FTICR-MS development was the 
evaluation of proteins and peptide fragmentation methods within the FTICR-MS.  This 
work demonstrated the use of MSAD as a replacement for more commonly applied 
fragmentation methods, such as SORI-CAD, within the FTICR as a feasible option for 
simple peptides solutions, tryptic digest and simple mixtures.  MSAD provides a 
fragmentation method that can fragment all peptides in the sample in one step eliminating 
the isolation step needed for SORI-CAD, which provides a more operationally simple 
and time saving method.  MSAD saves time during the experimentation process, 
although, the data analysis is in-depth and time consuming due to the complexity of the 
fragmentation spectra. Therefore, at this time we are not employing MSAD for intact 
protein analysis. These two fundamental studies provided better methods for protein 
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charge state determination under liquid chromatography conditions. Also, these studies 
provided alternative fragmentation methods of proteins and peptides within the FTICR-
MS, thereby advancing the field of top-down mass spectrometry.  
The combination of the top-down and bottom-up MS methodologies for the 
characterization of individual proteins, protein complexes and whole proteomes were the 
major focus of this dissertation work. While many proteomics groups are focusing on 
either top-down or bottom-up techniques, very few have tried to integrate the two 
technologies. Through the work of this dissertation we have pushed the forefront of this 
technology. Our initial effort was to analyze complex ribosomal protein mixtures from R. 
palustris and antibiotic resistant E. coli strains; this effort showed great promise for this 
integrated technology to obtain a detailed level of information not possible by either 
technique alone. This includes the determination of the position and number of post-
translational modifications on the intact protein product, as well as the determination of 
the number and position of amino acid changes (mutations) within intact proteins for 
most potential substations (Ile-Leu can’t be resolved because they are isobaric). The 
integrated top-down and bottom-up analysis of component proteins of the 70S ribosome 
from R. palustris enhanced several aspects of the analysis. For this study, the bottom-up 
approach was expanded to the use of 1D and 2D LC-MS/MS methodologies for the 
analysis of the enzymatically digested ribosomal protein complex. For the experiments on 
R. palustris ribosomal complexes, we performed LC-ES-FT-ICR for intact protein 
measurements. Not only was this method useful in the analysis of R. palustris ribosomes; 
the use of integrated top-down and bottom-up mass spectrometry approaches provided 
insight into the role of ribosomal proteins in streptomycin resistance in E. coli. In this 
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study, we employ an integrated top-down and bottom-up approach to characterize the 
ribosomal proteins from wild type K12 and two streptomycin resistant strains of E. coli. 
Using this method, a complement of ribosomal proteins with unique PTM series, 
isoforms, and point mutations were identified from all three strains.  For the first time, 
this method allowed for the interrogation of differential post translational modifications 
in the “compensation” process for E. coli, as well as further conformation of point 
mutations thought to confer antibiotic resistance.   
 The analysis of key regulation sites within protein complexes was the next step in 
the development of the integrated top-down and bottom-up platform.  To perform this 
analysis, affinity purifications of the R. palustris pII family of proteins consisting of 
GlnK1, GlnK2 and GlnB were analyzed.  In bacteria, the pII family generally plays a 
pivotal role in nitrogen metabolism regulation due to its ability to sense internal cellular 
ammonium concentrations.  The uridylylation of these proteins regulate ammonia 
transporters as well as glutamine synthetase.  Affinity purifications in conjunction with 
top-down and bottom-up mass spectrometry permitted the isolation and characterization 
of the functional state and isoforms for these proteins as a function of nitrogen 
availability.   From this work, it was determined that under nitrogen fixing conditions, all 
of these pII proteins are uridylylated, all on the Tyr-51 positions.  Thus, pII protein 
uridylylation appears to be tightly coordinated with nitrogen availability. By using a 
combined technique of protein affinity purifications and mass spectrometry, it was 
determined, for the first time, that GlnK2, GlnK1 and GlnB proteins possess an 
uridylylation under nitrogen fixing growth conditions in R. palustris.  This information 
allowed for a previously un-afforded glimpse into the modifications and isoforms of the 
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proteins that regulate the AmtB transporter and glutamine synthetase in R. palustris. Not 
only did this method provide a glimpse into a key regulation site for a protein complex it 
also expanded the capabilities of this approach for future systems. 
 At the outset of this dissertation a primary limitation of top-down analysis was 
bioinformatics tools for querying protein databases. The isotopic packets of intact 
proteins and the MS/MS spectra of intact proteins are both much more complicated than 
those derived from peptide measurements thereby enhancing this problem. This 
dissertation work provided the first informatics tools for combining top-down and 
bottom-up datasets to search for PTMs, amino acid substitutions, and N-terminal 
truncations. At the start of this dissertation, the ProSight PTM and PROCLAIM 
algorithms had been available for the analysis of intact protein and their MS/MS spectra 
against protein databases as well as PTM prediction. Even with these programs, no major 
effort had been made to integrate top-down analysis with traditional enzymatic bottom-up 
analysis for protein identification and PTM analysis. Our ORNL developed algorithm 
PTMSearchPlus is the first software providing a comprehensive search method that 
allows for the integration of top-down protein identification with the bottom-up peptide 
data to identify proteins and their associated PTMs.  The software is built around multiple 
instrumentation platforms and data inputs. These multiple instrumentation and data 
platforms include bottom-up ion trap data, as well as top-down high resolution data such 
as FTICR data. The software can accomplish independent top-down or bottom-up 
searches, as well as these two parts of the program being able to interact in a combined 
search. By combining these two search capabilities, the results from the top-down search 
can limit the number of the proteins that are used to generate the database used for the 
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bottom-up search (search time decrease) and in return, the results of the bottom-up search 
can be used as a confirmation for the proteins with associated PTMs found in the top-
down search.  This integration reduces the search time dramatically, allowing the user to 
search for more PTMs on proteins and peptides during a reasonable time frame.  The 
software was demonstrated with a protein standard mixture and complex ribosomal 
protein mixture. All proteins from the protein standard mixture, which was used as a 
training set, were identified using PTMSearchPlus.  The R. palustris complex ribosomal 
mixture was previously examined in an integrated fashion by manual comparison. Using 
PTMSearchPlus all of the identified ribosomal proteins identified in the previous study 
were identified in a fraction of the time. Both of these test cases showed the power of the 
integrated approach as well as demonstrating the accuracy and speed of PTMSearchPlus.   
 The final goal of this dissertation was to apply the developed integrated 
computational and experimental platforms developed to intact proteomes of microbial 
systems under different growth conditions. This is the first study of this magnitude to 
offer such a comprehensive list of intact identified proteins with their associated PTMs. 
Within this study, the first large-scale characterization of three growth states of R. 
palustris by an integrated top-down and bottom-up approach was performed. This global 
measurement strategy was able to provide information on intact proteins, including 
PTMs, isoforms, and signal peptides from a given growth state. The technological 
approaches developed in this dissertation provided information on the function and 
location of proteins, as well as providing confirming peptide MS/MS data. These tools 
were shown to be especially powerful when determining what modification states play a 
role in the switch between different growth conditions, characterizing known and 
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unknown proteins, and determining trends within protein expression across the chosen 
metabolic states. Our data indicates that it is possible to identify large numbers of intact 
proteins with and without PTMs and correlate this information to bottom-up MS/MS 
data. This technique should provide a starting point of future work with protein 
complexes and functional studies within this, as well as other microbial systems. 
This dissertation provided the first comprehensive platform for integrated top-
down and bottom-up analysis of proteins, but many areas of work remain. Four of the 
most important areas of work include intact protein separations, data-dependent MS/MS 
on intact proteins within liquid chromatography time scales, intact protein bioinformatics, 
and further analysis of PTMs once tentatively identified. Top-down technology in its 
current form has difficulties with the complex mixtures found in whole proteome 
analysis. Potential 2D separations of intact proteins such as the off-line FPLC followed 
by on-line HPLC employed in this dissertation may overcome some of these limitations 
by providing less complex protein fractions to analyze. However, the loss of protein is 
always a concern when employing multiple protein purification and separation steps, this 
is necessary to reduce the protein complexity from a proteome into more manageable 
fractions for the mass spectrometer.  The main area of concern, though, is the inability to 
separate some protein sizes and types with the commonly employed C4 reverse phase 
chromatography, such as proteins larger than 40- 50 kDa. This limitation exists due to on-
line chromatography of intact proteins is often difficult; because of the wide range of 
protein sizes and hydrophobicities within the complex proteome mixtures.  Parts of this 
problem can be addressed by employing shorter carbon chain reverse phase columns, 
such as a C2 column.  Another option is to use different stationary phases for intact 
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protein separation.  One example of an alternative is hydrophilic interaction 
chromatography (HILIC). HILIC is a variant of normal phase chromatography, where the 
stationary phase must be extremely polar. The elution order with HILIC is least to most 
polar, the opposite of that in reverse phase liquid chromatography.  This method provides 
promise, although, there are still issues with protein precipitation that need to be worked 
out. One other option is buffer additives, such as hexafluroisoporponal (HFIP), which 
acts as a chaotrope to help provide better separations.  These three solutions do provide 
some benefit, but in the future better separation methods for intact proteins are needed. 
One of the primary technological advances needed for this combined technology 
includes methods for data-dependent MS/MS on intact proteins on liquid chromatography 
time scales. Currently, the methods of IRMPD and ECD are employed for intact protein 
MS/MS. These methods, while powerful, still leave room for improvement in the ability 
to perform them on a liquid chromatography time scale and accomplish extensive 
fragmentation of the protein. New instrumentation, such as the use of resolving 
quadrupoles within the FT-ICR may help. Using the resolving quadrupole in the front of 
the FT-ICR the proteins can be targeted for dissociation more readily. Also the use of 
IRMPD in tandem with ECD provides two distinct forms of fragmentation and provides a 
wider range of fragmentation for proteins of varying sizes.  Hopefully the continuation of 
fundamental instrumentation research will provide some of the answers to this limitation. 
Work in this dissertation moved the field of top-down bioinformatics forward, by 
using an integrated top-down and bottom-up search method found in PTMSearch Plus. 
This program provides a great advance in integrated top-down and bottom-up searching, 
but more work is need in the areas of addressing point mutation, signal peptides, and 
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truncations. Amino Acid point mutations in proteins are one of the most difficult areas to 
include in a protein identification algorithm, due to the enormous combination of 
possibilities for all of the 20 amino acids within the protein sequence. Another area of 
future work is the automated prediction and identification of signal peptides. Signal 
sequences play an important role in protein processing and identification can sometimes 
be crucial to determining a protein’s function and possible location within the cell (i. e. if 
located within the periplasm). Hopefully, future work will advance the area of intact 
protein analysis by providing quick and automated ways of identifying these PTMs.  
The integrated top-down and bottom-up technology has already allowed for the 
characterization of hundreds of conserved unknown and unknown proteins and their 
associated PTMs as well as PTMs on known proteins. One of the clearest challenges is 
the integration of the field of PTM analysis in proteomics with rapid structural analysis, 
functional assays and genetic methods to develop rapid integrated methods to determine 
not only the identity of conserved unknown and unknown proteins, but also their function 
and the role the PTMs on them play. Another challenge is to determine what role 
identified PTMs play in the regulation of known proteins. For top-down proteomics to 
become truly useful at gaining insight into the function and regulation of the many 
proteins present in any microbial species, this must be accomplished 
The final major challenge is the application of this technology to microbial 
growth states for rapid and routine analysis. While small important steps were taken in 
the course of this dissertation, much work is still needed. The complexity of PTMs on 
proteins is truly daunting but unless initial steps are taken to attack this important aspect 
no progress will be made. Hopefully, the work presented in this dissertation brings us one 
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step closer to the ultimate goal of an integrated computational and experimental platform 
for characterizing protein isoforms and PTMs in microbial systems by top-down FT-ICR 
mass spectrometry.
 226
List of References
 227
 
 
[1] Ideker, T.; Galitski, T.; Hood L. (2001) A new approach to decoding life: systems 
biology.  Annu. Rev. Genomics Hum. Genet., 2, 343-372. 
 
[2] James, P. (2001) Mass Spectrometry and the Proteome, in Proteome Research: Mass 
Spectrometry, P. James, editor, Springer, Germany, p.6. 
 
[3] Alberts, B.; Bray, D.; Lewis, J.; Raff, M.; Roberts, K. and J. D. Watson, editors. 
(1994) “Molecular Biology Of the Cell,” Garland Publishers, New York. (ISBN 0-8153-
1619-4) 
 
[4] Driessen, H. P. C.; de Jong, W. W.; Tesser, G. I.; Bloemendal, H. (1985) The 
mechanism of amino-terminal acetylation of proteins. CRC Crit Rev Biochem. 18, 281–
325. 
 
[5] Persson, B.; Flinta, C.; von Heijne, G.; Jörnvall, H. (1985) Structures of amino-
terminally acetylated proteins. Eur J Biochem. 152, 523–527. 
 
[6] Polevoda, B.; Sherman F. (2000) Nα-terminal acetylation of eukaryotic proteins. J 
Biol Chem. 275, 36479–39482. 
 
[7] Polevoda, B; Norbeck, J.; Takakura, H.; Blomberg, A.; Sherman F. (1999) 
Identification and specificity of amino-terminal acetyltransferases from Saccharomyces 
cerevisiae. EMBO J. 18, 6155-6168. 
 
[8] Hunter, T. (1987) A thousand and one protein kinases. Cell. 50, 823-829.  
 
[9] Kim, J. and Kendall, D. A. (2000) Cell stress chaperones abstracts. Cell Stress 
Chaperones. 5(4), 267-275. 
 
[10] Harrison, F. H. and Harwood, C. S. (2005) The pimFABCDE operon from 
Rhodopseudomonas palustris mediates dicarboxylic acid degradation and participates in 
anaerobic benzoate degradation. Microbiology. 74, 727-736. 
 
[11] Harwood, C. S. and Gibson. (1988) Anaerobic and aerobic metabolism of diverse 
aromatic compounds by the photosynthetic bacterium Rhodopseudomonas palustris.  J. 
Appl. Environ. Microbiol. 54, 712-717. 
 
[12] Samanta, S. K.; Harwood, C. S. (2005) Use of the Rhodopseudomonas palustris 
genome to identify a single amino acid that contributes to the activity of a coenzyme A 
ligase with chlorinated substrates. Mol. Microbiol. 55, 1151- 1159. 
 
 
 228
 
[13]Larimer, F. W. et al. (2004) Complete genome sequence of the metabolically 
versatile photosynthetic bacterium Rhodopseudomonas palustris.  Nature Biotech. 22, 55-
60. 
 
[14] Oda, Y.; Samanta, S. K.; Rey, F. E.; Wu, L.; Liu, X.; Yan, T.; Zhou, J.; Harwood: C. 
S. J. (2005) Use of Rhodopseudomonas palustris genome sequence to identify a single 
amino acid that contributes to the activity of a coenzyme A ligase with chlorinated 
substrates.Bacteriology, 187, 7784-7794. 
 
[15]Buchanan, M.V. et al. (2002) Genomes to Life "Center for Molecular and Cellular 
Systems": a research program for identification and characterization of protein 
complexes. OMICS, 6, 287-303. 
 
[16] Blattner, F. R. et al. (1997). The complete genome sequence of Escherichia coli K-
12. Science, 277,1453-1462. 
 
[17] Fenn, J.B.; Mann, M.; Meng, C.K.; Wong, S.F.; Whitehouse, C.M.  (1989)  
Electrospray ionization for mass spectrometry of large biomolecules. Science 246, 64-71. 
 
[18] Hillenkamp, F.; Karas, M.; Beavis, R.C.; Chait, B.T.  (1991) Matrix-assisted laser 
desorption/ionization mass spectrometry of biopolymers. Anal. Chem. 63, 1193A-1203A. 
 
[19] Nakanishi T.; Okamoto N.,; Tanaka, K.,; Shimizu, A.  (1994)  Laser-Desorption 
Time-Of-Flight Mass-Spectrometric Analysis Of Transferrin Precipitated With 
Antiserum - A Unique Simple Method To Identify Molecular-Weight Variants. 
Biological Mass Spectrometry 23, 230-233.  
 
[20] Peng J. and Gygi, S.P. (2001) Proteomics: The Move to Mixtures. J. Mass Spec. 36, 
1083-1091. 
 
[21] Larsen, M.R. and Roepstorff, P.  (2000) Mass spectrometric identification of 
proteins and characterization of their post-translational modifications in proteome 
analysis. Fresenius J. Anal. Chem. 366, 677-690. 
 
[22] Little, D.P.; Speir, J.P.; O’Connor, P.B.; McLafferty, F.W.  (1994) Infrared 
multiphoton dissociation of large multiply charged ions for biomolecule sequencing. 
Anal. Chem. 66, 2809-2815. 
 
[23] Mortz, E.; O’Connor, P.B.; Roepstorff, P.; Kelleher, N.L.; Wood, T.D.; McLafferty, 
F.W. Mann, M.  (1996) Sequence tag identification of intact proteins by matching tandem 
mass spectral data against sequence data bases. Proc. Natl. Acad. Sci. USA 93, 8264-
8267. 
 
 
 229
 
[24] Kelleher, N.L.; Taylor, S.V.; Grannis, D.; Kinsland, C.; Chiu, H.J.; Begley, T.P.; 
McLafferty, F.W.  (1998) Efficient sequence analysis of the six gene products (7-74 kDa) 
from the Escherichia coli thiamin biosynthetic operon by tandem high-resolution mass 
spectrometry. Protein Sci. 7, 1796-1801. 
 
[25] McLuckey, S.A. and Stephenson, J.L. Jr.  (1998) Ion/ion chemistry of high-mass 
multiply charged ions. Mass Spectrom. Rev. 17, 369-407. 
 
[26] Hess, D.; Covey, T.C.; Winz, R.; Brownsey, R.W.; Aebersold, R.  (1993) Analytical 
and micropreparative peptide mapping by high performance liquid 
chromatography/electrospray mass spectrometry of proteins purified by gel 
electrophoresis. Protein Sci. 2, 1342-1351. 
 
[27] Mortz, E.; Vorm, O.; Mann, M.; Roepstorff, P.  (1994) Identification of proteins in 
polyacrylamide gels by mass spectrometric peptide mapping combined with database 
search. Biol. Mass Spectrom. 23, 249-261. 
 
[28] Shevchenko, A.; Jensen, O.N.; Podtelejnikov, A.V.; Sagliocco, F.; Wilm, M.; Vorm, 
O.; Mortensen, P.; Shevchenko, A.; Boucherie, H.; Mann M.  (1996a) Linking genome 
and proteome by mass spectrometry: large-scale identification of yeast proteins from two 
dimensional gels. Proc. Natl. Acad. Sci. USA 93, 14440-14445. 
 
[29] Wilm, M.; Shevchenko, A.; Houthaeve, T.; Breit, S.; Schweigerer, L.; Fotsis, T.; 
Mann M.  (1996) Femtomole sequencing of proteins from polyacrylamide gels by nano-
electrospray mass spectrometry. Nature 379, 466-469. 
 
[30] Gatlin, C.L.; Kleemann, G.R.; Hays, L.G.; Link, A.J.; Yates, J.R. 3rd  (1998) Protein 
identification at the low femtomole level from silver-stained gels using a new fritless 
electrospray interface for liquid chromatography-microspray and nanospray mass 
spectrometry. Anal. Biochem. 263, 93-101. 
 
[31] McCormack, A.L.; Schieltz, D.M.; Goode, B.; Yang, S.; Barnes, G.; Drubin, D.; 
Yates, J.R. 3rd  (1997) Direct analysis and identification of proteins in mixtures by 
LC/MS/MS and database searching at the low-femtomole level. Anal. Chem. 69, 767-
776. 
 
[32] Martin, S.E.; Shabanowitz, J.; Hunt, D.F.; Marto, J.A.  (2000) Subfemtomole MS 
and MS/MS peptide sequence analysis using nano-HPLC micro-ESI fourier transform ion 
cyclotron resonance mass spectrometry. Anal. Chem. 72, 4266-4274. 
 
[33] Shen, Y.; Zhao, R.; Belov, M.E.; Conrads, T.P.; Anderson, G.A.; Tang, K.; Paša-
Tolić, L.; Veenstra, T.D.; Lipton, M.S.; Udseth, H.R.; Smith, R.D.  (2001) Packed 
capillary reversed-phase liquid chromatography with high-performance electrospray 
 
 230
 
ionization Fourier transform ion cyclotron resonance mass spectrometry for proteomics. 
Anal. Chem. 73, 1766-1775. 
 
[34] Kelleher, N. (2004) Top-Down Proteomics Anal. Chem. 76, 196A-203A. 
 
[35] VerBerkmoes, N.C.; Bundy, J.L.; Hauser, L.; Asano, K.G.; Razumovskaya, J.; 
Larimer, F.; Hettich, R.L.; Stephenson, J.L. Jr.  (2002) Integrating “Top-Down” and 
“Bottom-Up” mass spectrometric approaches for proteomic analysis of Shewanella 
oneidensis. J. Proteome Res. 1, 239-252. 
 
[36] Blank, P.S.; Sjomeling, C.M.; Backlund, P.S.; Yergey, A.L.  (2002) Use of 
cumulative distribution functions of characterize mass spectra of intact proteins. J. Am. 
Soc. Mass Spectrom. 13, 40-46. 
 
[37 ]Gomez, S.M.; Nishio, J.N.; Faull, K.F.; Whitelegge, J.P.  (2002) The chloroplast 
grana proteome defined by intact mass measurements from liquid chromatography mass 
spectrometry. Mol. Cell Proteomics 1, 46-59. 
 
[38] Lee, S.-W.; Berger, S.J.; Martinović, S.; Paša-Tolić, L.; Anderson, G.A.; Shen, Y.; 
Zhao, R.; Smith, R.D.  (2002) Direct mass spectrometric analysis of intact proteins of the 
yeast large ribosomal subunit using capillary LC/FTICR.  PNAS.  99, 5942-5947. 
 
[39] Meng, F.; Cargile, B.J.; Patrie, S.M.; Johnson, J.R.; McLoughlin, S.M.; Kelleher, 
N.L.  (2002) Processing complex mixtures of intact proteins for direct analysis by mass 
spectrometry. Anal. Chem. 74, 2923-2929. 
 
[40] Merchant, M. and Weinberger, S.R.  (2000) Recent advancements in surface-
enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 
21, 1164-1167. 
 
[41] Ogorzalek Loo, R.R.; Cavalcoli, J.D.; VanBogelen, R.A.; Mitchell, C.; Loo, J.A.; 
Moldover, B.; Andrews, P.C.  (2001) Virtual 2-D gel electrophoresis: Visualization and 
analysis of the E. coli proteome by mass spectrometry. Anal. Chem. 73, 4063-4070. 
 
[42] Reid, G.E. and McLuckey, S.A. (2002) ‘Top down’ protein characterization via 
tandem mass spectrometry. J. Mass Spectrom. 37, 663-675. 
 
[43] Meng, F.; Cargile, B.J.; Miller, L.M.; Forbes, A.J.; Johnson, J.R.; Kelleher, N.L.  
(2001) Informatics and multiplexing of intact protein identification in bacteria and the 
archaea. Nature Biotech. 19, 952-957. 
 
[44] Stephenson, J.L. Jr.; Cargile, B.J.; McLuckey, S.A. (1999) Ion Trap Collisional 
Activation of Disulfide Linkage Intact and Reduced Multiply Protonated Polypeptides. 
Rapid Comm. Mass Spec. 13, 2040-2048. 
 
 231
 
[45] Nemeth-Cawley, J.F. and Rouse, J.C. (2002) Identification and sequencing analysis 
of intact proteins via collision-induced dissociation and quadrupole time-of-flight mass 
spectrometry. J. Mass Spectrom. 37, 270-282.  
 
[46] McLafferty, F.W.; Horn, D.M.; Breuker, K.; Ge, Y.; Lewis, M.A.; Cerda, B.; 
Zubarev, R.A.; Carpenter, B.K.  (2001) Electron capture dissociation of gaseous multiply 
charged ions by Fourier-transform ion cyclotron resonance. J. Am. Soc. Mass Spectrom. 
12, 245-249. 
 
[47] Horn, D.M.; Ge, Y.; McLafferty, F.W.  (2000a) Activated ion electron capture 
dissociation for mass spectral sequencing of larger (42 kDa) proteins. Anal. Chem. 72, 
4778-4784. 
 
[48] Ge, Y.; Lawhorn, B.G.; ElNaggar, M.; Strauss, E.; Park, J.-H.; Begley, T.P.; 
McLafferty, F.W.  (2002) Top down characterization of larger proteins (45 kDa) by 
electron capture dissociation mass spectrometry. J. Am. Chem. Soc. 124, 672-678. 
 
[49] Demirev, P.A.; Ramirez, J.; Fenselau, C. (2001)  Tandem mass spectrometry of 
intact proteins for characterization of biomarkers from Bacillus cereus T spores Anal. 
Chem. 73, 5725-5731  
 
[50] Laskin J.; Futrell J.H. (2003) Collisional Activation of Peptide Ions in FT-ICR Mass 
Spectrometry. Mass Spectrometry Reviews. 22, 158-181. 
 
[51] Forbes, A.J.; Mazur, M.T.; Patel, H.M.; Walsh, C.T.; Kelleher, N.L.  (2001) Toward 
efficient analysis of >70 kDa proteins with 100% sequence coverage. Proteomics. 1, 927-
933. 
 
[52] Li, W.; Hendrickson, C.L.; Emmett, M.R.; Marshall, A.G.  (1999) Identification of 
intact proteins in mixtures by alternated capillary liquid chromatography electrospray 
ionization and LC ESI infrared multiphoton dissociation Fourier transform ion cyclotron 
resonance mass spectrometry. Anal. Chem. 71, 4397-4402. 
 
[53] Little D.P.; Speir J.P.; Senko M.W.; O’Connor P.B.; McLafferty F.W. (1994) 
Infrared Multiphoton Dissociation of Large Mulitiply Charged Ions for Biomolecule 
Sequencing. Anal. Chem. 66, 2809-2815. 
 
[54] Strader, M.B. et al. (2004) Characterization of the 70S Ribosome from 
Rhodopseudomonas palustris using an integrated “top-down” and “bottom-up” mass 
spectrometric approach. J. Proteome Res., 3, 965-978. 
 
[55] http://www.ornl.gov/sci/GenomestoLife/index.shtml 
 
 232
 
[56] Mann, M. and Pandey, A. (2001). Use of mass spectrometry-derived data to annotate 
nucleotide and protein sequence databases. Trends Biochem Sci.  26, 54-61. 
 
[57] Marshall, A. G., C. L. Hendrickson, et al. (1998). Fourier transform ion cyclotron 
resonance mass spectrometry: a primer. Mass Spectrom Rev. 17, 1-35. 
 
[58] Henrickson, C. L. and Emmett C. R. (1999). Electrospray ionization Fourier 
transform ion cyclotron resonance mass spectrometry. Annu Rev Phys Chem. 50, 517-36. 
 
[59] Sharp, J.S; Becker, J.M.; Hettich, R.L. (2003) Protein surface mapping by chemical 
oxidation: structural analysis by mass spectrometry.  Anal. Biochem., 312, 216-225. 
 
[60] Stafford, G. (2002) Ion Trap Mass Spectrometry: A personnel perspective.  J. Am. 
Soc. Mass. Spectrom., 13, 589-596. 
 
[61] Tabb, D.L.; Hayes-McDonald, W.; Yates, J.R. (2002) DTASelect and Contrast: 
Tools for Assembling and Comparing Protein Identifications from Shotgun Proteomics.  
J. Proteome Res., 1, 21-26. 
 
[62] Eng, J.K.; McCormack, A.L.; Yates, J.R. 3rd (1994) An approach to correlate tandem 
mass spectral data of peptides with amino acid sequences in a protein database.  J. Am. 
Mass Spectrom., 5, 976-989. 
 
[63]Narasimhan, C.; Tabb, D. L.; VerBerkmoes, N. C.; Thompson, M. R.; Hettich, R. L.; 
Uberbacher, E. C.(2005) MASPIC: Intensity-based tandem mass spectrometry scoring 
scheme that improves peptide identification at high confidence. Anal. Chem. 77, 7581–
7593. 
 
[64] Marshall, A. G.; Hendrickson, C. L. (2002) Fourier transform ion cyclotron 
resonance detection: Principles and experimental configurations. Int. J. 
Mass Spectrom. 215, 59–75. 
 
[65] Laskin J.; Futrell J.H. (2003)  Collisional Activation of Peptide Ions in FT-ICR Mass 
Spectrometry. Mass Spectrometry Reviews. 22, 158-181. 
 
[66] Zubarev R.A.; Kelleher N.L.; McLafferty F.W. (1998) Electron Capture 
Dissociation of Multiply Charged Protein Cations. J. Am. Chem. Soc. 120, 3265-3266. 
 
[67] Laskin, J.; Denisov E.V.; Shukla A.K.; Barlow S.E.; Futrell J.H.(2002) Surface-
induced dissociation in a Fourier transform ion cyclotron resonance mass spectrometer: 
New instrument design and evaluation. Anal Chem. 74, 3255-3261. 
 
 
 233
 
[68] Little D.P.; Speir J.P.; Senko M.W.; O’Connor P.B.; McLafferty F.W. (1994) 
Infrared Multiphoton Dissociation of Large Mulitiply Charged Ions for Biomolecule 
Sequencing. Anal. Chem. 66 (1994) 2809-2815. 
 
[69] K. Hakansson, J. Axelsson, M. Palmblad, P. Hakansson. (2000) Mechanistic Studies 
of Multipole Storage Assisted Dissociation. J Am Soc Mass Spectrometry, 11, 210-217. 
 
[70] Sannes-Lowery K.A.; Hofstadler S.A. (2000) Characterization of Multipole Storage 
Assisted Dissociation: Implications for Electrospray Ionization Mass Spectrometry 
Characterization of Biomolecules. JASMS. 11, 1-9. 
 
[71] McFarland, M.A., Hendrickson, C.L., and Marshall, A.G. (2004) Ion "threshing": 
Collisionally activated dissociation in an external octopole ion trap by oscillation of an 
axial electric potential gradient. Analytical Chemistry, 76(6), 1545-1549. 
 
[72] Hofstadler, S.A., Sannes-Lowery, K.A., and Griffey, R.H. (1999) Infrared 
multiphoton dissociation in an external ion reservoir. Anal Chem, 71, 2067-70. 
 
[73] Hofstadler, S.A., Drader, J.J., Gaus, H., Hannis, J.C., and Sannes-Lowery, 
K.A.(2003) Alternative approaches to infrared multiphoton dissociation in an external ion 
reservoir. JASMS. 14, 1413-23. 
 
[74] Senko M.W.; Hendrickson C.L.; Emmett M.R.; Shi S.D.H.; Marshall A.G. (1997) 
External accumulation of Ions for Enhanced Electrospray Ionization Fourier Transform 
Ion Cyclotron Resonance Mass Spectrometry. JASMS. 8, 970-976. 
 
[75] Sannes-Lowery, K. A.; Griffey, R. H.; Kruppa, G. H.; Speir, J. P.; Hofstadler, S. A. 
(1998)  Multipole Storage Assisted Dissociation, a Novel In-Source Dissociation 
Technique for Electrospray Ionization Generated Ions. Rapid Commun. Mass Spectrom. 
12, 1957-1961.  
 
[76] Belov, M.E., Gorshkov, M.V., Udseth, H.R., and Smith, R.D. (2001) Controlled ion 
fragmentation in a 2-D quadrupole ion trap for external ion accumulation in ESI FTICR 
mass spectrometry. JASMS. 12,1312-1319. 
 
[77] Pan, C., Hettich, R.L. (2005) Multipole-Storage Assisted Dissociation (MSAD) for 
the Characterization of Large ProteinsMixtures by ESI-FTICR-MS. Anal. Chem. 77, 
3072-3082. 
 
[78] Keller, K.M., Brodbelt, J.S., Hettich, R.L., and Van Berkel, G.J.(2004) Comparison 
of sustained off-resonance irradiation collisionally activated dissociation and multipole 
storage-assisted dissociation for top-down protein analysis. J Mass Spectrom. 39, 402-11. 
 
 
 234
 
[79] Sannes-Lowery K.A.; Hofstadler S.A. (2000) Characterization of Multipole Storage 
Assisted Dissociation: Implications for Electrospray Ionization Mass Spectrometry 
Characterization of Biomolecules. JASMS. 11, 1-9.  
 
[80] Palmblad, M., Hakansson, K., Hakansson, P., Feng, X.D., Cooper, H.J., 
Giannakopulos, A.E., Green, P.S., and Derrick, P.J.(2000) A 9.4 T Fourier transform ion 
cyclotron resonance mass spectrometer: description and performance. Eur. J. Mass 
Spectrom. 6, 267-275. 
 
[81] Haselmann K.F.; Bundnik B.A.; Kjeldsen F.; Nielsen M.L.; Olsen J.V.; Zubarev 
R.A. (2002) Electronic excitation gives informative fragmentation of polypeptide cations 
and anions. Eur. J. Mass Spectrom. 8, 117-121. 
 
[82] Kubinyi, H. (1991) Calculation of isotope distributions in mass spectrometry-A 
trivial solution for a nontrivial problem. Anal. Chim. Acta. 247, 107–119. 
 
[83] McDonald, W. H.; Tabb, D. L.; Sadygov, R. G.; MacCoss, M. J.; Venable, J.; 
Graumann, J.; Johnson, J. R.; Cociorva, D.; Yates, J. R. (2004) MS1, MS2, and SQT—
Three unified, compact, and easily parsed file formats for the storage of shotgun 
proteomic spectra and identifications. Rapid Commun. Mass Spectrom. 8, 2162–2168. 
 
[84] PROWL: http://prowl.rockefeller.edu/ 
 
[85] Horn, D. M.; Zubarev, R. A.; McLafferty, F. W. (2000) Automated reduction and 
interpretation of high resolution electrospray mass spectra of large molecules. JASMS. 11, 
320–332. 
 
[86] McDonnell, L.A., Giannakopulos, A.E., Derrick, P.J., Tsybin, Y.O., and Hakansson, 
P. (2002) A theoretical investigation of the kinetic energy of ions trapped in a radio-
frequency hexapole ion trap. Eur. J. Mass Spectrom. 8, 181-189. 
 
[87] Uchiki, T., Hettich, R., Gupta, V., and Dealwis, C. (2002) Characterization of 
monomeric and dimeric forms of recombinant Sm1lp-histag protein by electrospray mass 
spectrometry. Anal. Biochem. 301, 35-48. 
 
[88] Link, A.J.; Eng, J.; Schieltz, D.M.; Carmack, E.; Mize, G.J; Morris, D.R.; Garvik, 
B.M.; Yates, J.R. 3rd (1999) Direct analysis of protein complexes using mass 
spectrometry.  Nat. Biotechnol., 17, 676-682. 
 
[89] Wittman ,H. G.(1982) Components of bacterial ribosomes. Annu. Rev. Biochem. 51, 
155-183. 
 
 
 235
 
[90] Arnold, R.J; Reilly, J.P. (1999) Observation of Escherichia coli ribosomal proteins 
and their posttranslational modifications by mass spectrometry.  Anal. Biochem., 269, 
105-112. 
 
[91] R. M. Kamp, R. M.; Srinivasa, B.R.; Von Knoblauch, K.; Subramanian, A. R. 
(1987) Occurrence of a methylated protein in chloroplast ribosomes. Biochemistry 26, 
5866-5870. 
 
[92] Yamaguchi, K.; Subramanian, A. R. (2000) Identification of all the proteins in the 
50S subunit of an organelle ribosome (chloroplast) J. Biol. Chem. 275, 28466-28482. 
 
[93] Kowalak, J.A.; Walsh K.A. (1996) Beta-methylthio-aspartic acid: identification of a 
novel posttranslational modification in ribosomal protein S12 from Escherichia coli. 
Protein Science, 5, 1625-1632. 
 
[94] Arnold, R. J.; Polevoda, B.; Reilly, J. P.; F. Sherman, F.(1999) the action of N-
terminal acetyltransferases on yeast ribosomal proteins. J. Biol. Chem. 274, 37035-37040. 
 
[95] Kalholz, B. P.; Myasnikov, A. G.; van Heel, M. (2004) Visualization of release of 3 
on the ribosome during termination pf protein synthesis. Nature. 427, 862-865.  
 
[96] Javelle, E. Severis, J. Thornton, J. Merrick. (2004)Ammonium Sensing in 
Escherichia coli. J. Bio. Chem. 279, 8530-8538. 
 
[97] van Heeswijk, W. C.; Wen,D.; Clancy, P.; Jaggi, R.; Ollis, D. L.; Westerhoff, H. V.; 
Vasudevan, S. G. (2000) The Escherichia coli signal transducers PII (GlnB) and GlnK 
form heterotrimers in vivo: Fine tuning the nitrogen signal cascade. PNAS, 97, 3942-
3947. 
 
[98] Arcondeguy, T.; Jack, R.; Merrick, M.(2001) P(II) Signal Transduction Proteins, 
Pivotal Players in Microbia Nitrogen Control, Microbial Mol. Biol. Rev. 65, 80-105. 
 
[99] Ninfa, A. J.; Atkinson, M. R. (2000) P(II) Signal Transduction Proteins, Trends 
Microbiol. 8, 172-190. 
 
[100] Thomas, G.; Coutts, G.; Merrick, M. (2001) The glnK amtB operon: a conserved 
gene pair in prokaryotes. Trends in Genetics 16, 11-14. 
 
[101] Atkinson, M. R.; Blauwkamp, T. A.; Ninfa, A. J. (2002) Context-Dependant 
Functions of the PII and GlnK Signal Transduction Proteins in Escherichia coli. J. 
Bacteriol. 184, 5364-5375. 
 
 
 236
 
[102] Javelle and Merrick (2005) Complex formation between AmtB and GlnK: an 
ancestral role in prokaryotic nitrogen control. Biochem. Soc. Trans. 33,170-172. 
 
[103] Zheng, L.; Kostrewa, D.; Berneche, S.; Winkler, F. K.; Li, X. (2004) The 
mechanism of ammonia transport based on the crystal structure of AmtB and Escherichia 
coli. PNAS 101, 17090-17095. 
 
[104] Forchhammer, K.; Hedler, A.; Strobel, H.; Weiss, V. (1999) Heterotrimerization of 
PII-like signaling proteins: implications for PII-mediated signal transduction systems. 
Molecular Micro. 33, 338-349. 
 
[105] Atkinson, M. R.; Ninfa, A. J. (1999) Characterization of the GlnK protein of 
Escherichia coli, Mol. Microbiol. 32, 301-313. 
 
[106] Atkinson, M. R.; Ninfa, A. J. (1998) Role of the GlnK Signal Transduction Protein 
in the Regulation of Nitrogen Assimilation in Escherichia coli. Mol. Microbiol. 29, 431-
447. 
 
[107] Blauwkamp, T.; Ninfa, A. J. (2002) Physiological Role of the GlnK Signal 
Transduction Protein of Escherichia coli: Survival of Nitrogen Starvation. Mol. 
Microbiol. 46, 203-214. 
 
[108] Coutts, G.; Thomas, G.; Blakey, D.; Merrick, M. (2002) Membrane Sequestration 
of the Signal Transduction Protein by the Ammonium Transporter AmtB. EMBO J. 21, 
536-545. 
 
[109] Javelle, A.; Serveri, E.; Thornton, J.; Merrick, M. (2004) Ammonium Sensing in 
Escherichia coli. Role of the Ammonium Transproter AmtB and AmtB-GlnK complex 
Formation. J Biol. Chem. 279, 8530-8538. 
 
[110] Drepper, T.; Grob, S.; Yakunin, A. F.; Hallenbeck, P. C.; Masepohl, B.; Klipp, W. 
(2003) Role of GlnB and GlnK in ammonium control of both nitrogenase systems in the 
phototrophic bacterium Rhodobacter capsulatus. Microbiology. 149, 2203-2212. 
 
[111] Zhang, Y.; Pohlmann, E. L.; Ludden, P. W.; Roberts, G. P. (2001) Functional 
Characterization of Three Homologs in the Photosynthetic Bacterium Rhodospirillum 
rubrum: Roles in Sensing Ammonium and Energy Status. J. Bac. 183, 6159-6168. 
 
[112] Maheswaran, M.; Frochhammer, K. (2003) Carbon-Source-Dependent Nitrogen 
Regulation in Escherichia coli is mediated Through Glutamine-Dependent GlnB 
Signalling. Microbiology. 149, 2163-2172. 
 
 
 237
 
[113] Perlova, O.; Ureta, A.; Nordlund, S.; Meletzus, D. (2003) Identificaiton of Three 
Genes Encoding PII-Like Proteins in Gluconacetobacter diazotrophicus: Studies of Their 
Role(s) in the Control of Nitrogen Fixation, J. Bac. 185, 5854-5861. 
 
[114] Mann, M.; Hendrickson, R. C.; Pandey, A. (2001) Analysis of proteins and 
proteomes by mass spectrometry. Annu. Rev. Biochem. 70, 437-473. 
 
[115] LeDuc, R. D.; Taylor, G.K; Kim, Y. B.; Januszyk, T. E.; Bynum, L. H.; Sola, J. V.; 
Garavelli J. S.; Kelleher, N. L  (2004)  ProSight PTM: an integrated environment for 
protein identification and characterization by top-down mass spectrometry. Nucleic Acids 
Research. 32, W340-W345. 
 
[116] Holmes, M. R.; Giddings, M. C. (2004) Prediction of Posttranslational 
Modifications Using Intact-Protein Mass Spectrometric Data. Anal. Chem. 76, 276-282 
 
[117] Narasimhan, C.; Tabb, D. L.; VerBerkmoes, N. C.; Thompson, M. R.; Hettich, R. 
L.; Uberbacher, E. C. (2005) MASPIC: Intensity-based tandem mass spectrometry 
scoring scheme that improves peptide identification at high confidence. Anal. Chem. 77, 
7581–7593. http://compbio.ornl.gov/MASPIC/] 
 
[118] Tabb, D.L.; Narasimhan, C.; Strader, M.B.; Hettich, R.L. (2005) DBDigger: 
Reorganized proteomic database identification that improves flexibility and speed. Anal. 
Chem. 77, 2464-74. 
 
 
[120 ] Hardy, S.J.S.; Kurland, C.G.; Voynow, P.; Mora, G. (1969) Ribosomal proteins of 
Escherichia coli .I. Purification of 30S ribosomal proteins. Biochem. 8, 2897. 
 
 
[121] Verberkmoes, N.C., et al. (2006) Determination and comparison of the baseline 
proteomes of the versatile microbe Rhodopseudomonas palustris under its major 
metabolic states. J. Proteome Research. 5, 287-298. 
 
[122] Dixon, R.; Kahn D. (2004) Genetic regulation of biological nitrogen fixation. Nat. 
Rev. Micro. 2, 621-631. 
 
[123] Connelly, H.M.; Pelletier, D.A.; Tse-Yuan, Lankford, P.K.; and Hettich, R.L. 
(2006) Characterization of GlnK and GlnB Uridylylation in Response to Nitrogen 
Availability for Rhodopseudomonas palustris.  Analytical Biochemistry, Accepted, In 
Press.  
 
[124] Bendtsen J.D.; Nielsen H.; von Heijne G.; Brunak S. (2004)  Improved prediction 
of signal peptides: SignalP 3.0. J Mol Biol. 340, 783-95. 
 
 
 238
 
[125] Hiller K.; Grote A.; Scheer M.; Munch R.; Jahn D. (2004)  PrediSi: prediction of 
signal peptides and their cleavage positions. Nucleic Acids Res. 32, W375-9. 
 
[126] Gardy JL, Laird MR, Chen F, Rey S, Walsh CJ, Ester M, Brinkman FS. (2004) 
PSORTb v.2.0: expanded prediction of bacterial protein subcellular localization and 
insights gained from comparative proteome analysis. Bioinformatics. 21, 617-23.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 239
 
Vita 
 
Heather Marie Connelly was born in Atlanta, Georgia on Decermber 5th 1977.  
She grew up in the small town of Jasper, Georgia with her parents, sister, and brother, 
where she graduated from Pickens County High School, as an honor student, in 1996.  
She received her Associate of Natural Science from Reinhardt College in 1998 and 
further received a Bacelor of Science degree in Chemistry and Biology from Shorter 
College in 2000.  Heather pursued and recived a Master of Science degree in Biology 
from the State University of West Georgia under the direction of Dr. Leos Kral in 2002. 
Her thesis work was entitled the “Genetic Population Structure of the Tallapoosa Shiner”.   
 She enrolled in the University of Tennessee-Oak Ridge National Laboratory 
Graduate School of Genome Science and Technology in 2002 to pursue her doctorate in 
Life Sciences.  She graduated with a Ph.D. in 2006.  She moved to Atlanta in 2006 and is 
pursuing research options. 
 
